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Abstract 
 
Ruthenium polypyridyl complexes have been under extensive 
investigation for many years across a range of optical applications, from solar 
energy conversion to sensing due to their unique photophysical properties 
including intense polarised luminescence, large Stokes shifts, red emission 
wavelengths, and good photostability.  These properties, along with the sensitivity 
of their luminenscene to molecular oxygen make them potentially invaluable 
probes for cellular imaging.   
 
This thesis describes the study of cell uptake and luminescence and 
resonance Raman imaging of a novel Ru(II) polypeptide conjugate and  attempts 
to attach an internal oxygen and pH insensitive reference to a related 
luminescent ruthenium complex to create a self-referenced probe. 
 
Chapter 1 overviews the photophysics of ruthenium polypyridyl complexes 
and discusses current state of the art in their application to cellular imaging.  In 
particular, we discuss how conjugation of these complexes to biomolecules has 
lead to more targeted and improved applications in medical diagnostics, 
photodynamic therapy and cellular imaging.  Chapter 2 describes the 
experimental methodology used in this thesis.   
 
Chapter 3 described the synthesis and photophysical characterisation of 
two novel ruthenium probes, [Ru (NO2phen)2 picCOOH]
2+ 
and [Ru (NO2phen)2 
picNH2]
2+
, where NO2phen is 5-nitro-1,10-phenanthraline and the pic ligands are 
2-(4-Carboxylphenyl)imidazo [4,5-f]1,10-phenanthroline and 2-(4-
Aminophenyl)imidazo[4,5-f]1,10-phenanthroline respectively.  Both the carboxyl 
and amino functionalised nitrophenanthroline complexes behave very similarly 
and may be characterised by comparable absorbance, emission, Raman profiles 
and similar pH dependence.  These complexes exhibited a Stokes‟ shift of over 
150 nm as well as having long lived emission lifetime (over 400 ns) which make 
them potential candidates for cell imaging.  In the latter part of this chapter 
attempts to conjugate these complexes to a reference probe are described. The 
ultimate goal of attaching both to a cell penetrating peptide and an internal 
reference proved unsuccessful despite numerous different attempts, and this 
 VIII 
chapter concludes with a discussion of a different synthetic approach which may 
ultimately lead to the target complex.   
 
Chapter 4 described the ability of a novel ruthenium – peptide conjugate to 
transport passively and irreversibly across the cellular membrane of mammalian 
SP2 and CHO cells.  Using confocal microscopy, by comparison, the parent 
complex was found not to transport across the cell membrane, confirming it is the 
peptide which is behaving as a cargo carrier in this instance.  Resonance Raman 
mapping was used to investigate the presence of the complex within both cell 
types, by analysing individual cells.  The most intense Raman signals, 
corresponding to the greatest concentration of dye, were observed in the center 
of each cell.  The localization of the dye within SP2 cells was not confirmed via 
co-localization studies, but it was found to localize in the endoplasmatic reticulum 
of CHO cells.  
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1.1 Ruthenium (II) Polypyridyl Complexes 
 
1.1.1 Introduction to Molecular Photophysics 
 
Luminescence is the emission of light from a molecule as it deactivates 
from an electronically excited state. This process is typically instigated following 
the absorption of a photon which leads to the promotion of a ground state 
electron to a higher – lying orbital.  The excited molecule is generally not a stable 
species and will seek to relax to ground state through radiative or non – radiative 
pathways or by undergoing a chemical transformation. Figure 1.1 shows the 
typical deactivation pathways available to an excited state molecule. 
 
 
     Luminescence 
 
           non – radiative decay 
 
M + h   M* 
 
        quenching 
 
    Primary photochemical product 
 
 
Figure 1.1 Typical excited state deactivation pathways 
 
Figure 1.2 shows a Jablonski diagram which illustrates the competing 
photophysical processes by which the molecule may lose its excess energy in 
returning back to its original ground state energy level. When a molecule absorbs 
a photon of light, a fluorophore is promoted from its ground state to a higher 
vibronic level.  
 
Depending on the nature of the excited state, radiative decay 
(luminescence) occurs as either fluorescence or phosphorescence; other non 
radiative processes are also possible.  All are described below. 
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Figure 1.2: Jablonski diagram illustrating the radiative and non-radiative 
processes involved in the absorption and resultant relaxation of a molecule 
following excitation by a photon of light energy 
[1] 
 
 
Fluorescence: Emission of a photon from one electronic state to a state of 
the same multiplicity.  Figure 1.2 shows this process in solution typically occurs 
from the first singlet excited state to the ground state (i.e.. S1  S0).  The excited 
molecule rapidly relaxes to the lowest vibrational state of S1.  The lifetime of this 
emission is usually very short, of the order of 10
-8 
s.  Fluorescence generally 
occurs from a thermally equilibrated excited state, that is, the lowest energy 
vibrational state of S1.  The excited electron is paired to the second electron in 
the ground state orbital by opposite spin.  This rapid return to the ground state is 
spin – allowed. 
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Phosphorescence: Emission of a photon as the electron moves between 
states of different multiplicity (e.g. T1  S0) is known as phosphorescence.  The 
electron in the excited state has parallel spin to the ground state () or () and 
is spin forbidden however phosphorescence can be promoted in the presence of 
heavy atoms by spin orbit coupling.  These forbidden transitions give slow 
emission decay rates (10
-3
 to 10
-1
s), i.e. several orders of magnitude smaller than 
those for fluorescence.
2
  As shown in the Jablonski diagram (Figure 1.12) and 
stated in Hund‟s rule: a singlet state (e.g. S1) will be of higher energy than a triplet 
state (e.g. T1) in the same configuration.  Phosphorescence will occur at lower 
energy and therefore longer wavelength than fluorescence from a given 
molecule.  
 
Internal Conversion: The non – radiative transition between electronic 
states of the same multiplicity (S2  S1) is known as internal conversion.  This is 
an isoenergetic crossover between vibronic states which is followed by rapid 
vibrational relaxation to the lowest vibrational level of S1.  This process generally 
occurs on a 10
-12
 scale, hence typically occurs prior to emission as fluorescence 
lifetimes are of the order of 10
-8 
s.  
 
Intersystem Crossing: The non – radiative, isoenergetic transition between 
vibronic states of different multiplicity (S1  T1) is known as intersystem crossing 
(ISC).  This transition can occur from any singlet state and leads, following 
vibrational relaxation, to population of the lowest excited triplet state (T1).  This 
spin forbidden process is promoted in the presence of heavy atoms by spin orbit 
coupling.  
 
  
 5 
1.1.2 Quantum Yield (Φ) and Lifetime (τ) 
The fluorescence lifetime and quantum yield are two key characteristics of 
a fluorophore.
[2]
  Quantum yield (f) is defined as the number of photons emitted 
relative to the number of photons absorbed.  The lifetime is important, as it 
determines the time available for the fluorophore to interact with or diffuse in its 
environment, and hence the information available from its emission.  It is defined 
as the time taken for the luminescence intensity to decay, following excitation to 
1/e
th
 of its initial intensity.  These parameters can be measured and used to 
provide insight into the relaxation processes of a molecule arising from its return 
to the ground state and can be determined by the emissive rate of the 
fluorophore ()  and its rate of non – radiative decay to the ground state (knr).  
The fluorescent quantum yield as shown in equation 1.1 reflects the fraction of 
fluorophores that decay through emission: 
 
         f   =  
nrr
r
kk
k

       eqn 1.1 
 
If the rate of non-radiative relaxation (knr) is faster than that of 
luminescence (kr), the quantum yield will be small and vice versa. Luminescent 
quantum yields can be close to unity if the radiationless decay rate is much 
smaller than the rate of radiative decay, that is knr < .  However due to 
vibrational/thermal losses, the energy yield of fluorescence is always less than 
unity.  The luminescent quantum yield is a key parameter in calculating 
quenching rate constants, energy transfer rates and radiative and non-radiative 
decay rate constants.
[3]
  The excited state lifetime of a fluorophore () is defined 
as the average time the molecule spends in the excited state prior to relaxation to 
the ground state.  Shown in equation 1.2 is the fluorescence lifetime of a 
molecule. 
    = 
nrr kk 
1
      eqn 1.2 
Fluorescence emission is a random process and few molecules emit their 
photons at precisely t = ,  the difference between the natural and measured 
lifetime 
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Emission lifetimes and emission quantum yields provide a convenient 
means of measuring the unimolecular phototransitions expected to occur in a 
molecule including internal conversion (IC), intersystem crossing (ISC), 
fluorescence (F) or phosphorescence (P).  Shown in equation 1.3 is the steady – 
state approximation for the concentration of the first excited singlet energy state 
[S1], which assumes that the rate of absorption of light is equal to the combined 
rates of deactivation of S1.   
 
   Iabs = (kIC  + kISC  + kF)  [S1]      eqn 1.3 
 
 The ruthenium complexes in this thesis deal with phosphorescence, which 
occurs from the triplet state [T1].  Shown in equation 1.4 is the steady – state 
approximation for the process which assumes that the rate of formation of triplet 
states is equal to their rates of deactivation. 
 
   KISC [S1]   = (kISC   + kP)   [T1]      eqn 1.4 
 
 For phosphorescent complexes under steady – state conditions, the 
quantum yield of key processes can be described as the ratio of the decay rates 
to the total deactivation rates of that state.  Shown in equation 1.15 is the 
expression of the quantum yields for these transitions. 
 
IC = kIC    /   (kF + kISC + kIC)                eqn 1.5 
   ISC = kISC   /   (kF + kISC + kIC)     eqn 1.6 
   P = ISC  x  kIC  /  (kP  + kISC)     eqn 1.7 
 
 The quantum yield can also be related to the lifetime () of the complex.   
As shown in equation 1.8, the singlet lifetime (s) is equal to the inverse of 
the sum of all rates that deactivate [S1].  It is important to note that these 
expressions assume that the only deactivating processes are the radiative and 
non-radiatiave photophysical pathways. 
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The triplet lifetime (T) is equal to the inverse of the sum of the rates that 
deactivate the energy level [T1] and is shown in equation 1.9. 
   s = 1   /  (kF + kISC + kIC)     eqn 1.8 
   T = 1   /    (kP  + kISC)      eqn 1.9 
 
Therefore, the expression of key quantum yield states may be defined 
from the following three equations. 
 
IC = (kIC)   (s)                  eqn 1.10 
   ISC = (kISC) (s)       eqn 1.11 
   P = (ISC) (kP) (T)       eqn 1.12 
 
 Experimentally, values of s and T may be evaluated directly by 
measurement of the decay of [S1] and [T1] as a function of time.  The most 
convenient method to monitor [S1] is usually by measuring the fluorescence 
intensity emitted from [S1].  Hence, s is generally the same as the measured 
fluorescence lifetime, F, but the measured values do not provide information on 
the pure radiative lifetime of fluorescence from the singlet energy state.  
However, measurement of the phosphorescence lifetime, P, provides a direct 
measure of the excited triplet energy state, T, as shown in equation 1.12.
[3]
   
 
 The fluorescence yield f and singlet lifetimes s of organic molecules are 
sometimes found to vary with temperature.
[1]
  An increase in temperature typically 
leads to a decrease in both the quantum yield and lifetime of a molecule as non-
radiative decay  through  such  as  vibrations,  rotations  and  collisions  become  
more  likely.  The population of the geometrically distorted 
3
MC states are 
thermally induced in ruthenium polypyridyl complexes, which can lead to 
decomposition of the complex, depending on the s-donor ability, i.e. ligand field 
splitting of the coordinating ligands.
[4, 5]
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1.1.3 Photophysics of Ruthenium (II) Polypyridyl Complexes 
 
Ru(II) is a d
6
 transition metal where the polypyridyl ligands usually have σ 
donor orbitals on the nitrogens and π donor and π *acceptor orbitals are 
delocalised on the aromatic rings
[6]
.  Shown in figure 1.3 is [Ru(bpy)3]
2+
 (where 
bpy = bipyridine), one of the most widely studied of ruthenium polypyridyls.   
 
N
N
Ru
N
N
N
N
2+
 
Figure 1.3: structure of [Ru(bpy)3]
2+
 
 
Figure 1.4 shows the molecular orbital diagram for an octahedral metal 
complex, Ru(II) polypyridyl complexes can be considered as pseudo-octahedral.  
 
Ruthenium polypyridyl complexes display intense absorption bands in the 
visible and near IR regions of the electromagnetic spectrum.  These absorbance 
bands are typically assigned to electronic transitions such as metal centred (MC), 
ligand centred (LC) or charge transfer (CT).  In general, the L and L ligand 
orbitals are full for d
6
 complex ground states.  Depending on the oxidation state of 
the metal, the M orbitals are partially filled and the remaining orbitals are usually 
empty.   
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Metal - centred transitions involve the molecular orbitals which are mainly 
composed of the central metal d-orbitals and their wavelength commonly 
corresponds to the wavelength of visible light.  d-d transitions in octahedral 
complexes involve a rearrangement populating the low-lying t2g orbital to the eg 
orbital.  Ligand centered transitions such as p-p transitions occur at higher energy 
than metal centered and charge transfer transitions.  Metal to ligand charge 
transfer (MLCT) is a common transition observed in Ru(II) complexes 
coordinated to organic ligands, such as polypyridyl derivatives and involves 
promotion of electrons from the highest occupied molecular orbital (HOMO) to the 
lowest unoccupied molecular orbital (LUMO)
[7]
.  
 
The multiplicity of each of the resulting excited states may be singlet or 
triplet, although spin – orbit coupling causes singlet – triplet mixing in metal 
centred complexes and results in the formation of 
3
MLCT excited states in Ru(II) 
complexes.
[8]
   
 
Metal orbitals       Ligand orbitals 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: Molecular orbital diagram for an octahedral metal complex. The 
arrows indicate the four types of transitions based on localized MO 
conﬁgurations[4]. 
 
As previously mentioned, [Ru(bpy)3]
2+
 is one of the most widely studied of 
the ruthenium polypyridyls, with extensive research into the molecule‟s 
photophysical and redox characteristics found in the literature.
[4, 5, 8, 9]
  It has been 
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commonly used as a reference to explain similar processes occurring in other 
ruthenium(II) complexes
[9]
 and is used to rationalise the behaviour of the 
ruthenium(II) complexes studied in this thesis.  Shown in figure 1.4 is the typical 
absorbance and emission spectra for [Ru(bpy)3]
2+
 in acetonitrile solution. 
 
 
Figure 1.4: Absorbance and emission spectra of [Ru(bpy)3]
2+
 (10M) in 
acetonitrile solution. 
 
 The absorbance spectrum of [Ru(bpy)3]
2+
 exhibits a characteristic 
ruthenium (d orbital) to bipyridyl ligand (* orbital) metal to ligand charge 
transfer (MLCT) at 455 nm.  An additional MLCT transition occurs at higher 
energy at 240 nm.  There are two shoulders present at 322 nm and 342 nm 
which are not incontrovertibly assigned but are thought to be due to MC d → d 
transitions.  The strong absorbance at approximately 285 nm in the spectrum
 
is 
assigned to π-π* transitions within the bipyridyl ligands.   
 
Excitation into the MLCT at 455 nm of the [Ru(bpy)3]
2+
 absorption band 
leads to an intense emission at approximately 610 nm which originates from a 
triplet MLCT state.   Inter-system crossing is promoted by the heavy Ru nucleus 
in this complex and occurs with unity quantum yield. 
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1.1.4 Ruthenium complexes with pH Sensitive Ancillary Ligands 
 
 Quaranta et al.
[10]
 have previously shown that the ionisation state of a 
benzimidazole group in a ruthenium complex can modify its luminescence 
behaviour.  More recently however, the ionisable Pic ligand has been the focus of 
much interest when it has been coordinated to a ruthenium metal centre.
[11-13]
  
Shown in figure 1.5 below, is the structure of 2-(4-
nitrophenyl)imidazo[4,5f][1,10]phenanthroline) [(picNO2)], a common Pic – ligand.  
The ligand possesses two ionisable sites: each nitrogen atom located on the 
imidazole ring.  These sites give rise to well defined acid-base characteristics and 
the terminus can be designed with a functionality that allows for efficient 
conjugation to biomolecules such as polypeptides.  In this thesis, a range of Pic 
ligands have been synthesised to contain carboxyl, amino and nitro terminals and 
a photophysical comparison of their Ru(II) complexes is detailed and discussed in 
chapter 4. 
 
 
 
Figure 1.5: ionisable sites on 2-(4-Nitrophenyl)imidazo[4,5-f]1,10-phenanthroline 
[PicNO2] ligand. 
 
 
 
Pic ligands are of particular interest in relation to transition metals 
complexes, as when coordinated to a metal centre they display longer lifetimes 
and increased emission intensity, than their trisbipy derivatives.  As these ligands 
are sensitive to their environment, they are potentially invaluable for probing 
complex biological structures.  Neugebauer et al.
[12]
 reported how intracellular pH 
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had a direct effect on both the lifetime and relative Raman peak intensities of the 
ruthenium(II) multimodal probe, containing this pH sensitive ancillary ligand, and 
is described further in section 1.3.  This thesis heavily features ruthenium 
polypyridyl complexes with pH sensitive ancillary ligands and their photophysics 
are characterised in chapter 4. 
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1.2 Polypeptides as Suitable Transmembrane Transporters 
 
1.2.1 Cell Penetrating Peptides 
 
Peptides are biopolymers of amino acids which are linked through a 
peptide bond.  A peptide bond, often referred to as an amide bond, is formed 
through the reaction of a carboxyl group of one molecule with the amino group of 
another molecule.  This process is a condensation reaction as it leads to a loss of 
a water molecule and usually occurs between amino acids.  Polypeptides are 
chains of amino acids which are held together by peptide bonds and are utilised 
in this thesis for the transport of novel probes across a cell membrane.  Shown in 
figure 1.6 is the schematic representation of a peptide bond formation.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6: Peptide bond formation from the dehydration (condensation) reaction 
of glycine and aniline. 
[14]
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A key aim of this thesis was to synthesise a transport carrying molecule 
which was capable of passive cell delivery, by the conjugation of a luminophore 
to a cell penetrating peptide.  Certain naturally occurring molecules may enter the 
cell through a facilitated transport pathway mediated by receptors on the cell‟s 
surface.  The nuclear transcription activator protein Tat is a protein which is 
encoded for by the Tat gene in HIV-1 and is an example of such a molecule.
[15]
  
Arginine is a commonly occurring, non – essential amino acid, meaning it can be 
produced in the body.  It is cationic in nature, even under biological conditions, 
due to the presence of a guanidinium group which allows the peptide to form 
bidentate hydrogen bonds with anions such as phosphate.
 [16, 17]
  Previous studies 
by Wender.
[15]
 demonstrated the importance of the guanidinium groups, as 
changing the cationic groups with neutral alanine residues led to a decrease in 
the cellular uptake which correlated directly with the number of arginine residues.   
 
These results led to extensive research into polyarginine peptides as cell 
penetrating molecular cargo carriers.  The number of guanidinium groups, and 
therefore overall polyarginine chain length greatly affects the ability of these 
peptides to diffuse across the cell membrane.  The most efficient uptake was 
found in peptides with chain lengths ranging from R6 – R11.  Polyarginine 
molecules with a chain length of less than six, show no significant uptake, while 
chain lengths exceeding eleven arginine groups show no increase in uptake.
[15, 18]
  
Shown in Figure 1.7 is  the structure of an arginine molecule with guanidinium 
highlighted in red. 
 
 
 
 
 
 
 
Figure 1.7: Arginine Structure ( (S)-2-Amino-5-guanidinopentanoic acid) with 
guanidinium group highlighted in red 
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The  four  main  routes  to  cellular  uptake  are  endocytosis,  active  
transport, facilitated diffusion and passive diffusion.
[19]
  Endocytosis is thought to 
involve the cell membrane wrapping itself around the extra-cellular peptide and 
engulfing it.  The peptide is then brought into the cell via small vesicles.  Shown 
in figure 1.8 are the various endocytosis pathways.   
 
Phagocytosis is the process where a cell membrane will change its shape 
to engulf particle solids to form an internal vesicle around the particle, known as a 
phagosome. The process is distinct from other forms of endocytosis as it is 
specific to the internalization of solids such as bacteria, as opposed to other 
processes which may internalize various liquids.  In the human body, 
macrophages and neutrophils are two of the most effective phagocytic cells, 
where they are drawn toward an area of infection or inflammation by means of 
chemoattractants given off by the bacteria and the infected tissue. 
 
Pinocytosis is another form of endocytosis where the plasma membrane 
forms an invagination and whatever substance is found within the area of 
invagination is brought into the cell‟s cytoplasm by tiny vesicles.  This process is 
not involved in the ingestion of larger particulate material and is often referred to 
as “cellular drinking” as the materials ingested by the cell are liquids and material 
dissolved in liquids.   
 
Receptor mediated endocytosis is a process by which cells internalize 
molecules or viruses. As its name implies, it depends on the interaction of that 
molecule with a specific binding protein in the cell membrane called a receptor. 
These receptors are brought into the plasma membrane by vesicles from the 
Golgi apparatus. After binding an endocytotic process occurs as a signal is sent 
through the membrane, leading to membrane coating, and formation of a 
membrane invagination.  The molecule is then ingested by the cell.  The protein 
involved in this process is the cytosolic protein clathrin, which contains receptor 
sites specific to the molecules being internalized.
[20]
   
 
 16 
 
Figure 1.8: Schematic diagram of the various endocytosis pathways
[21] 
 
Electrostatic attraction is the first process in which the highly positively 
charged polypeptides are attracted to the negatively charged phosphate groups 
at the cell phospholipid membrane.  Electrostatic attraction across the cell 
membrane draws some of the positive ions on the outside and some of the 
negative ions on the inside to the respective surfaces of the membrane.  Heparan 
sulfate proteoglycan (HSPGs) located on the cell membrane then binds to these 
peptides and modulate Heparan sulphate mediated endocytosis. 
Macropinocytosis is reported as one of the major pathways of uptake for arginine 
rich peptides.
[22, 23] 
 
It is widely believed that endocytosis is the most likely mechanism of 
cellular uptake of arginine rich cell penetrating peptides as results have shown 
the process to be temperature and therefore, energy dependent which is 
indicative of endocytosis.
[12, 22-24]
  Fuchs et al.
[23]
 have previously reported the 
internalisation of a fluorescein labelled polypeptide by entocytoic means.  
Examining the internalization pathway of penetrating peptide into mammalian 
cells, nonaarginine was found in the cytosol as well as the nucleolus when cells 
were fixed, but observed only in the endocytic vesicles of live cells.  
Colocalization studies with vesicular markers confirmed the peptide was 
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internalized by endocytosis rather than passive diffusion across the plasma 
membrane.   
Pellegrin
[11]
 described the extensive photophysical characterisation of the 
ruthenium(II) polypyridyl complex, [Ru(bpy)2(picCOOH)]
2+
, containing a pH 
sensitive ancillary ligand.  With the aim of exploiting the acid – base 
characteristics of this molecule for the exploration of cellular environments, the 
complex was subsequently conjugated to a polypeptide.  Neugebauer
[12]
 
subsequently advanced this work by conjugating the pH sensitive probe to a cell 
penetrating peptide. Shown in figure 1.24 is a flow chart which depicts the uptake 
of the complex and its subsequent activity in a cellular environment.  Consistent 
with endocytosis, the transport of the peptide conjugated dye across the cell 
membrane was found to be temperature dependent.
[23]
  The use of this complex 
and other ruthenium probes in a cellular environment is discussed in further detail 
in section 1.3.1 below. 
 
 
Figure 1.9: Flow diagram illustrating the cellular uptake and determination of 
intercellular pH (using Raman spectroscopy) and oxygen levels (using lifetimes) 
using the ruthenium (II) polypyridyl complex, [Ru(bpy)2(picCOOH)]
2+
.
[25]
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 As endocytosis is thermally activated process, its efficiency is hindered at 
lower temperatures, for example 4°C instead of 37°C.  It has been previously 
shown that in many systems endocytosis does not occur below 10°C.  However, 
internalization of polypeptides has been reported at 4°C, where endocytic 
pathways do not function.  A temperature independent pathway would suggest an 
uptake mechanism such as passive diffusion, which is energy independent, and 
in some examples both temperature dependent and independent pathways have 
been seen to co-occur.
[24, 26] 
 
Knipp et al.
[27]
 have described hydrophobic peptides that are capable of 
permeating heterogenous human epithelial cells via passive diffusion.  These 
peptides are more lipophilic when they exhibit significant beta – turn structure in 
solution which causes them to permeate the cell more readily.   
 
Figure 1.10 illustrates an alternative mechanism which has been proposed 
for polyarginine uptake, called the translocation mechanism of polypeptides 
across the cell membrane via non-endocytotic pathways.
[28]
  In this mechanism, 
the P – N dipole vector is in the plane of the membrane as shown in Figure 1.10 
(a).  Figure 1.10 (b) then illustrates the how the dipole bends towards the interior 
of the membrane when the peptide attracts the phosphate groups as it 
approaches the surface of the membrane.  As this conformation is not favoured 
by the system, the peptide inserts into the interface between the hydrophilic head 
groups and the carbon chains.  Figure 1.10 (c) shows how the peptide orients 
away from the choline groups.  The cell membrane then becomes thinner as the 
density of the peptide increases, as illustrated in Figure 1.10 (d).  The next stage 
of the process (Figure 1.10 (e)) involves translocation of an arginine amino acid 
with local bending of the membrane on both sides of the bilayer.  This bending 
reduces the energetic barrier of the translocation.  The final step in the 
mechanism is shown in Figure 1.10 (f) which illustrates the formation of a pore 
and the peptide translocates, bound to the interior of the bilayer surface. 
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Figure 1.10:  Schematic diagram illustrating qualitatively the steps involved in the 
translocation mechanism.  The orientation of the dipole moment vector formed by 
the phosphate group (negatively charged) and the choline group (positively 
charged) denoted by P and N, respectively is shown.
[28]
  
 
 Despite endocytosis being widely believed to be the most likely 
mechanism of cellular uptake of cell penetrating peptides, evidence of passive 
(unactivated) diffusion and translocation methods of cellular uptake as potential 
uptake routes means the topic is still hotly debated.  As the process has been 
demonstrated to be temperature and energy dependent, endocytosis seems a 
likely uptake mechanism.  However, no method or process has been conclusively 
proven or universally accepted.  Nonetheless, the results discussed suggest that 
polyarginine is very effective as a transmembrane molecular cargo carrier. 
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1.3  Metal Complexes as Bioanalytical Probes 
 
 Traditional organic probes used for diagnostic purposes have a number of 
limitations which reduce their suitability as probes for bioanalysis.  Typically, 
organic fluophores have short-lived excited state lifetimes (<10 ns) and are 
susceptible to photobleaching when used in laser scanning microscopy.  Such 
probes are also not suitable for resonance Raman as their relatively small 
Stoke‟s shift means ﬂuorescence overwhelms the weaker Raman response.[13]  
Short lived probes are also unable to monitor important long lived biomolecular 
processes such as membrane diffusion, protein rotation and protein folding.   
 
Overall, in order for a luminophore to be a suitable candidate for exploring 
a cellular environment it must be photostable, have a high quantum yield, be 
relatively non – toxic, cell permeable and have visible to near IR emission. 
 
 Many transition metal complexes offer numerous advantages over such 
organic fluorphores and have been exploited in cellular imaging,
[11]
 diagnostics,
[5]
 
and supramolecular assemblies
[29, 30]
 in recent years.   Lo
[31]
 have previously 
described a series of luminescent cyclometalated iridium(III) polypyridine 
complexes which exhibit a triplet metal-to-ligand charge-transfer (
3
MLCT) 
emission.  Shown in figure 1.31 is the absorbance (a) and emission (b) spectra of 
a range of iridium (III) complexes.  As with many transition metal complexes, 
these Ir (III) luminophores exhibit significant flexibility where by changing the 
ligands the absorbance and emission characteristics of the complex can be 
tuned.   
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Figure 1.31: Structures of a series of iridium (III) polypyridine complexes with 
varying polpyridine ligands; electronic absorption spectra (a) and emission 
spectra (b) of a range of these complexes in CH2Cl2 at 25°C.
[31]
 
 
 
 A key objective of this thesis was to examine the cellular uptake, including 
the uptake speed, transport mechanism and localization, of a peptide conjugated 
ruthenium probe in two mammalian cell lines.  The conjugation of a metal 
complex to a cell penetrating peptide facilitates efficient diffusion across 
mammalian cell membranes without destroying the lipid bilayer and without the 
need for membrane permeabilisation by artificial means such as detergent or 
organic solvent.  The ability of a peptide conjugated ruthenium complex to 
penetrate mammalian cells was investigated using mouse Sp2/0-Ag14 myeloma 
cells.  The myeloma is a cancerous plasma cell and was used as a model of a 
suspension mammalian cell.   
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Many transition metal complexes, containing ruthenium(II), osmium(II) or 
rhenium (I) with diimine ligands show characteristically long emission lifetimes 
(up to and beyond 1 µs) and can be synthesized to target key biological sites.  
One promising advancement involving a transition metal complex in cellular 
imaging is the recently reported synthesis of a zinc(II) complex containing 
Triapine.   Shown in figure 1.31 is the structure of Triapine (3-aminopyridine-2-
carboxaldehyde thiosemicarbazone), which is a a potent inhibitor of 
ribonucleotide reductase, the rate determining enzyme in the supply of DNA 
building blocks.   
 
N
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Figure 1.31: Structure of Triapine and coordinated zinc complex
[32] 
 
 Coordination of the Triapine unit to a zinc(II) metal centre was found to 
increase the antineoplastic activity.  Shown in figure 1.32 are live cell images of 
human colon carcinoma cells incubated with Triapine and the zinc(II) coordinated 
complex; the Zn (II) complex is shown to display selective affinity for the nucleoli 
of the cells.  The false colour images in figure 1.32 (A) and (B) illustrates that the 
Triapine molecule and its Zn(II) complex localize to different areas of the cell.  Co 
– localization studies using nucleolar protein fibrillarin shown in figure 1.32 (C) 
and (D) illustrate the preferential selectivity of the Zn(II) complex toward the 
nucleoli of the cells.
[32] 
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Figure 1.32: False colour images (A and B) of human colon carcinoma cells 
incubated with Triapine (0.25 mM) in PBS and Zn (II) Triapine complex (0.25 mM) 
in 0.5% DMSO/PBS; luminescence images (C and D) using nucleolar protein 
fibrillarin as a counter stain with Zn (II) Triapine complex (0.25 mM) in 0.5% 
DMSO/PBS.
[32]
 
 
In another very recent study, Lo
[33]
 reported on rhenium(I) complexes as 
novel trifunctional biological probes capable of bioconjugation and intracellular 
detection.  The emission behaviour and cellular uptake properties of many 
luminescent rhenium (I) complexes have been reported in the literature
[34]
, shown 
in figure 1.33 are novel trifunctional biological probes which were synthesised 
containing a ﬂuorous moiety.   
 
Figure 1.33: Structure of three rhenium (I) polypyridine complexes.
[33]
 
 
The cellular uptake of the thiourea complex (3) in HeLa cells was 
examined using live–cell confocal imaging.  As shown in figure 1.34, the complex 
was found to transport readily across the membrane and localize in the 
juxtanuclear region at 37°C, however uptake at 4°C led to less efficient uptake.  
This is evidence of uptake occurring through an energy dependent pathway such 
as endocytosis.  Although not discussed in the paper, it is important to note that 
the Re(I) complex was incubated with 1% DMSO prior to imaging and that will 
have permeabilized the cell membrane making it difficult to assess if the 
compound is truly membrane permeable or to conclude anything about the 
uptake pathway.  
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Organic  solvents,  such  as  DMSO  and ethanol, are frequently used in 
cellular uptake analysis.  While DMSO is not toxic at this concentration, it causes 
the cell membrane to become less ridged, making it more susceptible to facilitate 
membrane diffusion.
[46]
  DMSO will also permeabilize cells, meaning the dye is 
not penetrating a healthy cell membrane.
[47, 48] 
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Figure 1.34: Luminescence images (ex = 405 nm) of HeLa cells incubated with 
[Re(Me2bpy)(CO)3((py-Rf-TU-C2H5))](PF6)  (5 M) in 1% DMSO at 37°C (A) and 
4°C (B).
[33] 
 
The punctuate emissive dots displayed in figure 1.34 were investigated 
further, as their proximity to the nucleus suggested they may be mitochondria.  
To confirm this, HeLa cells were counter – stained with MitoTracker Deep Red 
FM and examined using confocal microscopy, which is shown in figure 1.35.  As 
is evidence from the significant overlap, the complex is found predominantly in 
the mitochondria of HeLa cells incubated at 37°C.  The cationic charge of the 
complex, combined with it being highly hydrophobic in nature, is responsible for 
the mitochondrial – targeting properties of the complex.[35] 
 
Figure 1.35: Luminescence confocal images  (ex  =  405  nm, (a); (ex  =  633  
nm, (b)) of HeLa cells incubated with [Re(Me2bpy)(CO)3((py-Rf-TU-C2H5))](PF6)  
(5 M) in 1% DMSO for one hour (a) at 37°C and MitoTracker Deep Red FM (100 
nM) for 20 minutes (b). Images are overlaid in (c). 
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Of the complexes synthesised, isothiocyanate complex (2) has been used 
to label bovine serum albumin (BSA) and glutathione (GSH).  The complex may 
also be separated from a mixture of 20 amino acids using Fluorous Solid Phase 
Extraction (FSPE).
[35]
  Investigation into the cytotoxicity of the amine complex (1) 
and the thiourea complex (3) was carried out using the MTT cell viability assay 
with HeLa cells as a model cell line.  While both complexes were found to have 
high cytotoxicity (similar to related rhenium (I) complexes), their cytotoxicity can 
be readily modified with a choice of ligands with different lipophilicity.   
 
While these novel trifunctional biological probes offer new and unique 
properties, it is noted that the isothiocyanate complex was omitted from the MTT 
assay because it is unstable in aqueous solution.  The use of DMSO in a cellular 
environment raises doubts over the permeability of the cell and hence the 
suitability of the complex to live – cell imaging. 
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1.3.1  Use of ruthenium complexes in cellular imaging 
 
The biological activity of ruthenium complexes has been of interest since 
the 1950‟s, when a range of tris (polypyridyl) complexes were found to have 
bacteriostatic and anti – viral activities.[36]  More recently, two ruthenium(II) 
anticancer drugs (NAMI-A and KP1019) have reached clinical trials.
[37,38]
  Several 
complexes were also shown to induce mitochondria mediated apoptosis in 
human cancer cells and interestingly display a lower toxicity than many traditional 
cisplatin based cancer treatments.
[7]
   
 
These probes have also been utilised in protein hydrodynamics, where 
[Ru(bpy)2L]
2+
 and [Ru(dpp)2L]
2+
 based probes to explore the binding of an 
antibody to ruthenium-labelled HSA and their conjugation to immunoglobulins,  
ferritin, concavilin A, and plasmid DNA.
[39-41]
  Very recently a ruthenium complex 
conjugated to estradiol was shown to be cell permeable, attributed to the 
lipophilicity of the steroid pendant.
[42]
  Ruthenium(II) complexes have been used 
surprisingly little in biophotonics, given their optical and photophysical properties.  
In the past five years, ruthenium complexes have been utilised in conjunction with 
confocal microscopy to explore their cellular activity across a range of cell lines 
and environmental conditions. 
 
Svensson
[43]
 recently reported the ability of ruthenium polypyridyl 
complexes to transport across the cell membrane of Chinese Hamster Ovary 
(CHO) cells.  The synthesis of a series of [Ru(phen)2(dppz)]
2+
 derivatives was 
described, where the alkyl chain length was altered to vary the compounds 
lipophilicity. Shown in figure 1.36 is the generic structure of the 
[Ru(phen)2(dppz)]
2+
  derivatives and associated chain lengths of the three 
complexes prepared. 
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Figure 1.36: Range of [Ru(phen)2(dppz)]
2+
 complexes with varying lipophilicity 
altered by the alkyl chain length.
[43] 
 
The cellular uptake of the series of [Ru(phen)2(dppz)]
2+
 complexes in  
CHO-K1  cells  was  studied  using  confocal microscopy.  Shown in figure 1.36 is 
the time dependent uptake and distribution of [Ru(phen)2(dppz)]
2+
 (D4) in CHO 
cells.  Immediately after addition, D4 stains the cell membrane and remains in the 
plasma membrane.  After 7 minutes, internalization of the dye was found to 
increase dramatically, accumulating in internal membranes.  The time dependent 
nature of the dye uptake is consistent with endocytosis.
[44] 
 
 
Figure 1.37: Luminescent confocal images (ex = 488 nm) showing the time 
dependent uptake and cellular distribution of [Ru(phen)2(dppz)]
2+
 (D4) (10M) in 
CHO – K1 cells after 3 minutes (A), 5 minutes (B) and 7 minutes (C).   Scale bars 
are 10 µm.
[43] 
 
Shown in figure 1.37 is the distribution of the assorted dyes throughout the   
cell structure using confocal fluorescence microscopy.  Ruthenium 
dipyridophenazine (dppz) complexes were found to localize in the endoplasmic 
reticulum or nucleus of fixed CHO cells.  Slight modifications of the dppz ligand‟s 
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lipophilicity led to great variations in membrane binding.  The least lipophilic 
complex (D2), was found predominantly in the nucleus, while complexes of 
increasing lipophilicity were found to be more homogenously distributed in the 
cells with comparable emission intensities inside the nucleus and in the 
cytoplasm.
[43]
   
 
       
Figure 1.35: Luminescent confocal images (ex = 488 nm) showing the cellular 
distribution of [Ru(phen)2(dppz)]
2+
 complexes in fixed CHO-K1 cells after 10 
minutes. D2 (A), D4 (B), D6 (C) (10 µM) were added to cells fixed in methanol 
(−20 °C) for 15 minutes. Scale bars are 10 µm.[43] 
 
Each dye was dissolved in media and DMSO (1% v/v), which is commonly 
used when imaging various metal complexes to aid solubility issues.
[45]
  It is 
reported that uptake of the ruthenium complexes may occur through endocytosis 
or passive diffusion which would be expected for the more lipophilic 
complexes.
[19, 49]
  The use of DMSO and the fixing of the CHO cells using ethanol 
bring into question the permeability of the cells and hence whether or not the 
complexes are genuinely cell permeable. 
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1.3.2 Ruthenium conjugated polypeptides in cellular imaging 
 
 As described in section 1.2.1, Neugebauer et al.
[12]
 were the first to 
conjugate a ruthenium coordinated complex to a cell penetrating polypeptide, for 
the purpose of exploiting the complex in live cell imaging.  Shown in Figure 1.36 
are the structures of two novel ruthenium(II) polypeptides which were 
synthesized. 
 
n + 2 
 
 
             n 
 
 
Figure 1.36: Structure of [Ru(bpy)2(picCOOH)Argn]
2+n
 (n is 5 or 8).  In the parent 
complex, [Ru(bpy)2(picH2)]
2+
, the   aryl   amide   pendant   on   the imidazole ring 
was replaced by an aryl acid. 
 
 A key aim of this work was to assess whether the peptide conjugated 
ruthenium probe could passively transport across a cell membrane.  The 
octaarginine dye conjugate [Ru(bpy)2(picCOOH)Arg8]
10+
 was found to transport 
across the membrane of SP2 myeloma cells without the need to use organic 
solvents.  To confirm that uptake into the cell was facilitated by the polypeptide, 
the parent complex, [Ru(bpy)2(picCOOH)]
2+
 was investigated and no 
luminescence was observed from within the cells, even after extensive 
incubation.   
 
Interestingly, the short chain length [Ru(bpy)2(picCOOH)Arg5]
7+
 also 
showed no evidence of distribution across the cell membrane, which indicates 
that polypeptide chain length has a huge bearing on its membrane 
permeabilisation abilities.  Diffusion of the parent complex was achieved 
however, by introducing the detergent Triton, DMSO or ethanol which would 
permeabilise the cell.   
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SP2 cells in a buffered solution were exposed to 
[Ru(bpy)2(picCOOH)Arg8]
10+
 with a final concentration of 3.5 x 10
-5
 M.  Shown in 
figure 1.37 are luminescence images of SP2 cells which highlight the uptake 
capabilities of probe.  In the absence of permeabilisation, the octaarginine dye – 
peptide was found to accumulates and preconcentrate inside the cell, with uptake 
confirmed to be irreversible and temperature dependent (Fig. 1.37(a) & (b)).  The 
dye initially concentrates in the cell membrane, before distributing into the cell.  
Distribution of the dye inside the cell was not homogenous, resulting in brighter 
and darker areas, presumably due to different organelles.   
 
After between 10 and 15 minutes the process was complete and no 
further changes were observed.  In contrast, the parent complex was found to 
concentrate only on the cell membrane (Fig. 1.37(c)), before permeablisation of 
the cell membrane on exposure to Triton, allowed the dye to transport into the 
cell (Fig. 1.37(d)). 
 
 
Figure 1.37: Luminescence images (ex = 458 nm, em = 610 nm) of SP2 
myeloma cell incubated with [Ru(bpy)2(picCOOH)Arg8]
10+
 (3.5 x 10
-5
 M) after (a) 3 
minutes and (b) five minutes.  (c) Myeloma cell incubated with the parent 
complex [Ru(bpy)2(picCOOH)]
2+
 (3.5 x 10
-5
 M) for 26 minutes and (d) for 5 
minutes upon permeablizing the cell with Triton (1% v/v) 
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 To assess the distribution of the dye in cellular organelles, myeloma cells 
were counterstained with commercial cell permeable dyes which exhibit specific 
staining.  3,3'-dihexyloxacarbocyanine iodide (DiOC6(3)) selectively stains 
mitochondria at low concentrations and other structures in the cell, including the 
lysozomes and  endoplasmatic reticulum at higher concentrations.
[50]
  Shown in 
figure 1.38 are luminescence images of SP2 myeloma cells stained with 
[Ru(bpy)2(picCOOH)Arg8]
10+
 and counter stained with DiOC6(3).  From both 
figures, it is shown there is no overlap between [Ru(bpy)2(picCOOH)Arg8]
10+
 and 
DiOC6(3) it can be concluded that [Ru(bpy)2(picCOOH)Arg8]
10+ 
does not localize 
in the mitochondria, lysozomes or endoplasmic reticulum of myeloma cells.
[25]
   
 
 
Figure 1.38:   Luminescence  images  (ex = 458 nm, em =  515nm(a), 615 
nm(b))  of SP2 cells incubated with [Ru(bpy)2(picCOOH)Arg8]
10+
 (3.5 x 10
-5
 M) (b) 
and  DiOC6(3) (5 M) (a) in PBS (pH 7.4). Overlay (c). 
 
To ensure that [Ru(bpy)2(picCOOH)Arg8]
10+
 was capable of penetrating 
live cells without leading to their destruction, it was necessary to perform cell 
viability assays.  Sytox green is a probe which only penetrates cells with 
compromised plasma membrane and was used to assess if the ruthenium 
stained cells were still viable.  Shown in figure 1.39 are SP2 cells stained with the 
ruthenium peptide dye and in which the external buffer contains 0.5 µg/mL of 
Sytox green.  Both dyes were excited with 458nm laser irradiation.  The Sytox 
green fluorescence was collected with a band pass filter from 490nm – 515nm, 
while [Ru(bpy)2(picCOOH)Arg8]
10+
 was collected through a 615 nm longpass 
filter.   
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The results indicate that Sytox green does not enter SP2 cells stained with 
[Ru(bpy)2(picCOOH)Arg8]
10+
 labelled indicating that at least over the time-scale of 
these experiments (several hours) the ruthenium labelled cells remain viable.  
Importantly, these results demonstrate the ability of a peptide conjugated 
ruthenium probe to passively transport across the cell membrane of live myeloma 
cells and distribute throughout the cell‟s cytoplasm without causing cell apoptosis. 
 
 
 
 
 
 
 
 
 
Figure 1.39: Luminescence  images  (ex  =  458  nm,  em  =  505(A), 615  nm(B))  
of SP2 cells incubated with [Ru(bpy)2(picCOOH)Arg8]
10+
 (3.5 x 10
-5
 M) in which 
the external buffer contains 0.5 µg/mL of Sytox green. 
 
A key advantage of ruthenium polypyridyl complexes when compared to 
traditional ﬂuorescent imaging dyes is their long lived excited states, making them 
far more sensitive to their environment.  The long lived fluorescent lifetime of 
[Ru(bpy)2(picCOOH)Arg8]
10+ 
is of particular interest, as it allows for discrimination 
from the shorter-lived background fluorescence present in many biological 
samples.  Another advantage of the large Stokes shift of the dye is that it reduces 
the likelihood of self – quenching.  FLIM imaging, where the contrast of the image 
is generated from variations in the measured emission lifetimes, is independent 
of concentration, light scattering, light path length and laser excitation power.  As 
its emission is also removed from regions of the spectrum where 
autofluorescence of biological samples can occur, this allows for the use of 
fluorescent light imaging (FLIM).  A long lifetime that is distinguishable from 
cellular autofluorescence is important for FLIM imaging.
[51]
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Shown in Figure 1.40 (a) is the fluorescence intensity map of a myeloma 
cell incubated for 12 minutes with [Ru(bpy)2(picCOOH)Arg8]
10+
 and (b) a false 
colour lifetime image of the same cell.  From Fig. 1.40 (a) is it determined that the 
dye residing in the outer membrane displays the shortest lifetime.  This is 
expected as the higher solubility of O2 in the membrane will result in greater 
quenching of the ruthenium probe.
[52]
  The complex could potentially have 
applications as a luminescence O2 mapping agent. 
 
 
Figure 1.40: (a) Fluorescence intensity image and (b) false colour FLIM image of 
[Ru(bpy)2(picCOOH)Arg8]
10+
 (3.5 x 10
-5
 M in aqueous PBS buffer) upon 
incubation in an SP2 myeloma cell for 15 minutes 
 
 
As the [Ru(bpy)2(picCOOH)Arg8]
10+
 probe was found to be pH and oxygen 
dependent, it was possible to exploit this sensitivity to measure both parameters 
in a single environment.
[25]
  From FLIM images shown in Figure 1.41, it was 
possible to calculate the oxygen concentration within the cell, based on the 
luminescent lifetimes obtained.  Once pH was defined from resonance Raman 
spectroscopy, the same ruthenium complex can be used to probe the O2 
concentration using FLIM.  Luminescence intensity is not a reliable measure of 
oxygen concentration without an internal reference as it depends on the 
concentration of the dye, which varies throughout the cell.  However, the 
luminescence lifetime reflects oxygen concentration and is not affected by local 
concentrations of dye.   
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Three regions of distinct luminescence lifetime inside the cell were 
identified from these images by comparison with Raman and confocal 
luminescence images.  These were identified as the cellular membrane, the 
cytoplasm and the nucleus.  A lifetime of 513 (± 21) ns was obtained for the 
background medium, 453 (± 25) ns for the outer cellular layer, 540 (± 12) ns for 
the cytoplasm, and 620 (± 8) ns for the nucleus.  A key advantage of these dyes 
is their long lived excited state, in relation to many conventional imaging dyes. 
 
 
Figure 1.41: (a) Fluorescent intensity map of an SP2 myeloma cell incubated for 
12 minutes with [Ru(bpy)2(picCOOH)Arg8]
10+
 in PBS and (b) a false colour 
lifetime image of the same cell.
[25] 
 
Raman spectroscopy is a fundamentally weak phenomenon, as only 1 in 
10
6
 photons are inelastically scattered. However if the excitation laser coincides 
with an intense optical transition of the molecule, the signal may be significantly 
enhanced.  Ruthenium polypyridyl complexes exhibit up to 200 nm separation 
between their absorbance and emission maxima which allows the collection of 
intense interference free resonance Raman spectra at a wavelength that also 
excites emission.
[53]
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While the electronic spectroscopy in the visible region for 
[Ru(bpy)2(picCOOH)Arg8]
10+
 exhibits relatively weak pH dependence, the 
resonance Raman spectra show significant sensitivity to pH.  Shown in Figure 
1.42 is the Resonance Raman spectra of [Ru(bpy)2(picCOOH)Arg8]
10+
 at a range 
of pH intervals following irradiation at 458 nm.  As shown in the figure below, the 
ratio of the height/area of the pH dependent [Pic-COOH] ligand modes (at 1608 
and 1550 cm
-1
) and the height/area of the pH independent bipyridyl ligand modes 
(at 1488 and 1317 cm
-1
) can be used to produce a pH plot.  The bipyridyl ligand 
modes were found to be well resolved and were found, in terms of both intensity 
and wavelength to be unaffected by pH over the range explored.  These modes 
were therefore selected as internal reference bands.   
 
Resonance Raman signals were collected and mapped from SP2 
myeloma cells containing [Ru(bpy)2(picCOOH)Arg8]
10+
 in PBS buffer, as 
described in section 1.3.3.  From the pH dependent Raman calibration curve, the 
cellular membrane was found to have a pH of 6.7, while the nucleus and 
cytoplasm had values of pH 6.8 and pH 7.2 respectively.  The results obtained 
from this technique are in agreement with values previously reported by Machen 
et al.
[54]
   
 
Figure 1.42: Resonance Raman spectra of [Ru(bpy)2(picCOOH)Arg8]
10+
 collected 
at a range of pH values 
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Puckett
[55]
 has also published results recently detailing the ability of a 
peptide conjugated ruthenium probe to passively permeate HeLa cells after 
incubation for 30 minutes at 37°C.  Similarly to results published by 
Neugebauer
[12]
 the parent complex [Ru(phen)(bpy)(dppz))]
2+
 showed no evidence 
of crossing the cell membrane.  However, once conjugated to octaarginine the 
dye was found to distribute throughout the cell after 30 minutes.  At higher 
concentrations, the localization of the ruthenium-Arg8-fluoroscein changes 
significantly.  At concentrations up to 10 μM, the complex is restricted to punctate 
structures in the cytoplasm, whereas, at 15–20 μM the population of the cells was 
found to be heterogeneous. The punctate distribution implicates endocytosis,
[56]
 
which as previously discussed is a proposed internalization mechanism for 
polypeptides.  As shown in figure 1.43, these results show the uptake of a 
ruthenium-Arg8-fluoroscein probe being far more efficient than that of a 
ruthenium-Arg8 probe alone.  It is believed that the greater lipophilicity of the 
fluorescein moiety compared to the ruthenium increases the interactions with the 
cell membrane, which in turn may give rise to additional uptake methods for the 
fluoroscein probe. 
 
Figure 1.43: structures and corresponding luminescence images of 
complexes synthesised by Puckett et al. in HeLa cells at 37°C 
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1.3.3 Ruthenium conjugated polypeptides in Raman Mapping 
 
Label free Raman mapping of cells has the ability to provide detailed 
concentrations of key biochemicals within the cell and as such has been the 
focus of a number of studies.
[13]
  The low sensitivity of conventional Raman 
requires long acquisition times, leading to potentially damaging dwell times of the 
laser on a single spot.
[57]
  Unlike luminescence, Raman is not influenced by 
oxygen concentration or other environmental parameters unless they directly 
affect a compound‟s structure (e.g. protonation).  Through the introduction of an 
external label into the cell, excited under resonance absorption conditions, the 
dye‟s distribution and, unique to Raman, its structure, can be probed with 
excellent sensitivity.  It is possible to develop a single label dye which can be 
used for both luminescence and resonance Raman imaging of cells.  As 
discussed in this chapter, fluorescent organic dyes are not suitable for this 
purpose since  their  small  Stokes  shift  means  ﬂuorescence overwhelms  the  
weaker  Raman  response.  The enhanced vibrations are restricted to those 
involving the chromophores participating in the optical transition so tend to lead to 
simplified Raman spectra.[58]   
 
A key advantage of ruthenium polypyridyl complexes with regards to 
Raman spectroscopy is their capacity to make their photo-physical properties 
dependent on their environment.  For example, a single ruthenium dye can be 
used to probe both pH and oxygen concentration in a single environment.  If the 
pH of a complex is defined from resonance Raman spectroscopy, luminescence 
lifetime imaging of the same ruthenium complex can be used to probe the O2 
concentration.
[58]
   
 
Raman mapping is a technique which generates detailed images based 
on a compound‟s Raman spectrum.  A complete spectrum is acquired at multiple 
designated pixels of an image and these spectra are then interrogated to 
generate false colour images.  A resonance Raman image is generated by 
analysing the intensity of individual or multiple bands in a spectrum.  The   plot   
intensity   represents   the   intensity   of   these vibrational modes and therefore 
the relative dye concentration around the cell.
[13]
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A typical experiment uses sequential sample movement and spectrum 
acquisition, with acquisition time for one spectrum a crucial value, as it influences 
the acquisition time of the image which can consist of thousands of Raman 
spectra.  From an image, it is possible to determine a compound‟s concentration 
and distribution, which is not possible with standard microscopy.
[59, 60]
    
 
In a recent study, Cosgrave
[13]
 investigated the use of a peptide 
conjugated ruthenium probe for the purposes of multimodal cellular imaging.  
Shown in Figure 1.43 is the structure the novel environmentally sensitive 
[Ru(dppz)2(pic)Arg8]
10+.  The dppz ligands confer „molecular light switch‟ 
properties on the ruthenium complex due to hydrogen bonding to the phenazine 
nitrogens, which leads to emission quenching in aqueous environments.  Upon 
increasing addition of water aliquots to [Ru(dppz)2(pic)Arg8]
10+
 in acetonitrile, the 
emission steadily decreased and was completely extinct at 18% v/v water.   
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Figure 1.43: Structure of [Ru(dppz)2(pic)Arg8]
10+
.
[13] 
 
 Shown in Figure 1.44 is Raman intensity plot of an SP2 myeloma cell 
constructed from the intensity of ruthenium(II) vibrational modes and hence the 
relative dye concentration within the cell.  Fig. 1.44(a) and (b) show white light 
images of the myeloma cells investigated, while Fig. 1.44(c) shows that the dye is 
clearly distributed throughout the cell but that the parent dye remains in the outer 
cell membrane as shown in Fig. 1.44(d).  The concentration of 
[Ru(dppz)2(pic)Arg8]
10+
 is highest close to the centre of the cell in the cytoplasm.  
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Figure 1.44: Resonance Raman intensity map of live SP2 myeloma cells after 
incubation with [Ru(dppz)2(pic)Arg8]
10+
 (c) and the unconjugated parent dye (d) 
after excitation at 458 nm. (a) and (b) represent white light images of the cells in 
PBS.
[13] 
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1.3.4 Mechanism of cellular uptake of ruthenium dyes 
 
As mentioned in section 1.2, while endocytosis is widely believed to be the 
most likely mechanism of cellular uptake of cell penetrating peptides and also 
other metal complexes, there is still much debate around the topic.   
 
Puckett and Barton
[19]
 have previously examined the mechanism of 
cellular entry for a ruthenium(II) polypyridyl complex in HeLa cells.  Using flow 
cytometry, the extent of uptake of Ru(DIP)2dppz
2+
 (where DIP = 4,7-diphenyl-
1,10-phenanthroline) was determined.  Transport of the dye across the cell 
membrane was first assessed using confocal microscopy.  As shown in Figure 
1.45, the ruthenium complex was found to accumulate inside the cell rather than 
associating solely at the membrane surface.   
 
To determine whether the uptake mechanism was energy dependent, the 
complex was incubated with HeLa cells after ATP depletion by deoxyglucose (a 
glucose analog that inhibits glycolysis) and oligomycin (an inhibitor of oxidative 
phosphorylation).
[61, 62]
  Fluorescently labelled transferrin was used as a positive 
control as it is known to be internalized by clathrin-mediated endocytosis.  HeLa 
cells were pretreated for one hour with deoxyglucose (50 mM) and oligomycin (5 
M), then rinsed and incubated with Ru(DIP)2dppz
2+
 (5 M) or transferrin-
AlexaFluor488 for one hour. 
 
Shown in Figure 1.46 are flow cytometry confocal microscopy images 
measuring the effect of metabolic inhibition on the uptake of Ru(DIP)2dppz
2+
 in 
HeLa cells.  The mean luminescence was determined to be 659 ± 12 compared 
to 675 ± 10 for the cells not treated with deoxyglucose and oligomycin.  This 
suggests the ruthenium complex is entering the cells via an energy independent 
pathway.  The endocytosis of transferrin was found to display a significant 
fluorescence decrease under metabolic inhibition.  The mean fluorescence was 
shown to decrease from 3034 ± 52 to 210 ± 5, which is in contrast to the results 
for Ru(DIP)2dppz
2+
.  While transferrin is known to cross the cell membrane 
through endocytotic pathways, the large difference in the mean fluorescence 
decrease between complexes suggests differing uptake mechanisms. 
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Figure 1.45: Chemical structure of Ru(DIP)2dppz
2+
; Luminescence confocal 
image of  HeLa cells incubated with Ru(DIP)2dppz
2+
 (5 M) for four hours.
[19] 
 
Figure 1.46: Flow cytometry measuring the effect of metabolic inhibition on 
uptake of Ru(DIP)2dppz
2+
 in HeLa cells.  Cells treated with inhibitors (red) are 
compared to control cells (blue). Top: Ru(DIP)2dppz
2+
 uptake. Bottom: transferrin-
AlexaFluor488 uptake.
[19] 
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As shown in Figure 1.37, Svensson
[43]
 recently reported the ability of a 
series of ruthenium polypyridyl complexes to transport across the cell membrane 
of CHO cells.  Uptake of the dyes was found to increase dramatically with time 
with distribution in internal membranes complete after seven minutes.  The time 
dependent nature of this internalization suggests that the Ru(II) complexes cross 
the cell membrane via endocytosis.
[44]
   
 
 However, an aspect of both the research of Svensson,
[43]
 Barton
[19]
 and 
many other reported studies on coordination compounds that must be considered 
is their use of DMSO (1%) to aid the solubility of metal complexes.   
 
As discussed in section 1.3.2, Neugebauer et al.
[12]
 synthesized a cell 
penetrating ruthenium polypeptide, with the parent complex showing no signs of 
entering the cell.  This suggests that results obtained using DMSO are in fact 
studying permeabilized cells, meaning the dye is not penetrating a healthy cell 
membrane.
[47, 48]
   
 
It is widely believed that endocytosis is the most likely mechanism of 
cellular uptake of arginine rich cell penetrating peptides as results have shown 
the process to be temperature and energy dependent which is indicative of 
endocytosis.
[12, 22-24]
  This process involves the cell membrane wrapping itself 
around the extra-cellular peptide and engulfing it. The peptide is then brought into 
the cell via small vesicles.  Fuchs et al.
[24]
 have previously reported the 
internalisation of a fluorescein labelled polypeptide by entocytoic means. 
Internalization of complexes in myeloma cells has been reported to follow clathrin 
mediated endocytosis
[63]
, while CHO cells internalize complexes predominantly 
through caveolin – mediated pathways, with clathrin inhibition showing no effects 
on uptake.
[64]
   
 
Clathrin dependent endocytosis is a process by which cells internalize 
molecules through the inward budding of proteins coated with the cytosolic 
protein clathrin, which contains receptor sites specific to the molecules being 
internalized.
[20]
  Caveolin form a unique endocytic and exocytic compartment at 
the surface of most cells and are capable of importing molecules and delivering 
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them to specific locations within the cell.
[65]
  However, it has also been reported 
that obstruction of caveolin mediated pathways did not completely eliminate the 
uptake of ﬂuorescently labelled alginate – chitosan complexes in CHO cells, 
evidence that other internalization pathway(s) are involved.
[64]
  
 
 
As the process has been demonstrated to be temperature and energy 
dependent, endocytosis seems a likely uptake mechanism.  However, no method 
or process has been conclusively proven or universally accepted. 
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1.4     Ruthenium complexes as intracellular sensors 
 
1.4.1 Ruthenium(II) complexes as pH and O2 sesnors 
 
There is currently considerable interest in luminescence imaging of 
essential biological parameters such as pH, pO2, hydrogen peroxide and 
calcium.
[66-71]
  Intracellular pH is of particular importance for the activity of 
enzymes, synthesis of macromolecules (protein, DNA, RNA), the conductivity of 
ion channels and controlling the cell cycle.
[72]
  The pH of cellular tissue could be 
used as a marker of disease in tumor cells which have been found to display 
abnormally acidic cytoplasmic pH.
[73, 74]
  Fluorophores sensitive to pH undergo 
changes in emission intensity or spectral shift upon protonation.  At appropriate 
wavelength the fluorescence intensity of such sensor is a function of the pH of 
the surrounding environment.  Therefore, a probe capable of measuring 
intracellular pH could be invaluable in live cell imaging.  
 
Acidotropic partition dyes are a range of fluorescent dyes whose presence 
in acid compartments can be detected from fluorescence alone.  Acridine orange 
will enter acidic compartments such as lysozomes, becoming protonated and 
sequestered, and will emit orange light when excited by blue light.  However, a 
limitation to the use of this probe in live cell imaging is the frequent occurrence of 
dye photoconvertion during image acquisition.
[125]
  The structure of acridine 
orange is shown in figure 1.47. 
 
 
Figure 1.47: Structure of Acridine Orange 
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As described in section 1.3.2, Neugebauer et al.
[25]
 have previously 
described the resonance Raman spectroscopy of [Ru(bpy)2(pic-arg8)]
10+
 over a 
range of pH values.  Using both a pH dependent and independent Raman 
features as internal references, the ratio of two modes was used to estimate the 
pH in different regions of an SP2 myeloma cell.   
 
Shown in figure 1.48 is the peak ratio plot of the pH-sensitive pic-Raman-
band at 1575 cm
-1
 and the pH-independent bpy-band at 1317 cm
-1
 versus pH.  
The solid line shows the fitted Henderson – Hasselbalch model which provided a 
pKa of 8.5 ± 0.2, which was in agreement with values obtained from UV/vis 
absorption spectroscopy.  Using confocal scanning microscopy, the outer cellular 
membrane was found to have a pH of 6.7, while the nucleus and cytoplasm had 
values of pH 6.8 and pH 7.2 respectively.  Typical values for the pH within the 
cytoplasm are between 7.0 and 7.4.
[72]
  This technique may provide insights into 
intracellular activity, as the relative low value inside the nucleus suggests a low 
activity of DNA and RNA synthesis, as the optimal range is between 7.0 and 
8.0.
[72]
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Figure 1.48: Plot of the change of the relative intensities of two Raman bands 
from [Ru(bpy)2(pic-arg8)]
2+
 centered at 1575 cm
-1
 and 1317 cm
-1
 with pH.
[25] 
 
 A recent study has described the activity of an intracellular oxygen 
sensitive probe based on phosphorescent porphyrin dyes conjugated to cell-
penetrating peptides.
[75]
  Shown in figure 1.49 is the structure of one of the 
probes, comprised of uncharged derivatives of Pt(II)-coproporphyrin I covalently 
linked to positively charged TAT-derived peptides.  Both the rate of consumption 
and concentration of cellular oxygen are linked to physiological processes such 
as oxidative phosphorylation, generation of ATP, production of reactive oxygen 
species (ROS), nitric oxide (NO), oxidative burst, and adaptive responses to 
 49 
hypoxia.
[76-79]
  As conjugation to the cell penetrating peptide allows for passive 
transport across the cell membrane, these probes provide a simple and versatile 
tool for O2 monitoring in live cells and in tissue.  Shown in Figure 1.49 is the 
phosphorescence lifetime of the probe in respiring and nonrespiring cells. 
 
 
Figure 1.49 Chemical structure of phosphorescent porphyrin probe.
[75]
 
 
 
 
 
Figure 1.50: Phosphorescence lifetime at different O2 concentrations for the 
resting dPC12 cells loaded with PtCPTE-CFR9 probe (10 m) for 16 hours and 
for the same cells treated with antimycin A.
[75] 
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1.4.2   BODIPY complexes as biological probes 
 
Borondipyrromethenes (BODIPY) derivatives are a synthetically versatile 
class of ﬂuorophore which have attracted much interest for their function as 
molecular probes,
[80]
 light-harvesting molecular arrays
[81]
 and photo – dynamic 
therapy via singlet oxygen generation.
[82]
  They are known for their robust 
photophysical properties, such as strong absorption of visible light high 
fluorescence quantum yield and good photostability.
[83]
  Several BODIPY 
derivatives have been commercialized for biological labelling.   
 
Shao et al.
[84]
 have recently described a dinitrobenzenesulfonyl 
(DNBS) BODIPY probe capable of specific detection of cysteine over other 
biological molecules, such as glutathione and amino acids.  Cysteine was 
reported to cleave the DNBS moiety, which resulted in a 46 – fold emission 
enhancement.  Shown in Figure 1.51 is the skeletal structure of BODIPY, which 
has several positions on the chromophore available for functionalisation.  
Functionalisation is commonly achieved through pyrrole substitution with a phenyl 
or alkyl group or attachment of functional groups such as ligands or biomolecules 
via the aryl group highlighted on position 8 below.
[85] 
 
 
Figure 1.51: Skeletal structure of the BODIPY system showing 8 available 
positions for functionalisation (left); fluorescent photographs of BODIPY 
derivatives taken under UV light (hand-held UV lamp, 365 nm) in toluene at room 
temperature.
[83] 
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An initial aim of this project was to produce a ruthenium – peptide 
conjugate with both an oxygen or pH sensitive and insensitive fluorophore as a 
self-referenced sensor for confocal microscopy.  In a cellular environment, it may 
be difficult to identify whether certain probes have been converted to another 
species, as fluorescence intensity is a less reliable reporter than emission lifetime 
for sensing but is a much more commonly applied technique.   
 
Ruthenium probes are useful in cell O2 sensors due to their large long-
lived emissive triplet state which is readily quenched quantitatively by molecular 
oxygen.  Other properties which make them good probes are their Stokes shifts, 
good photostability and red emission wavelengths (away from possible 
autofluorescence of biological material).
[12]
   
 
However, by combining with a pH or oxygen insensitive probe, the ratio of 
luminescence at two wavelengths (one sensitive, one insensitive to its 
environment) will be unaffected by the concentration of the dye and will therefore 
have potential application as an intracellular sensor in conventional microscopy.   
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Shown in figure 1.52 is a theoretical display of how such a sensor could 
be utilised to determine oxygen concentration based on emission intensity ratio. 
 
 
 
Figure 1.52: Theoretical emission spectrum of a BODIPY – conjugated ruthenium 
complex, showing an orange oxygen insensitive BODIPY peak at 515 nm and an 
oxygen sensitive ruthenium peak at 641 nm.  Such a complex should be excited 
using a 458 nm laser.  The graph was obtained by overlaying a spectra of a 
BODIPY-COOH (15 M) complex with one of [Ru(NO2phen)2(picNH2)]
2+
 (20 M), 
after both were excited using a 458 nm laser.  The graph was subsequently 
normalised using MATLAB Spectrum Analyzer.   
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The target complex in this project was designed with the aim of attaching 
two cell penetrating peptides and one BODIPY reference probe to a single 
supramolecular unit.  This approach had two major advantages: (I) the second 
CPP would lead to a greatly increased overall charge on the complex and (II)  
only a single reference was to be used as two highly luminescent BODIPY 
probes may dwarf the ruthenium emission.  The ruthenium complex was 
designed to have on amino terminus in order to exploit this group for EDC/NHS 
coupling to a carboxyl functionalised BODIPY dye.   
 
This reaction scheme is shown in Figure 1.53, where the EDC crosslinker 
activates the carboxyl group, which readily allows reaction with primary amines.  
The intermediate formed is susceptible to hydrolysis and is unstable in aqueous 
environments.  The intermediate is stabilized by the addition of an NHS ester 
which forms a more stable amine – reactive ester which may be coupled with an 
amine. 
 
Figure 1.53: Schematic representation of the EDC/NHS coupling mechanism
[86]  
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Shown in Figure 1.54 is the chemical structure of the ruthenium(II) 
complex designed for conjugation to a BODIPY dye and two cell penetrating 
peptides.    The nitro containing phenanthroline ligands attached to the metal 
centre can be reduced, which provides for the possibility of conjugating a 
BODIPY group at the pic - NH2 terminus; with two cell penetrating peptides then 
conjugated to the complex at the NO2 groups after reduction.  As described in 
section 4.2.1, the reduction of [(Ru(NO2phen)2Cl)]
2+
 has a high yield (> 85%) and 
the nitro functionality can be readily reduced to NH2 groups.  The ruthenium 
complex may be conjugated to a cell penetrating peptide with a resin – bound 
peptide and spacer. 
 
 
Figure 1.54: Structure of ruthenium(II) complex designed for conjugation to a 
BODIPY dye and two cell penetrating peptides.  Highlighted in blue are the two 
sites intended to link cell penetrating peptides; highlighted in pink is the site 
designated for linking to a BODIPY dye 
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2.1 Experimental Methods and Instrumentation 
 
2.1.1 Chemicals 
 
All chemicals and reagents were purchased from Sigma Aldrich Ireland 
and used without any further purification steps.  All reactions were performed in 
air unless otherwise stated. 
 
2.1.2 Nuclear Magnetic Spectroscopy (NMR) Spectroscopy  
  
1
H-NMR was performed on a Brucker AC 400 MHz using deuterated 
DMSO-d6 or deuterated Methanol (MeOD) as solvent unless otherwise specified.  
Peak positions are relative to TMS (0 ppm chemical shift). All NMR spectra were 
processed and analysed using Topspin NMR software. 
 
2.1.3 Absorption Spectroscopy 
 
UV-Vis spectra were recorded on a Varian Cary 50 spectrophotometer.  
Samples were analysed  in  a  quartz  cuvette  with  a  path length  of  1  cm  with  
a  spectral  range  of 200 – 600 nm unless otherwise stated.  The background 
was corrected for blank solvent absorbance prior to every measurement and was 
collected at room temperature. 
 
2.1.4 Fluorescence Spectroscopy 
 
Emission spectra were recorded on a Varian Cary Eclipse fluorescence 
spectrophotometer with an excitation slit width of 5 nm and an emission slit width 
of 5 nm, PMT detector voltage was 600 V.  All experiments were performed using 
a 1 cm path length quartz cuvette.  The background was corrected for blank 
fluorescence before each measurement and was collected at room temperature. 
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2.1.5 Calculating Quantum Yields 
 
The phosphorescent quantum yield for ruthenium(II) complexes were 
estimated by matching the MLCT absorbance transition of both the complex and 
standard [Ru(bpy)3]
2+
 [P = 0.0642 in acetonitrile].
[87]
  Both solutions were excited 
into the MLCT region of maximum absorbance and the corresponding emission 
recorded.  The luminescent quantum yield was calculated using the formula 
shown in Equation 2.11. 
 
P(x) =  (Ax/As) (Fs/Fx) (nx/ns)
2
 P(s)      eqn 2.11 
 
where P is the phosphorescent quantum yield, A is absorbance at the excitation 
wavelength, F is the area under the corrected emission spectrum and n is the 
refractive index of the solvents used.  X and s refer to the unknown and standard 
respectively.  All quantum yield experiments were carried out three times and the 
average quantum yield was then reported.  
 
2.1.6 Lifetime Measurements 
 
Luminescent lifetimes were obtained using a Picoquant Fluotime 100 Time 
Correlated Single Photon Counting (TCSPC) system exciting at 450 nm and 
using a 510 nm narrow band pass dielectric filter for ruthenium complexes.  The  
instrument  response  function  was  determined  by  using  ledox  AM30 colloidal  
silica  solution  with  an  excitation  source  (picosecond  pulse  diode lasers) of 
450 nm for ruthenium samples respectively.   
 
10,000 counts were collected for each lifetime measurement and all 
measurements were performed in triplicate using Nanoharp software to confirm 
results.  Typical pulse rates of the excitation source were 1 x 10
5
 s
-1
 with typical 
pulse widths of 300 ps.  The aerated and degassed lifetime was recorded for 
each sample, with degassed samples being degassed with nitrogen for 20 
minutes prior to analysis.    
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The calculation of the luminescent lifetimes were carried out by fitting an 
exponential decay function to each decay plot to extract the lifetime information 
using FluoFit software.  Due to the inherently long lifetimes of ruthenium(II) 
complexes all data was fitted to mono/bi-exponential decay functions to the 
baseline of the decay curve using tail-fit with an x2 value of between 0.9-1.1. 
 
2.1.7 Chromatographic Techniques 
 
All products were purified using an automated flash chromatography 
system (Varian Intelliflash 310 series) using a Basic Alumina (Al2O3), 125 m 
particle size, 112 mm, 24 gram column; or a Silica Gel, 50 m particle size, 98 
mm, 15 gram column.  This allowed purification by separation of compounds into 
fractions and separation was followed using UV detection (200 – 400 nm) and an 
auto collector.  The detection wavelength monitored was dependent on the 
maximum absorbance of the compound in the detector limitations, while also 
collecting peaks above a slope sensitivity of 0.5.   
 
Thin layer chromatography (TLC) was performed to follow progress of 
reactions on glass silica gel (Merck, 250 m thickness) or alumina (Alumina GF, 
Aldrich, 250 m thickness).  The sample plate was then placed in a TLC chamber 
containing the selected mobile phase and analysed under UV light (254 and 365 
nm). 
 
2.1.8 Resonance Raman Spectroscopy 
 
Resonance Raman spectra were obtained on a HORIBA Jobin – Yvon 
Labram HR 1000 spectrometer coupled to a Digital Instruments Bioscope II with 
an inverted microscope.  The Raman band of a silicon wafer at 520 cm
-1
 was 
used for calibration.  The area of the laser spot on the samples was 1 m in 
diameter and laser power was set from 1 to 2 mW using the laser power control.  
Data acquisition times were set to 2 seconds and 5 acquisitions were carried out 
for each spectra. 
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2.2 Cell Culture 
 
Cells were maintained in a 37C incubator with 5% CO2 and 95% 
humidified air. Sp2/0-Ag14 cells were grown in complete Dulbecco's Modified 
Eagle's Medium, while CHO-K1 cells were grown in ATCC-formulated F-12K 
Medium.  Both media were supplemented with 10% Fetal Bovine Serum, which is 
widely used for the in vitro cell culture of eukaryotic cells
[88]
. Due to the high 
growth of the CHO cells, the FBS was reduced to 5% after passage 10. 
Supplemented media was subsequently stored at 4C.  All cells and supplements 
were purchased from LGC Standards. 
 
 
2.2.1 Cell enumeration and viability assay 
 
Cell viability was assessed using the trypan blue exclusion method.
[89]
  
This method is based on the principal that dead or dying cells which do not have 
an intact cell membrane will take up the dye and subsequently be stained blue. 
100 μL of cell suspension was mixed with 150 μL PBS and 250 μL of trypan blue 
solution (0.4% (v/v)).  After approximately two minutes cells were applied to a 
brightline haemocytometer (Sigma
®
) and examined under high-power 
magnification ( 40) using an inverted microscope (Olympus CKX31, Olympus 
Corporation, Tokyo, Japan). Cells that were inside the central grid of 25 squares 
were counted.  
 
 
A viable cell count was achieved 
by using the following formula: 
Cells / ml   =  N x 5 x 104  
Where N = total number of cells 
counted, 5 = dilution factor and 
10
4
 = constant. 
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2.2.2 Sp2/0-Ag14 culture protocol 
 
After removal from liquid nitrogen and rapid thawing, cells were 
decontaminated by spraying with 70% ethanol. The contents of the vial were 
transferred to a centrifuge tube containing 9 cm
3
 complete culture medium and 
spun at 100 rpm (approx. 125xg) for 6 minutes. The cell pellet was resuspended 
in 10cm
3
 of media and transferred to a 25cm
2
 culture flask. Cells were seeded at 
a concentration between 1 x 10
5
 and 5 x 10
5
 cells/ml each time and culture flasks 
were left in the incubator.  Depending on cell density fresh medium was added 
every 2 – 4 days and cell concentration was never allowed to exceed 1 x 
10
6cells/ml. The base medium for this cell line is ATCC formulated Dulbecco‟s 
Modified Eagle‟s Medium (30-2002). This medium was made complete by the 
addition of fetal bovine serum (ATCC: 30-2020) to a final concentration of 10%.  
 
 
2.2.3 CHO-k1 culture protocol 
 
After removal from liquid nitrogen and rapid thawing, cells were 
decontaminated by spraying with 70% ethanol. The contents of the vial were 
transferred to a centrifuge tube containing 9 cm
3
 complete culture medium and 
spun at 100 rpm for 6 minutes. The cell pellet was resuspended in 15 cm
3
 of 
media and transferred to a 75cm
2
 culture flask. Cells were subcultured by 
removing the medium and rinsing the cell layer with 0.25%(w/v) Trypsin- 0.53mM 
EDTA solution to remove all traces of serum which contains Trypsin inhibitor. 
After rinsing, 3 cm
3
 of Trypsin-EDTA solution was added to the flask and placed 
in an incubator for five minutes to disperse the cell layer. The flask was removed 
from the incubator and 7 cm
3
 of medium was added, transferred to a centrifuge 
tube and spun spun at 100rpm for 6 minutes. Cells were seeded at a 
concentration between 1 x 10
5
 and 2 x 10
5
 cells/ml each time and culture flasks 
were left in the incubator. 
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2.3.1 Confocal Fluorescence Microscopy 
 
 Confocal microscopy is an imaging technique that uses point illumination 
and a spatial pinhole which eliminates light thicker than the focal plane.  The 
resulting higher z-resolution and reduced out-of-focus blur make confocal 
pictures crisper and clearer.  Shown in Figure 2.31 is a schematic representation 
of a confocal microscope.   
 
Figure 2.31: Schematic diagram illustrating the components of a confocal 
microscope.
[90] 
 
The objective lens focuses the incident light into a cone shaped beam so 
that the maximum intensity of the beam strikes a single spot within the sample.  
The luminescence from the sample  is  then  focused  by  the  dichroic beam 
splitter mirror  onto  a  pinhole  aperture,  eliminating   out-of-focus light or glare in 
specimens whose thickness exceeds the immediate plane of focus.  A key 
advantage of confocal microscopy compared with traditional widefield microscopy 
is that single optical sections are projected on one plane, resulting in a clean 
image without any out-of-focus noise.  While selecting a small pinhole diameter, it 
is only possible to image a thin optical section, although this will achieve the 
highest resolution possible.
[90]
  Throughout this thesis, the standard pinhole size 
used was 1 airy unit; the microscope used was a Zeiss LSM510 META Confocal 
Imaging System. 
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 Shown in Figure 3.22 is an example of the higher resolution images 
achieved with confocal microscopy in comparison to traditional microscopy and 
also a visualisation of the difference in incident light between the two techniques.  
Any noise that is present in an image can be greatly reduced via the acquisition 
of several frames which may be accumulated and averaged. 
 
Figure 3.22: Comparison of the standard fluorescence image (left) and the 
incident light (right) of confocal and widefield microscopy.
[91] 
 
 The co – localization studies described in Chapter 3 are made possible 
through multi – channel detection.  In this mode, only one laser line is active, 
exciting one ﬂuorophore at a time which then emits its signal and is collected by 
one active photo-multiplier tube PMT.  Then Laser & PMT are switched off and 
the next laser line and PMT are activated in order to capture the next channel. 
 
Also described in Chapter 3 is the z – stack technique, which is possible 
due to the automatically adjustable microscope stage.  This technique allows for 
the acquisition of data images of varying optical depth.  The number of optical 
sections deﬁnes the resolution in the data set. 
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2.3.2 Resonance Raman Mapping 
  
Raman mapping is a technique which generates detailed images based 
on a compound‟s Raman spectrum.  A resonance Raman image is generated by 
analysing the intensity of individual or multiple bands in a spectrum wherein the 
Raman excitation wavelength is resonant with an optical absorption of the 
sample.   
 
Resonance Raman maps were obtained on a HORIBA Jobin – Yvon 
Labram HR 1000 spectrometer coupled to a Digital Instruments Bioscope II with 
an inverted microscope.  The Raman band of a silicon wafer at 520 cm
-1
 was 
used for calibration.  An individual cell of interest was identified and then a white 
light image of this cell was recorded.  The Raman maps shown in this thesis were 
obtained for live cells without the use of an incubator, and thus at approximately 
25°C.  The total number of data points may be selected before each acquisition, 
however to ensure cell viability, images were collected in a time not exceeding 
twenty minutes.   
 
The Raman maps shown in this thesis were obtained through the use of 
sequential sample movement and spectrum acquisition, with the final image 
consisting of thousands of Raman spectra.  
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Chapter 3: Synthesis and Characterisation of ruthenium complexes suitable 
for bioconjugation 
 
3.0     Introduction 
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 3.1.1 Synthesis of pic ligands 
 3.1.2 Synthesis of BODIPY dye 
 3.1.3 Synthesis of ruthenium complexes 
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 3.2.2 
1
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  3.2.3.2 Photophysics 
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  3.2.4.1 Absorbance 
  3.2.4.2 Photophysics 
  3.2.4.3 pH Dependence Studies 
  3.2.4.4 Resonance Raman Spectroscopy 
  3.2.4.5 Photostability – UV irradiation 
 3.2.5 Synthesis of ruthenium – BODIPY sensor 
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3.0     Introduction 
 
As described, ruthenium polypyridyl complexes have numerous unique 
photophysical properties which make them potentially invaluable for cellular 
imaging such as their intense polarised luminescence, large Stokes shift, red 
emission wavelengths as well as their environmental sensitivity.
[12]
  A key 
advantage of many ruthenium (II) complexes is that they are not susceptible to 
much of the degradation exhibited by organic fluorophores.  The focus in this 
thesis was on two Ru(II) polypyridyl complexes, both with ionisable ligands, one 
an imidazole and the other triazole. 
 
The complex [Ru(bpy)2(picCOOH)]
2+
, where picCOOH is 2-(4-
Carboxylphenyl)imidazo[4,5-f]1,10-phenanthroline has been synthesized and its 
photophysical properties explored recently by a number of groups, including our 
own.
[11,12, 92]
  One of the attractive properties of this complex, is that unlike most  
common fluorophores its emission intensity and lifetime are enhanced in an 
aqueous compared to non-polar environment.  Conjugation of 
[Ru(bpy)2(picCOOH)]
2+
 to a cell penetrating peptide was carried out via the 
carboxyl terminus and the dye was subsequently found to be a useful probe for 
cellular imaging.   
 
 An initial aim of this work was to synthesise a BODIPY – conjugated 
ruthenium dye and attach this complex to a cell-penetrating peptide, to produce a 
molecule capable of reporting on pH and oxygen concentrations in a cellular 
environment (Ru centre), with self-referencing to a non-environmentally sensitive 
luminophore (BODIPY).  The conjugation of a metal complex to a cell-penetrating 
peptide facilitates efficient diffusion across mammalian cell membranes without 
destroying the lipid bilayer.  The synthetic approach taken was to design a 
ruthenium(II) complex with two nitrophenanthroline ligands capable of linking to a 
cell penetrating peptide, and also containing an amino terminus in order to exploit 
this group for EDC/NHS coupling to a carboxyl functionalised BODIPY dye.   
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Peptide – conjugated ruthenium(II) probes have previously been shown to 
transport passively across a myeloma cell membrane (believed to occur via 
endocytosis) and distribute throughout the cell.
[12]
  BODIPY complexes are known 
for their robust photophysical properties, such as strong absorption of visible light 
high fluorescence quantum yield, good photostability and are also pH and O2 
insensitive which make them useful as reference compounds. 
 
The first part of this chapter presents detailed and comparative 
photophysical and spectroscopic studies for two nitrophenanthroline – 
ruthenium(II) – pic complexes with different terminal functionality, as well as the 
phenanthroline parent complex.  Mass spectrometry was used in conjunction with 
NMR (
1
H-NMR / COSY) to confirm the purity and structure of the complexes 
synthesised.  Although the final complex was not completed these novel 
complexes form the first two components of the route to the novel chromophores 
from where future work will commence. 
  
The second part of this chapter describes the synthesis of a ruthenium(II) 
– triazole complex and it‟s subsequent conjugation to a cell penetrating peptide.  
The cellular activity of this probe and it‟s parent complex is described in Chapter 
4.  Here, a complete photophysical, resonance Raman and photostability study is 
described to support the cellular imaging results discussed in the following 
chapter and also to provide a comparison between the parent and the peptide – 
conjugated complex.  
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3.1.1 Synthesis of Pic ligands 
 
Chemicals 
 
 All chemicals and reagents were purchased from Sigma Aldrich Ireland 
and used without any further purification steps.  All reactions were performed in 
aerated media unless otherwise stated. 
 
 
The preparation of 2-(4-carboxylphenyl)imidazo[4,5-f]1,10-phenanthroline 
[(picCOOH)]  
 
           CH3COONH4 
        +          / CH3COOH 
                   reflux 6 hours    
 
 
 
phendione   4-carboxybenzaldeyde  2-(4-carboxylphenyl)imidazo 
[4,5-f]1,10-phenanthroline 
 
The ligand was prepared using a modification to a method previously 
described in the literature.
[11]
 1,10-Phenanthroline-5,6-dione (0.21 g, 1 mmol), 4-
carboxybenzaldeyde (0.15 g, 1 mmol) and ammonium acetate (1.5 g, 20 mmol) 
were suspended in glacial acetic acid (20 cm
3
) and refluxed overnight.  The 
reaction vessel was cooled down and water (100 cm
3
) was added to the reaction 
mixture to induce crystallisation and was stored at 4C overnight.  The product 
precipitated as yellow solid and was collected by filtration.  The solid was washed 
with water and methanol and dried in air. Yield (79%, 0.269 g) 
 
 
1
H NMR (400 MHz, DMSO-d6):  (ppm) 13.99 (s, 1H), 9.06 (d, 2H), 8.95 (d, 2H, J 
= 2.4 Hz), 8.41 (d, 2H, J = 8.4 Hz), 8.20 (d, 2H, J = 8.4 Hz), 7.87 (m, 2H). 
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The preparation of 2-(4-Nitrophenyl)imidazo[4,5-f]1,10-phenanthroline 
[PicNO2] 
 
 
           CH3COONH4 
        +          / CH3COOH 
                   reflux 6 hours    
 
 
 
 
phendione   4-nitrobenzaldeyde  2-(4-nitrophenyl)imidazo 
[4,5-f]1,10-phenanthroline 
 
1,10-Phenanthroline-5,6-dione (0.406 g, 1.93 mmol), 4-nitrobenzaldeyde 
(0.345 g, 2.32 mmol) and ammonium acetate (2.975 g, 38.6 mmol) were 
suspended in glacial acetic acid (35 cm
3
) and left to reflux at 130C for eight 
hours.  The reaction vessel was cooled down and water (200 cm
3
) was added to 
the reaction mixture to induce crystallisation and was stored at 4C overnight.  
The product precipitated as yellow solid and it was collected by filtration.  The 
solid was washed with water and methanol and dried in air (0.567 g, 86%).   
 
1
H NMR (DMSO-d6):  (ppm) 9.07 (d, 2H, J = 1.6 Hz), 8.89 (d, 2H, 1.6 Hz), 8.51 
(m, 4H, J = 8.8 Hz, J = 7.2 Hz, J = 9.2 Hz), 7.86 (m, 2H).   
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The preparation of 2-(4-Aminophenyl)imidazo[4,5-f]1,10-phenanthroline 
[PicNH2] 
 
 
     Pd / hydrazine 
      hydrate / EtOH 
     reflux 4 hours 
 
 
2-(4-nitrophenyl)imidazo     2-(4-aminophenyl)imidazo 
[4,5-f]1,10-phenanthroline     [4,5-f]1,10-phenanthroline 
 
 
2-(4-nitrophenyl)imidazo[4,5-f]1,10-phenanthroline [(PicNO2)] (1.500 g, 4.3 
mmol) was dissolved in absolute ethanol (35 cm
3
) and to this solution palladium 
5% wt on activated carbon (0.130 g) was added.  Hydrazine hydrate (1.13 cm
3
, 
2.54 mmol) was added dropwise via a syringe and the resulting solution was left 
to reflux at 90C for four hours.  The solution was filtered through celite 
(compacted with ethanol / dichloromethane), to remove the palladium, and 
evaporated to dryness.  The solid was then purified using an alumina (basic) 
chromatographic column using 10% (v/v) methanol :  dichloromethane mobile 
phase to yield a dark yellow product. (1.285 g, 94%).  
 
1
H NMR (DMSO-d6):  (ppm) 13.32 (s, 1H), 8.98 (d, 2H), 8.91 (d, 2H), 7.97 (d, 2H, 
J = 8.8 Hz), 7.81 (m, 2H), 6.73 (d, 2H, J = 8.4 Hz), 5.63 (s, 2H).   
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3.1.2 Synthesis of BODIPY dye 
 
The preparation of 8-benzoic acid-4,4-difluoroboradiazaindacene 
[BODIPY-COOH] 
 
 
 
         RT 3 hours  
      
 
Dimethylpyrrole 4-formylcarboxylic   8-benzoic acid-4,4-difluoro 
acid           boradiazaindacene 
 
The ligand was prepared using a modification to a method previously 
described in the literature.
[124]
  2,4-dimethylpyrrole (0.428 g, 4.5mmol) and 4-
formylcarboxylic acid (0.301 g, 2.0 mmol) were dissolved in dichloromethane 
(150 cm
3
).  One drop of trifluoroacetic acid was added and the solution was left to 
stir at room temperature.  The reaction was monitored by TLC until complete 
consumption of the carboxylic acid was confirmed. 2,3-Dichloro-5,6-dicyano-1,4-
benzoquinone (DDQ) (0.454 g, 2.0 mmol) was added to the mixture followed by 
the addition of triethylamine (4 cm
3
).  The mixture was stirred for another two 
hours, washed with water, dried and the solvent evaporated under reduced 
pressure.  The resulting solid was then purified using a silica chromatographic 
column using 40% (v/v) hexane :  ethyl acetate mobile phase to yield a purple 
product. Yield (66%, 0.484 g). Mol Wt 367.15gmol
-1
 
 
 
 
1
H NMR (400 MHz, acetone-d6):  (ppm) 8.25 (d, 2H), 7.60 (d, 2H), 6.15 (s, 2H), 
2.52 (s, 6H), 1.42 (s, 6H). 
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3.1.3 Synthesis of ruthenium complexes 
 
The preparation of ruthenium-(bis-1,10-phenanthroline)dichloride 
[Ru(phen)2Cl2]  
 
  LiCl / DMF   
RuCl3 . H2O +     
      Reflux 18 hours 
 
 
Ruthenium tri          1,10-phenanthroline    ruthenium-(bis-1,10- 
chloride hydrate                phenanthroline)dichloride 
 
Dimethylformamide (21 cm
3
) was degassed under nitrogen for two hours.  
RuCl3.3H2O (0.5 g, 1.91 mmol), was dissolved in the degassed DMF in a three 
neck round bottomed flask.  To this lithium chloride (0.55 g, 12.99 mmol) was 
added followed by 1,10 phenanthroline (0.690 g, 3.83 mmol) in equal portions 
over 30 minutes.  The reaction was refluxed at 140C under nitrogen for 20 
hours.  
 
The reaction mixture was allowed to stand to cool to room temperature 
and acetone (15 cm
3
) was added to promote precipitation, before storing the flask 
at 4C overnight.  The precipitate was then filtered and the solid washed with 
acetone, water and diethyl ether giving a dark purple solid. Yield: 71% (0.76g) 
MW: 532gmol
-1
.   
 
1
H NMR (400 MHz, DMSO-d6):  (ppm) 10.21 (d, 2H), 8.65 (d, 2H), 8.24 (d, 2H), 
8.17 (m, 4H), 8.08 (d, 2H), 7.68 (d, 2H), 7.28 (dd, 2H). 
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The preparation of ruthenium-(bis-1,10-5-nitrophenanthroline)dichloride 
[Ru(NO2 phen)2Cl2] 
 
 Dimethylformamide (21 cm
3
) was degassed under nitrogen for two hours. 
RuCl3.3H2O (0.58 g, 2.22 mmol), was dissolved in the degassed DMF in a three 
neck round bottomed flask.  To this lithium chloride (0.71 g, 15.09 mmol) was 
added followed by 5-nitro-1,10-phenanthroline (1.001 g, 4.44 mmol) in equal 
portions over 30 minutes.  The reaction was refluxed at 140C under nitrogen for 
20 hours.  
 
The reaction mixture was allowed to stand to cool to room temperature 
and acetone (15 cm
3
) was added to promote precipitation, before storing the flask 
at 4C overnight.  The precipitate was then filtered and the solid washed with 
acetone, water and diethyl ether.  This solid was then purified using a silica 
chromatographic column using 10% methanol :  dichloromethane mobile phase 
to yield a dark purple product. Yield: 68% (0.808g) MW: 621gmol
-1
 
 
1
H NMR (400 MHz, DMSO-d6):  (ppm) 10.34 (d, 2H), 9.35 (s, 1H), 9.20 (s, 1H), 
9.03 (d, 1H), 8.94 (d, 1H), 8.61 (d, 1H), 8.48 (d, 1H)., 8.31 (m, 2H), 8.01 (dd, 2H), 
7.45 (m, 2H) 
 
ESI-MS (CH3OH, m/z): 854.3.  
ESI-MS: M2+ 1105.6 m/z,   M2+/2 553.5 m/z  
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The preparation of ruthenium-(bis-1,10-5-aminophenanthroline)dichloride 
[Ru(NH2 phen)2Cl2] 
 
Ruthenium-(bis-2,2-5-nitrophenanthroline) dichloride [Ru(NO2phen)2Cl2] 
(0.120 g, 0.19 mmol) was dissolved in absolute ethanol (10 cm
3
) and to this 
solution palladium 5% wt on activated carbon (0.014 g) was added.  Hydrazine 
hydrate (0.071cm
3
, 1.46mmol) was added dropwise via a syringe and the 
resulting solution was left to reflux at 90
0
C for four hours. 
 
The solution was filtered through celite (compacted with ethanol/ 
dichloromethane), to remove the palladium, and evaporated to dryness.  The 
solid was then purified using an alumina (basic) chromatographic column using 
10% methanol :  dichloromethane mobile phase to yield a light purple product. 
(0.104g, 83%).  
 
1
H NMR (400 MHz, DMSO-d6):  (ppm) 9.98 (m, 1H), 9.57 (m, 1H), 9.08 (m, 1H), 
8.61 (d, 1H), 8.43 (d, 1H), 8.25 (m, 1H), 8.01 (dd, 2H), 7.64 (d, 1H), 7.46 (m, 1H), 
7.24 (d, 2H), 7.13 (s, 1H), 6.98 (s, 1H), 6.89 (s, 2H), 6.74 (s, 2H). 
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The preparation of ruthenium (bis-2,2-phenanthroline)-2(4-
carboxyphenyl)imidazo[4,5-f]1,10-phenanthroline  
[(Ru (phen)2 PicCOOH)]
2+
  
 
 
     
      EtOH / H2O 
    +     
      reflux 18 hours  
 
 
ruthenium-(bis-1,10,    2(4-carboxyphenyl)imidazo   (bis-1,10-phenanthroline)-2(4 
phenanthroline          [4,5-f]1,10-phenanthroline  carboxyphenyl) 
dichloride      imidazo[4,5-f]1,10-phenanthroline
         
[Ru(phen)2Cl2] (0.125 g, 0.23 mmol) and 2(4-carboxyphenyl)imidazo[4,5-
f]1,10-phenanthroline [PicCOOH] (0.088 g, 0.25 mmol) were placed in a 25 cm
3
 
round bottomed flask and left to reflux at 85
0
C in ethanol (10 cm
3
) for 18 hours.  
 
The reaction was allowed to stand until it had cooled to room temperature. 
A saturated solution of NaCl4 was added and the precipitate was collected.  The 
solid was then washed with diethyl ether and chloroform to yield a dark orange 
solid.  
 
The product was then dissolved in acetonitrile and filtered to remove any 
unreacted PicNH2.  The filtrate was then collected and dried leading to an orange 
solid. Yield (0.140g, 78%) Mol Wt: 803.7gmol
-1
.  
 
 
1
H NMR (400 MHz, DMSO-d6):  (ppm) 14.51 (s, 1H), 9.09 (d, 2H), 8.80 (d, 2H), 
8.73 (d, 2H), 8.46 (d, 2H), 8.40 (m, 4H). 8.24 (d, 2H), 8.14 (m, 2H), 8.08 (d, 2H), 
8.02 (d, 2H), 7.77 (m, 4H). 
 
ESI-MS (CH3OH, m/z): 903.27 
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The preparation of ruthenium (bis-1,10-5-nitrophenanthroline)-2(4-
Aminophenyl)imidazo[4,5-f]1,10-phenanthroline [(Ru(NOphen)2PicNH2)]
2+
  
 
 
     
        EtOH / H2O 
        +     
      reflux 18 hours  
 
 
ruthenium-(bis-1,10,      2(4-carboxyphenyl)imidazo   (bis-1,10-phenanthroline)-2(4-  
5-nitrophenanthroline  [4,5-f]1,10-phenanthroline  aminophenyl) imidazo 
dichloride        [4,5-f]1,10-phenanthroline 
 
Ru (NO2phen)2Cl2 (0.285g, 0.45mmol) and 2(4-Aminophenyl)imidazo[4,5-
f]1,10-phenanthroline [PicNH2] (0.171 g, 0.54 mmol) were placed in a 50 cm
3
 
round bottomed flask and left to reflux at 85C in ethanol (25 cm
3
) for 18 hours.  
 
The reaction was allowed to stand until it had cooled to room temperature. 
A saturated solution of sodium perchlorate was added and the precipitate was 
collected.  The solid was then washed with diethyl ether and chloroform to yield a 
dark orange solid.  
 
The product was then dissolved in acetonitrile and filtered to remove any 
unreacted PicNH2.  The filtrate was then collected and dried leading to an orange 
solid. Yield (0.302g, 78%) Mol Wt: 862.1gmol
-1
.  
 
1
H NMR (400 MHz, DMSO-d6):  (ppm) 9.21 (d, 2H), 9.10 (t, 2H), 9.01 (ds, 2H), 
8.77 (t, 2H), 8.24 (t, 2H), 7.94 (d, 2H). 7.88 (m, 2H), 7.76 (m, 4H), 7.61 (dt, 2H), 
6.74 (d, 2H), 5.39 (s, 2H). 
 
ESI-MS (CH3OH, m/z): 961.89  
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The preparation of ruthenium (bis-1,10-5-nitrophenanthroline)-2-(4-
Carboxylphenyl)imidazo[4,5-f]1,10-phenanthroline  
[(Ru(NOphen)2PicH2)]
2+
  
 
 
     
        EtOH / H2O 
        +     
      reflux 18 hours  
 
 
ruthenium-(bis-1,10,      2(4-carboxyphenyl)imidazo    (bis-1,10-phenanthroline)-2(4-  
5-nitrophenanthroline  [4,5-f]1,10-phenanthroline   aminophenyl) imidazo 
dichloride        [4,5-f]1,10-phenanthroline 
 
Ru(NO2phen)2Cl2 (0.170 g, 0.19 mmol) and 2-(4-
Carboxylphenyl)imidazo[4,5-f]1,10-phenanthroline [PicH2] (0.112 g, 0.23 mmol) 
were placed in a 50 cm
3
 round bottomed flask and left to reflux at 85C in ethanol 
for 18 hours.  
 
The reaction was allowed to stand until it had cooled to room temperature. 
A saturated solution of sodium perchlorate was added and the precipitate was 
collected.  The solid was then washed with diethyl ether and chloroform to yield a 
dark orange solid.  
 
The product was then dissolved in acetonitrile and filtered to remove any 
unreacted [pic] ligand. The filtrate was then collected and dried leading to an 
orange solid. Yield (0.137 g, 81%) Mol Wt: 892.1 gmol
-1
.  
 
1
H NMR (400 MHz, DMSO-d6):  (ppm) 14.47 (s, 1H), 8.03 (d, 2H), 7.95 (m, 2H), 
7.88 (m, 2H), 7.64 (m, 2H), 7.06 (m, 4H). 7.04 (m, 2H), 6.91 (dd, 2H), 6.79 (dt, 
2H), 6.58 (m, 4H), 6.51 (d, 2H). 
 
ESI-MS (CH3OH, m/z): 990.37 ([M- ClO4]
2+
): 891.23 
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3.1.4    Synthesis of ruthenium peptide conjugate 
 
Synthesis of 2-(5-(5-bromo-2-methoxyphenyl)- 4H-1,2,4-triazol-3-yl) pyridine 
 
        
     ethylene glycol 
     reflux, 40 mins   
 
 
N'-(imino(pyridin-2-yl)methyl)-           2-(5-(5-bromo-2- methoxyphenyl) 
5-bromo-2-methoxybenzohydrazide  4H-1,2,4-triazol-3-yl)pyridine 
 
The ligand N'-(imino(pyridin-2-yl)methyl)-5-bromo-2-
methoxybenzohydrazide was prepared using modification to a method previously 
described in the literature.
[93, 94]
  A slurry of the ligand (10.4 g, 29.78 mmol) was 
refluxed in ethylene glycol (30 cm
3
) for one hour. The solution was then cooled to 
approximately 90C and water (30 cm
3
) added, and the mixture was stored at 
4C for 18 hours.  The precipitate was collected, washed with water, and dried 
under vacuum at 80C for one hour (3.7 g, 37.51%).  The crude product was 
used in next step. 
 
1
H NMR (400 MHz, DMSO-d6):  (ppm) 3.75 (s, 3 H), 7.00 (d, 1 H), 7.10 (m, 1 H), 
7.38 (d, Hz, 1 H), 7.78 (t, 1 H), 8.14 (s, 1 H), 8.15 (s, 1 H), 8.29 (m, 1 H). 
 
ESI-MS (CH3OH, m/z): calculated (M) 331.1, found 332.1 (M + H
+
) 
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Synthesis of ruthenium bis(2,2-bipyridyl) {2-[5-5-(5-bromo-2-
methoxyphenyl)-4H-1,2,4-triazol-3-yl] pyridine} 
 
 
 
           1. Ru(bpy)2Cl2.2H2O 
          MeOCH2CH2OH / H2O 
    4hr reflux, N2 
            2. KPF6 
 
 
2-(5-(5-bromo-2- methoxyphenyl)      ruthenium bis(2,2-bipyridyl) 
   4H-1,2,4-triazol-3-yl)pyridine     {2-[5-5-(5-bromo-2-methoxyphenyl) 
-4H-1,2,4-triazol-3-yl] pyridine} 
 
 [Ru(bpy)2Cl2] (0.529 g, 1.09 mmol) and 2-(5-(5-bromo-2- methoxyphenyl) 
4H-1,2,4-triazol-3-yl)pyridine (0.406 g, 1.22 mmol) were placed in a 100 cm
3
 
round bottomed flask containing 2-methoxyethanol (60 cm
3
) and water (20 cm
3
) 
which was deoxygenated with nitrogen for ten minutes. The mixture was then 
refluxed under nitrogen for four hours.  After cooling to room temperature, the 
solvents were evaporated and to the resulting orange residue water (20 cm
3
) was 
added.  Potassium hexafluorophosphate (KPF6) (1.5 g) was then added to the 
solution and the precipitated product was extracted with DCM, organic solution 
was dried with magnesium sulfate and the solvent was evaporated under 
vacuum.  The solid was then purified using a silica chromatographic column 
using 10% v/v methanol :  dichloromethane mobile phase to yield an orange 
product (0.70 g, 72%).  
 
1
H NMR (400 MHz, acetonitrile-d3)  ppm 8.44 (d, 1 H), 8.46 (d, 1 H), 8.39 (d, 1 
H), 8.42 (d, 1 H), 8.13 (d, 1 H), 7.98 (m, 1 H), 7.97 (dd, 1 H), 7.91 (m, 3 H), 7.86 
(m, 2 H), 7.76 (m, 3 H), 7.52 (d, 1 H), 7.41 (m, 2 H), 7.36 (m, 2 H), 7.29 (dd, 1 H), 
7.23 (m, 1 H), 7.19 (d, 1 H), 7.15 (dd, 2 H), 6.95 (d, 1 H), 3.71 (s, 3 H) 
 
ESI-MS (CH3OH, m/z): calculated (M) 745.1, found 745.1 (M) 
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Chemical Formula: 
C34H27BrF6N8OPRu
Molecular Weight: 889,57
Chemical Formula: C37H30F6N8O3PRu
Molecular Weight: 880,72
Synthesis of ruthenium bis(2,2-bipyridyl) [(2E)-3-{4-methoxy-3-[5-
(pyridinyl)- 1,2,4-triazol-3-yl] phenyl} propenoic acid]  
 
 
 
 
 
 
 
 
 
ruthenium bis(2,2-bipyridyl)          ruthenium bis(2,2-bipyridyl) 
{2-[5-5-(5-bromo-2-methoxyphenyl)  [(2E)-3-{4-methoxy-3-[5-(pyridinyl)- 
-4H-1,2,4-triazol-3-yl] pyridine}   1,2,4-triazol-3-yl] phenyl} 
             propanoic acid 
 Ruthenium bis(2,2-bipyridyl) {2-[5-5-(5-bromo-2-methoxyphenyl)-4H-1,2,4-
triazol-3-yl] pyridine} (0.261 g, 0.29 mmol), sodium carbonate (0.420 g, 5.04 
mmol), tetrabutylammonium bromide (0.1 g, 0.31 mmol), palladium (II) chloride 
(0.03 g, 0.17 mmol) and acrylic acid (0.045 g, 0.63 mmol) were added to a 100 
cm
3
 round bottomed flask containing water (25 cm
3
) and 2-methoxyethanol (15 
cm
3
) and the mixture refluxed under nitrogen for twenty hours.  The solvents were 
removed by rotary evaporation and the orange residue was collected. The solid 
was then dissolved in water (40 cm
3
) and extracted three times with 
dichloromethane.  The organic layer was discarded and to the aqueous solution 
concentrated hydrochloric acid (to pH=1) and KPF6 (1 g) were added.  The 
product was extracted with DCM and the solvent evaporated under vacuum 
(0.162 g, 63%). 
 
1
H NMR (400 MHz, acetonitrile-d3)  ppm = 8.47 (t, 2 H), 8.40 (d, 1 H), 8.35 (d, 1 
H), 8.29 (d, 1 H), 8.05 - 7.99 (m, 2 H), 7.98 (m, 2 H), 7.91 (m, 2 H), 7.84 (m, 2 H), 
7.80 (d, 1 H), 7.74 (d, 1 H), 7.60 (m, 2 H), 7.46 (m, 2 H), 7.41 (m, 3 H), 7.26 (dd, 
1 H), 7.24 (t, 1 H), 7.06 (d, 1 H), 6.17 (d, 1 H), 3.79 (s, 3 H) 
 
ESI-MS (CH3OH, m/z): calculated (M)+ 735.1; found 735.1 (M)+ 
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Synthesis of ruthenium bis(2,2-bipyridyl) [(2E)-3-{4-methoxy-3-[5-
(pyridinyl)- 1,2,4-triazol-3-yl] phenyl} prop-2-enoyl]oxy}pyrrolidine-2,5-
dione) 
 
 
 
 
 
 
 
 
ruthenium bis(2,2-bipyridyl)      ruthenium bis(2,2-bipyridyl)  
[(2E)-3-{4-methoxy-3-[5-(pyridinyl)-             [(2E)-3-{4-methoxy-3-[5-(pyridinyl)- 
1,2,4-triazol-3-yl] phenyl}          1,2,4-triazol-3-yl] phenyl} 
propanoic acid   prop-2-enoyl]oxy}pyrrolidine-2,5-dione) 
 
To a solution of ruthenium bis(2,2-bipyridyl) [(2E)-3-{4-methoxy-3-[5-(pyridinyl)- 
1,2,4-triazol-3-yl] phenyl} propenoic acid] (0.042 g, 0.05 mmol) in anhydrous 
acetonitrile (3 cm
3
), dicyclohexylcarbodiimide (DCC) (0.02 g, 0.09 mmol) were 
added.  The resulting mixture was stirred at room temperature for five minutes 
and N-hydroxysuccinimide (0.01 g, 0.84 mmol) in anhydrous acetonitrile (1 cm
3
) 
was added.  After stirring at room temperature for twenty four hours the solvent 
was evaporated an the crude product purified on silica using gradient acetonitrile 
– 1,5%aq KNO3 (starting from 0%  to 20% of KNO3(aq)).  The product was 
dissolved in DCM (20 cm
3
) and a solution of potassium hexafluorophosphate (0.2 
g, 1.08 mmol) in water (5 cm
3
) was added.  The organic solution was dried with 
magnesium sulfate, filtered and the solvent was evaporated (0.032 g, 64%). The 
active ester was used in next step immediately.  
 
1
H NMR (400 MHz, acetonitrile-d3)  ppm =  8.50 (m, 5 H), 8.10 (m, 1 H), 8.03 (m, 
10 H), 7.82 (m, 2 H), 7.69 (dd, 1 H), 7.53 (m, 1 H), 7.44 (dd, 1 H), 7.39 (dd, 2 H), 
7.23 (m, 1 H), 7.16 (m, 1 H), 7.10 (d, 1 H), 6.57 (d, 1 H), 5.45 (s, 2 H), 3.78 (s, 3 
H) 
ESI-MS (CH3OH, m/z): calculated (M)
+
 832.2; found 832.2 (M)
+ 
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Synthesis of ruthenium bis(2,2-bipyridyl) [(2E)-3-{4-methoxy-3-[5-
(pyridinyl)- 1,2,4-triazol-3-yl] phenyl} prop-2-enoyl]amino}ethyl)-2,5-
dioxopyrrolidin-3-yl]- L-cysteinyl-L-arginyl-L-arginyl-L-arginyl-L-arginyl-L-
arginyl-L-arginyl-L-arginyl-L-argininamide} 
 
 
 
 
 
 
ruthenium bis(2,2-bipyridyl)    ruthenium bis(2,2-bipyridyl) 
[(2E)-3-{4-methoxy-3-[5-(pyridinyl)-      [(2E)-3-{4-methoxy-3-[5-(pyridinyl)- 
1,2,4-triazol-3-yl] phenyl}    1,2,4-triazol-3-yl] phenyl} 
prop-2-enoyl]oxy}pyrrolidine-2,5-dione)  prop-2-enoyl]amino}ethyl)-2,5-           
dioxopyrrolidin-3-yl]- octaarginine 
 
To a solution of ruthenium bis(2,2-bipyridyl) [(2E)-3-{4-methoxy-3-[5-
(pyridinyl)- 1,2,4-triazol-3-yl] phenyl} prop-2-enoyl]oxy}pyrrolidine-2,5-dione) 
(0.019 g, 0.021 mmol) in anhydrous acetonitrile (2 cm
3
) N-(2-
aminoethyl)maleimide trifluoroacetate (0.006 g, 0.02 mmol)  and 
diisopropylethylamine (0.05 cm
3
, 0.07 mmol) were added and the mixture stirred 
at room temperature for twenty one hours.  The solvents were evaporated under 
vacuum and the crude product was dissolved in acetonitrile (1 cm
3
) (This stock 
solution was used in next step immediately).  To a solution of NH2CysArg7ArgNH2 
(0.019 g, 0.015 mmol) in HEPES buffer (3 cm
3
, 10 mmol, pH 7.2) containing 
EDTA (1 mmol) a stock solution of active ester was added and the resulting 
solution was stirred at room temperature for seventy-two hours.  The solvents 
were then evaporated under vacuum the crude product was dissolved in water (5 
cm
3
), the insoluble fragments discarded and trifluoroacetic acid (0.1 cm
3
) was 
added to the solution before freeze drying.  Then the crude product was purified 
twice on silica gel C-18 (2 x 10 g) using water-acetonitrile (0,1% of TFA) 3-2 as 
eluent. The first fraction was collected and freeze-dried (0.04 g, 59 %). 
MALDI-MS: calculated for C94H140N44O13RuS (M+H)
+
:
 
2228.0478;  found 
2228.8857 Da (M+H)
+
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3.1.5 Synthesis of ruthenium – BODIPY conjugate  
 
 
 
 
 
           +        
 
 
 
 
 
 
[Ru(NO2phen)2(picNH2)]
2+
 (0.201 g, 0.232 mmol), 8-benzoic 
acidpyrrolidine-2,5-dione-4,4-difluoroboradiazaindacene [BODIPY-NHS] (0.85 g, 
0.182 mmol) and N,N-Diisopropylethylamine (135 L) were added to a 10 cm
3
 
round bottomed flask containing dichloromethane (4 cm
3
) and acetonitrile (15 
cm
3
) and the mixture stirred for eighteen hours.   
 
The solvents were removed by rotary evaporation and the orange residue 
was collected.  The solid was then purified using an alumina (basic) 
chromatographic column using 10% methanol :  dichloromethane mobile phase.  
A separate purification was attempted using a silica chromatographic column 
using 40% (v/v) hexane :  ethyl acetate mobile phase.  Pure product was never 
isolated.   
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conjugation using EDC/NHS coupling reagents 
 
 
 
 
 
              +        
 
 
 
 
 
8-benzoic acid-4,4-difluoroboradiazaindacene [BODIPY-COOH] (0.027 g, 
0.074 mmol)  and 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride 
[EDC] (0.012 g, 0.074 mmol) were added to a 10 cm
3
 round bottomed flask 
containing PBS buffer pH 7.0 (5 cm
3
) and stirred for 10 minutes.  Then, N-
hydroxysulfosuccinimide [NHS] sodium salt (0.008 g, 0.074 mmol) was added to 
the solution and it was left to stir for an additional 30 minutes.  
 
[Ru(NO2phen)2(picNH2)]
2+
 (0.077 g, 0.089 mmol) and N,N-
Diisopropylethylamine (381 L, 0.223 mmol) were added was then added to the 
reaction mixture and left stirring overnight. 
 
 
The solvents were removed by rotary evaporation and the orange residue 
was collected.  The solid was then purified using an alumina (basic) 
chromatographic column using 10% methanol :  dichloromethane mobile phase.  
A separate purification was attempted using a silica chromatographic column 
using 40% (v/v) hexane :  ethyl acetate mobile phase.  Pure product was never 
isolated.   
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3.2 Results & Discussion 
 
3.2.1 Synthesis 
 
The synthesis of the imidazole (pic) ligand was reported previously and is 
dependent on  the  acid  catalysed reaction of 1,10-phenanthroline 5,6-dione with 
the excess ammonium acetate to provide the  critical  1,10-phenanthroline  5,6-
di-imine  intermediate  (1) .  This intermediate was then reacted with a chosen 
aldehyde to undergo an aldol-type of condensation, forming a second 
intermediate.  This step is followed by a two hydrogen shift leading to the loss of 
a water molecule forming the imidazole complex as shown in figure 3.11
[95] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11: Mechanism illustrating the formation of the imidazole ligand.
[95]
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The synthesis of [(Ru(phen)2L-L)]
2+
 and [(Ru(NO2phen)2L-L)]
2+
 (where L-L 
are bidentate polypyridyl ligands) complexes from [(Ru(phen)2L-L)]
2+
 
and[(Ru(phen)2L-L)]
2+
 proceeds by the replacement of two chloride atoms with 
water molecules under reflux in water.  Lability of the water ligands in the 
resulting complexes allows a facile attachment of a designated Pic ligand.  The 
first chloride atom can be replaced at low temperatures in organic solvents such 
as acetone and ethanol.  There is a difference in lability of the two chloride atoms 
and the second atom must be replaced using a solvent with a high boiling point or 
with the addition of water
[96]
.  All complexes were synthesised under reflux using 
an ethanol / water (1:1) mixture and purified by column chromatography on 
alumina.  
 
The initial route to the synthesis of [Ru(NH2 phen)2Cl2] followed similar 
reactions to those reported in the literature using [RuCl3] and (NH2phen) and 
proved to be unsuccessful.
[97]
  It was then decided to attempt an alternative, novel 
approach via the preparation of [(Ru(NO2phen)2Cl)]
2+ 
and subsequent reduction 
of the nitro to amine groups.  Reduction of the aminophenantrholine ligand after it 
had been already coordinated to the metal centre was successful with the 
reduction step giving a high yield (>85%).  
 
The ease of synthesis of Pic ligands with selective functional terminal 
group grants the possibility of linking further complexes to additional ligands.  The 
COOH and NH2 groups allow for the facile extension of the functionality of the 
molecule.  The nitro containing phenanthroline ligands attached to the metal 
centre are modifiable for reduction, which provides for the possibility of 
conjugating one moiety at the pic terminus with one or more different groups at 
the NO2 after reduction. 
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Fig. 3.12: structural representations of [Ru(phen)2Cl2](I) and [Ru(NO2phen)2Cl2](II) 
 
 
     
 
 
 
 
 
(I)      (II)
Phen 
proton 
[Ru(phen)2Cl2] 
ppm 
NO2phen 
proton 
[Ru(NO2phen)2Cl2] 
ppm 
H
A
 / H
A’
 
10.21 
(d, 2H) H
A
 / H
A’
 
10.34 
(m, 2H) 
H
B
 / H
B’
 
8.65  
(d, 2H) H
B
 
9.35 
(s, 1H) 
H
C
 / H
C’
 
8.24 
(d, 2H) H
C
 
9.20 
(s, 1H) 
H
D
 / H
D’ 
/H
E
/H
E’ 
8.17 
(m, 4H) 
H
D 
9.03 
(d, 1H) 
H
F
 / H
F’
 
8.08 
(d, 2H) H
E
 
8.94 
(d, 1H) 
H
G
 / H
G’
 
7.68 
(d, 2H) H
F
 
8.61 
(d, 1H) 
H
H
 / H
H’
 
7.28 
(dd, 2H) H
G
 
8.48 
(d, 1H) 
  
H
H
 / H
H’
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(m, 2H) 
 
 
H
I
 
8.01 
(m, 2H) 
  H
J
 / H
J’ 
7.45(dt, 2H) 
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Figure 3.12: [pic-R] ligand illustrating numbering scheme for 
1
H-NMR analysis 
 
proton [picCOOH] 
ppm 
proton [picNO2] 
ppm 
proton [picNH2] 
ppm 
carboxyl-H 13.91 
(s, 1H) 
H1, H11 9.07 
(d, 2H) 
H4 13.38 
(s, 1H) 
H1, H11 9.06 
(d, 2H) 
H3, H9 8.92 
(d, 2H) 
H1, H11 9.06 
(d, 2H) 
H3, H9 8.95 
(d, 2H) 
H5, H6, 
H7, H8 
8.52 
(m, 4H) 
H3, H9 8.96 
(d, 2H) 
H6, H7 8.41 
(d, 2H) 
H2, H10 7.86 
(m, 2H) 
H5, H8 8.02 
(d, 2H) 
H5, H8 8.20 
(d, 2H) 
  H2, H10 7.88 
(d, 2H) 
H2, H10 7.87 
(m, 2H) 
  H6, H7 6.81 
(d, 2H) 
    amino-NH2 5.72 
(s, 2H) 
 
Table 3.11: 
1
H-NMR resonances for [pic-R] ligand with various functional groups, 
carried out in DMSO-d6.  The integration and peak splitting are shown in 
brackets. 
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Mass spectrometry was used in conjunction with NMR (
1
H-NMR / COSY) 
to confirm the purity and structure of the complexes synthesised.  Table 3.11 
shows the full 
1
H-NMR data for each of the three pic ligands synthesised. The R-
group on each of the ligands contains constituents that differ in their electron 
donating and electron withdrawing properties.  As a result the protons showing 
the largest change in chemical shift are located on the phenyl ring of the pic 
ligand. The nitro and carboxylic acid groups are electron withdrawing and draw 
electron density away from nearby protons; thus deshielding other protons on the 
rings resulting in a chemical shift downfield.  
 
In the amino-pic ligand, the electron donating NH2 group has lone pairs 
adjacent to the phenyl ring which increase the electron density on the ring, 
leading to an upfield shift of the phenyl protons.   This is most notably observed in 
the comparison of the electron donating amino group and the electron donating 
nitro group.  The protons located at positions H6 and H7 on the amino 
functionalised pic ligand are shifted upfield to 6.81 ppm, while the corresponding 
atoms on the nitro-pic ligand have a chemical shift of 8.52 ppm.  The protons on 
the imidazole ligand were not observed in the [picCOOH] or [picNO2] ligands, 
presumably due to the protons being very active and therefore readily 
exchangeable between the two nitrogens on the imidazole ring and deuterium in 
the solvent.
[98]
 
 
 The 
1
H-NMR spectra for the [Ru(phen)2Cl2] and [Ru(NO2phen)2Cl2] 
showed signals at 10.21 and 10.34 ppm respectively, each integrating for 2H.  
These peaks are attributed to the protons neighbouring the two chlorine atoms, 
as the electron density is decreased around each proton and they are shifted 
downfield.  These peaks would only be expected at such a frequency is bis-
complexes, as displacement of the chlorine atoms will change the chemical 
environment of the protons.  The coordinating pic ligand leads to greater electron 
density around these protons, resulting in greater shielding of the external 
magnetic field, and a shift upfield of approximately 1 ppm.  
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[Ru (NO2phen)2 picCOOH]
2+ 
[Ru (NO2phen)2 picNH2]
2+ 
NO2phen protons 
ppm 
picCOOH 
protons ppm 
NO2phen protons 
ppm 
picNH2 protons 
ppm 
H
B
 / H
C
 
7.88 (m, 2H) 
H1, H11 
8.03 (d, 2H) 
H
J
 / H
J ‘
 
9.10 (t, 2H) 
H1, H11 
9.21 (d, 2H) 
H
F
 / H
G
 
7.64 (m, 2H) 
H5, H8 
7.95 (m, 2H) 
H
B
, H
C
 
9.01 (ds, 2H) 
H5, H8 
7.94 (d, 2H) 
H
I
 / H
I „ 
7.06 (m, 4H) 
H3, H9 
7.06 (m, 4H) 
H
H
 / H
H‟ 
8.77 (t, 2H) 
H3, H9 
7.76 (m, 4H) 
H
F
 / H
G
 
7.04 (m, 2H) 
H2, H10 
6.91 (dd, 2H) 
H
A
 / H
A‟
 / H
D
 / H
E
 
8.24 (m, 4H) 
H2, H10 
7.61 (dt, 2H) 
H
J
 / H
J ‘
 
6.91 (dd, 2H) 
H6, H7 
6.51 (d, 2H) 
H
I
 / H
I „ 
7.88 (m, 2H) 
H6, H7 
6.74 (d, 2H) 
H
H
 / H
H‟ 
6.79 (dt, 2H)  
H
F
 / H
G
 
7.76 (m, 4H) 
NH2 
5.39 (s, 2H) 
H
A
 / H
A‟
 / H
D
 / H
E
 
6.58 (m, 4H)    
 
Table 3.12: 
1
H-NMR resonances for [pic-R] ligand with various functional groups, 
carried out in methanol-d4.  The integration and peak splitting are shown in 
brackets. 
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Table 3.13 shows the relative shift in ppm of the free [pic] ligand compared 
to the metal coordinated [pic] ligand. The greatest change for the pic ligands were 
located at H3 and H9 following the ligand‟s coordination to the ruthenium center. 
This change is attributed to an increase in electron density around each proton as 
they are shifted upfield.  The ruthenium complex has a d
6
 filled shell and it‟s 
coordination increases the electron density on the pic ligand, which causes a 
delocalised shielding effect focused on the protons at H3 and H9. As with the free 
ligands, the protons on the imidazole ligand were not observed for either metal, 
again presumably due to the protons being very active and can be readily 
exchanged between the two nitrogens on the imidazole ring. 
 
Proton [Ru (NO2phen)2 picCOOH]
2+
 
Δ ppm 
[Ru (NO2phen)2 
picNH2]
2+
 
Δ ppm 
H1 0.02 0.04 
H2 0.12 0.01 
H3 -1.18 -1.21 
H5 0.02 -0.08 
H6 0.59 -0.06 
H7 0.57 -0.07 
H8 0.02 -0.08 
H9 -1.16 -1.20 
H10 0.12 0.02 
H11 0.02 0.04 
 
Table 3.13: Δ ppm of 1H NMR shifts of coordinated complexes compared to free 
ligand 
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3.2.3 Optical Characterisation of ruthenium complexes 
 
3.2.3.1 Absorbance 
 
 
 
 
       [Ru(NO2phen)2(picCOOH)]
2+ 
       
[Ru(phen)2(picCOOH)]
2+ 
       [Ru(NO2phen)2(picNH2)]
2+
 
 
 
 
 
 
 
 
Figure 3.13:  Overlaid absorbance spectra of ruthenium (II) polypyridyl complexes 
(10M) in acetonitrile solution. 
 
Shown in Figure 3.13 is an overlay of the absorbance spectra for the three 
novel ruthenium(II) pic complexes.  The UV-vis spectra of all three complexes are 
distinguished by a ruthenium d to ligand * metal to ligand charge transfer 
(MLCT) at 457 nm (phen-carboxyl), 457 nm (nitrophen-carboxyl) and 462 nm 
(amino) band respectively.  The shift in the max of the amino complex of 
approximately 5 nm to longer wavelength compared to the carboxyl complexes, is 
consistent with the fact that the amino ancillary ligand is a slightly better σ-
donating ligand.
[99]
  This shift to longer wavelength suggests a decrease in the 
HOMO-LUMO band gap for the t2g to ligand * transition.   
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The strong absorbance peak at approximately 265 nm in the spectrum of 
[Ru(phen)2(picCOOH)]
2+ 
may be assigned to π-π* transitions within the 
phenanthroline ligands.  This peak has shifted approximately 9 nm to a longer 
wavelength for both complexes containing nitro functionalised phenanthroline 
ligands, when compared to [Ru(phen)2(picCOOH)]
2+
.  These peaks are found at a 
wavelength approximately 10 – 15 nm shorter than [Ru(bpy)2(picCOOH)]
2+
, 
described previously in the literature.
[11]
  The wavelength of the peak is clearly 
dependent on the phenanthroline ligand, which confirms the peak as a π-π* 
transition of the NO2phen ligands.  These ILCT π-π* transitions permit 
hyperconjugation between the electronic structures and aromatic rings which 
increases the stability of the complexes.  This causes a decrease in the HOMO-
LUMO energy gap which results in a shift to longer wavelengths.
[100, 101]
 
 
The other transitions in the UV/VIS spectra of each complex at 
approximately 340 nm are attributed to π-π* transitions of the [pic-R] ligands. 
This is confirmed as these bands exhibit a strong pH dependence, as expected 
as the pic ligands contain two ionisable protons on the imidazole ring, as 
discussed in the introduction.  The 260 nm transition is thought to have MLCT 
character as a high energy CT transition was observed in [Ru(bpy)3]
2+
.
[5] 
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Emission Intensity of ruthenium complexes vs Wavelength 
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3.2.3.2 Photophysics 
 
 
 
[Ru(NO2phen)2(picCOOH)]
2+ 
       
[Ru(phen)2(picCOOH)]
2+ 
       [Ru(NO2phen)2(picNH2)]
2+
 
 
 
 
 
 
 
 
Figure  3.14:  Overlaid  emission  spectra  of 10M  acetonitrile  solutions  of 
[Ru(NO2phen)2(picCOOH)]
2+ 
(excited at 457 nm), [Ru(phen)2(picCOOH)]
2+
 
(excited at 457 nm) and  [Ru(phen)2(picNH2)]
2+
 (excited  at  462  nm).    Emission 
slit:  5 nm, excitation slit: 5 nm, PMT detector voltage: 600V.    Samples are not 
absorbance matched.  
 
Shown in Figure 3.14 are the emission spectra for the synthesised 
ruthenium(II) complexes.  Table 3.21 summarizes the spectroscopic data for the 
three complexes.  The  emission  spectrum  of  [Ru(NO2phen)2(picCOOH)]
2+
  
exhibits  a maximum emission at 621 nm when excited into the MLCT 
absorbance band at 457 nm.  Excitation into the [Ru(phen)2(picCOOH)]
2+ 
MLCT 
band
 
also resulted in an intense emission at 619 nm.  The emission spectrum of 
[Ru(NO2phen)2(picNH2)]
2+
 exhibits a slight red shift to 634 nm.  This is again a 
result of the electron donating nature of the amino substituent, which leads to a 
decrease in the LUMO energy for the picNH2 ligand.   Importantly, the Stokes 
shift for all synthesized complexes exceeds 150 nm, reducing the possibility for 
concentration quenching or self-absorption by the complex where these 
complexes are used in imaging.  The Stokes shift also allows the possibility for 
the acquisition of resonantly enhanced Raman spectra without interference from 
the emission of the complex when exciting into the MLCT band. 
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3.2.3.3 Emission Lifetime 
 
 
 
 
 
 
 
 
  
Figure 3.15: Emission lifetime of [Ru(NO2phen)2(picCOOH)]
2+
 (20 M) in 
acetonitrile solution 
 
The emission decays of all three complexes follow mono-exponential 
kinetics in aerated and in degassed acetonitrile (using argon).  The lifetime of 
[Ru(NO2phen)2(picCOOH)]
2+ 
was 159 ns in aerated acetonitrile and 451 + 3 ns in 
degassed acetonitrile, while the lifetime of [Ru(phen)2(picCOOH)]
2+
 was 151 ns in 
aerated acetonitrile and 430 + 5 ns in degassed acetonitrile.  The observed 
lifetime increase in the absence of oxygen is indicative of the triplet MLCT 
character of the emission.  The quenching mechanism is expected to be triplet to 
triplet energy transfer to oxygen resulting in loss of emission at the ruthenium 
centre and production of singlet oxygen.  The lifetime of 
[Ru(NO2phen)2(picNH2)]
2+
 was 61 ns in aerated acetonitrile and 79 ns in 
degassed acetonitrile.  As oxygen quenching is a diffusion controlled process the 
oxygen sensitivity is lower in short lived complexes.  
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Table 3.21: Optical properties of Ruthenium (II) Complexes Synthesised. 
Absorbance measurements were carried out at room temperature at 
concentrations of 20 x 10
6
 M. Lifetime values were measured in aerated / 
degassed acetonitrile at room temperature and fit to monoexponential 
decay plots. Photoluminescent quantum yield () measured in degassed 
acetonitrile at room temperature, using [Ru(bpy)3]
2+
 as a standard.  
 
compound 
Absorbance 
max 
(, dm
3
mol
-1
cm
-1
) 
Emission 
max 
 (ns) 
aerated / 
degassed 
 
[Ru(phen)2(picCOOH)]
2+
 
457 nm (13,193) 
336 nm (20,090) 
265 nm (51,297) 
611 nm 159 / 451 0.048 
[Ru(NO2phen)2(picCOOH)]
2+
 
457 nm (11,871) 
338 nm (21, 304) 
274 nm (44,611) 
611 nm 151 / 430 0.042 
[Ru(NO2phen)2(picNH2)]
2+
 462 nm (11,984) 
337 nm (27,545) 
274 nm (45,135) 
632 nm 61 / 79 0.031 
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3.2.4 Ruthenium triazolate complexes and their Polypeptide conjugates 
 
3.2.4.1 Absorbance 
 
Shown in figure 3.21 is the UV/VIS absorbance of the [Ru(bpy)2htrz-arg8]
9+
 
and its parent dye which exhibits four electronic transitions at approximately 227 
nm, 258 nm, 290 nm and 458 nm. The molar extinction coefficients of the 
ruthenium peptide conjugate were calculated to be 78,9426 M
-1
cm
-1
, 64,037 M
-
1
cm
-1
 117,611M
-1
cm
-1
 and 19,800 M
-1
cm
-1
 respectively.  Conjugation of the 
ruthenium(II) dye to the peptide did not cause any significant alterations to the 
wavelength of absorbance and emission of the conjugate when compared to the 
parent dye. 
 
 The UV-vis spectra of both complexes are distinguished by a ruthenium 
d to ligand * a metal to ligand charge transfer (MLCT) at 458 nm, with the tail of 
the dye – peptide extending to a slightly longer wavelength. The shoulder at 
approximately 340 nm is attributed to π-π* transitions of the triazole ligand. As 
reported in section 1.1.4, these bands exhibit strong pH dependence as the 
ligands contain two ionisable protons on the triazole ring.  The strong absorbance 
peak at approximately 289 nm may be assigned to π-π* transitions within the 
bipyridine ligands. 
 
The absorption band at 458 nm is similar to that of ruthenium triazole 
complexes previously described by Lees et al.
[102]
 who reported MLCT transitions 
at 460 nm and 461 nm.  In these complexes, a red shift of approximately 25 nm 
was observed for pyridine based complexes explained by the strong -donor 
effect of the pyridine ring.  [Ru(bpy)2htrz-arg8]
9+
 and its parent dye also show the 
same spectral properties as those of the corresponding [Ru(bpy)2(2-ppt)] complex 
where ppt is 5-(pyridin-2-yl)-1,2,4-triazole.
[103]
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3.21: Absorbance spectra of [Ru(bpy)2htrz-arg8]
9+
 and [Ru(bpy)2htrz]
+
 (20 x 10
-6
 
M) in PBS buffer (pH 7.4) solutions 
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3.2.4.2 Photophysics 
 
 Shown in Figure 3.22 is the emission spectrum of [Ru(bpy)2htrz-arg8]
9+
 
and its parent dye. The emission spectrum of the parent complex exhibits a 
maximum emission at 651 nm when excited into the MLCT absorbance band at 
458 nm with a quantum yield of 0.005 in PBS. The emission decays follow 
monoexponential kinetics with the excited state lifetime of [Ru(bpy)2htrz-arg8]
9+
 in 
the presence of oxygen in PBS reduced from 147 ns to 91 ns, with the parent 
complex being reduced from 139 ns to 84 ns. The decrease in lifetime in the 
presence of oxygen is also an indication of the triplet MLCT character of the 
emission.
[12]
  Table 3.22 compares the photophysical results of the parent 
ruthenium dye and the ruthenium – peptide conjugate. The lifetimes and quantum 
yields are very similar in the comparison of the free ruthenium (II) dye with the 
conjugated complex indicating that the peptide had little effect on the 
photophysics of the luminophore. These results correspond well with previous 
studies into ruthenium bipyridyl peptide conjugates which also showed little 
impact on optical or photophysical properties when conjugated.
[12]
  Ruthenium 
triazole complexes containing two carboxy-bipyridine ligands reported by Lees et 
al. had an emission maxima of over 670 nm, a red shift of 20 nm with respect to 
the values observed for bpy derivatives.
[102]
  Emission in ruthenium polypyridyl 
complexes occurs from a triplet metal to ligand charge transfer (
3
MLCT) state.  
Detailed resonance Raman studies, excited state pKa measurements and 
isotopic labelling studies have shown that for pyridine triazole complexes this 
emitting state is bpy-based,  irrespective  of  the  state  of  protonation  of  the  
triazole  ring.
[104]
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Compound 
Absorbance 
max 
(, dm3mol-1cm-1) 
Emission 
max 
 (ns) 
aerated / 
degassed 
 
[Ru(bpy)2htrz]
2+
 457 nm (19,626) 
290 nm (116,931) 
258 nm (64,129) 
227 nm (78,302) 
651 nm 84 / 139 0.005 
[Ru(bpy)2htrz-arg8]
10+
 458 nm (19,800) 
291 nm (117,611) 
258 nm (64,037) 
227 nm (78,942) 
651 nm 91 / 147 0.006 
Table 3.22: Optical properties of ruthenium peptide conjugate and parent 
complex. Absorbance measurements were carried out at room temperature at 
concentrations of 20 x 10
6
 M. Lifetime values were measured in aerated / 
degassed PBS at room temperature and fitted to monoexponential decay plots. 
Photoluminescent quantum yield () were measured in degassed PBS at room 
temperature, using [Ru(bpy)3]
2+
 as a standard. 
 
 
 
 
 
3.22: Overlaid emission spectra of [Ru(bpy)2htrz-arg8]
9+
 and [Ru(bpy)2htrz]
+
 (20 x 
10
-6
 M) in PBS buffer (pH 7.4) solutions. Emission slit:  5 nm, excitation slit: 5 nm. 
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3.2.4.3    pH Dependence Studies 
 
[Ru(bpy)2(htrz)]
+
 contains a triazole moiety, and is therefore ionizble – 
comparable ligands have been discussed previously and the protonation state of 
the trizole, dramatically affects the optical properties of the complex.
[104]
  This is 
due to the triazole ring being directly bonded to the metal and its protonation 
state affects the s-donor properties of the ligand.  Vos
[105]
 has previously reported 
a Ru (II) bipyridyl triazole complex where deprotonation of the triazole ligand 
resulted in lower oxidation potentials and in a red shift of the lowest energy dπ-π* 
absorption band.  This effect is due to the stronger σ-donor ability of the 
deprotonated ligand.  The acid – base behaviour of the triazole also has a 
profound effect on the photostability of the complex and this is discussed further 
in chapter 4. 
 
In order to measure the effect of pH on the absorbance and emission 
spectra, [Ru(bpy)2(htrz)]
+
 was dissolved in phosphate buffered saline (pH 7.4) 
and pH was increased using sodium hydroxide; a separate aliquot of the same 
solution was decreased in pH with the gradual addition of perchloric acid.  The 
absorbance and emission spectra were recorded at 0.5 pH unit intervals.  To 
avoid spectral changes due to volume adjustment, working solutions of 20 cm
3
 
were used in conjunction with L aliquots of acid or base. 
 
Shown in Figure 3.23 are the three ionisable sites exhibited by 
[Ru(bpy)2(htrz)]
+
, two on the triazole and one on the carboxylic acid.  Monitoring 
the electronic absorption spectra allows the protonation and deprotonation of 
these sites to be studied which can provide insight into the extent of electronic 
communication within the metal complex as a function of pH
[11]
.  
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Figure 3.23: Available ionisable sites on [Ru(bpy)2htrz]
+
 
 
Shown in figure 3.24 the ligand centered π-π* transition of the protonated 
species at 342 nm is shifted slightly to a shorter wavelength compared to the 
deprotonated species.  The shift to lower wavelength and therefore higher energy 
suggests an increase in the HOMO-LUMO energy gap due to carboxylate 
formation.
[11]
 The bpy π-π* transition appears slightly shifted from 284 nm to 281 nm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  3.24:  Absorbance  spectra  of  [Ru(bpy)2(htrz)]
+ 
(10M) in PBS buffer 
solution, upon addition of µl aliquots of perchloric acid solution.(inset) pH titration 
curve  of [Ru(bpy)2(htrz)]
+ 
in PBS  solution,  monitoring  the  changes in 
absorbance at 283 nm upon addition of perchloric acid. 
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Deprotonation of the species leads to the triazolate complex above pH 6, 
showing a red shift in the MLCT from 449 nm to 472 nm, LC (htrzCOOH) π-π* 
transition at 345 nm and a shift in bpy π-π* transition from 284 nm to 287 nm.   
As the triazole ring is directly bound to the ruthenium centre, deprotonation of the 
ligand leads to increased s-donation ability and therefore increased ligand field 
splitting causing the t2g level to be reduced, which results in the observed red shift.  
These effects have been previously noted in imidazole and triazole ligands.
[11]
 
 
The ground state pKa values were determined by monitoring the spectral 
changes at 283 nm in the absorbance spectrum across a pH range of 0.8 – 12.7.  
Shown in figures 3.24 inset and 3.25 inset are plots of absorbance at 340 nm 
versus pH and from this data the point of inflection was determined by 
differentiation.  The pKa values were estimated to be 1.9 and 6.9 respectively.  
Protonation  of  the  triazole,  to  give  the  triazolium,  occurs  at  low  pH  so the 
pKa value can only be given as an estimate.  This protonation at low pH is 
believed to be due to coulombic repulsion between the positively charged 
triazolium ring and the positive metal centre.
[11] 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  3.25:  Absorbance  spectra  of  [Ru(bpy)2htrz]
+ 
(10M) in PBS buffer 
solution, upon addition of µl aliquots of 7M sodium hydroxide solution.(inset) pH 
titration curve  of [Ru(bpy)2htrz]
+ 
in PBS  solution,  monitoring  the  changes in 
absorbance at 283 nm upon addition of 7M sodium hydroxide solution. 
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Protonation of the triazole on the ancillary ligand greatly affects both 
luminescent intensity and emission wavelength when compared to 
[Ru(bpy)2htrz]
+
.  The red shift observed is greater than that observed in the 
equivalent absorbance spectra and may therefore due to a stabilising 
electrostatic interaction between the MLCT generated bpy anion radical and the 
extra positive charge of the triazolium.
[11]
  The excited state pKa* values were 
estimated to be 1.6 and 8.5, respectively, from the graphs in Figures 3.26 (inset) 
and 3.27 (inset).   These values were calculated using the Förster cycle. 
 
The pKa values for the ground and excited state are similar, which 
suggests that the location of the excited state is not on the ionisable ligand but on 
the bipyridine ligands.  This is also consistent with the excited state pKa* studies 
on comparable triazole complexes.  Vos et al. have previously demonstrated that 
a large change in pKa values would be expected if the excited state was on the 
triazole ligand.
[103] 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.26:  Overlaid emission spectra of [Ru(bpy)2htrz]
+ 
(10M) in PBS buffer 
upon addition of perchloric acid.   Emission slit:  5 nm, excitation slit: 5 nm, PMT 
detector voltage: 600v, (inset) pH titration curve of [Ru(bpy)2htrz]
+ 
in PBS  
solution,  monitoring  the  difference in emission intensity upon addition of 
perchloric acid. 
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A significant red shift is observed upon deprotonation with sodium 
hydroxide from 629 nm to 652 nm.  This spectral shift is most likely due to the 
stabilising electrostatic interaction between the MLCT generated bpy anion 
radical and the extra positive charge of the triazolium. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.27:  Overlaid emission spectra of [Ru(bpy)2htrz]
2+ 
(10M) in PBS buffer 
upon addition of sodium hydroxide solution.   Emission slit:  5 nm, excitation slit: 5 
nm, PMT detector voltage: 600v, (inset) pH titration curve of [Ru(bpy)2htrz]
+ 
in 
PBS  solution,  monitoring  the  difference in emission intensity upon addition of 
7M sodium hydroxide solution. 
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3.2.4.4 Resonance Raman Spectroscopy 
 
Raman spectroscopy is a fundamentally weak phenomenon, as only 1 in 
10
6
 photons are inelastically scattered.  However if the excitation laser coincides 
with an intense optical transition of the molecule, the signal may be significantly 
enhanced.  This phenomenon, known as resonance Raman spectroscopy 
provides an enhancement of 10
3
 up to 10
7
 in signal in the vibrations of the 
chromophores involved in the transition, as described in greater detail in the 
general introduction.  It has been used in biosensors to detect dye labelled 
targets as dyes can provide strong resonance Raman signals.
[106, 107]
  Resonance 
with the MLCT transitions of ruthenium (II) polypyridyl  complexes can yield  
intense Raman spectra with excellent signal-to-noise  ratio.  One of its key 
applications in studying coordination compounds with mixed ligands has been in 
the assignment of the optical transitions. 
 
[Ru(bpy)2(htrz)]
+ 
was irradiated with 458, 488 and 514 nm laser lines.  The 
458 nm laser line is coincident with  the  main  visible  MLCT  absorption  of  the  
complex  (as  described  in  the  UV-vis absorbance spectrum) and under these 
resonance conditions the vibrational modes associated only with the 
chromophores are enhanced.  No pre-resonance lines of higher energies were 
used in this analysis.    
 
Shown in figure 3.28 is an overlay over the resonance Raman spectra of 
the complex irradiated at 458, 488 and 514 nm.  The signature bipyridyl 
vibrational modes are observed in each with no significant changes observed 
between the data, the frequencies and approximate assignments are shown in 
table 3.23.  This suggests that the lowest energy optical transition in each case, 
arises from a ruthenium (dπ) to bipyridyl ligand (π*) MLCT transition.  There is 
also evidence of a weak ruthenium-nitrogen stretch at 375 cm
-1
 also consistent 
with this assignement.  All the Raman modes were collected in solution and 
assigned according to the published data.
 [108, 109]
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Shown in figure 3.29 is an overlay of the resonance Raman spectra of the 
complex at pH 12 irradiated at 458, 488 and 514 nm. This pH range allowed 
exploration of the deprotonated species, two additional Raman peaks at 1082cm
-
1
 and 1126cm
-1
 are observed at this pH with 514 nm excitation.  While they 
appear at pH 12 when excited using the 458 nm and 488 nm laser lines, the 
peaks are much weaker and appear with far greater intensity with 514 nm 
excitation.  As these peaks are more pronounced in the 514 nm spectrum, they 
may be attributed to lower energy Raman signals due to pyridyl in-plane twisting 
modes. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.28: Stacked Raman spectra of [Ru(bpy)2(htrz)]
+
. Samples were 
measured in their solid state using 458  nm  (top),  488  nm  (middle)  and  514  
nm (bottom) excitation laser lines.  All spectra were gathered with 5 acquisitions 
and an exposure  time  of  2  seconds  with  a  laser  power  of  10mW 
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Figure 3.29: Stacked Raman spectra of [Ru(bpy)2(htrz)]
+ 
at pH 12. Solid Samples 
were measured in their solid state using 458 nm (top), 488 nm (middle) and 514 
nm (bottom) excitation laser lines.  All spectra were gathered with 5 acquisitions 
and an exposure  time  of  2  seconds  with  a  laser  power  of  10mW. 
 
 
 
Table 3.23: General assignment of Raman vibrational modes of the ruthenium (II) 
complexes synthesised using 458 nm excitation. 
458 nm excitation (cm
-1
) Assignment 
Bipyridyl vibrational 
modes: 
~ 1609 
~ 1564 
~ 1490 
~ 1315 
~ 1281 
~ 1189 
~ 1030 
~ 668 
C = C stretch 
C = C stretch 
C = C stretch 
C = C stretch 
C-C (inter-ring bending) 
CCH (in-plane bending) 
Ring breathing 
Pyridyl in-plane twisting 
ruthenium – ligand 
vibrational modes: 
~ 375 Metal-ligand stretch 
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3.2.4.5 Photostability – irradiation under white light 
 
 One of the key disadvantages of conventional organic fluorophores used 
in cell imaging, such as fluorescein and its derivatives is the very poor 
photostability.  This can severely restrict their usefulness in monitoring dynamic 
processes in cells where continuous irradiation over seconds or minutes is 
required.  Neugebauer
[12]
 has previously reported the improved photostability of 
Ru(II) complexes in cell applications compared to such probes.  However, Ru(II) 
triazole complexes in particular have been reported to exhibit very high 
photostability.
[102-104]
  Therefore, here we examined and compared the order to 
determine the stability of [Ru(bpy)2(htrz)]
+
 under white light irradiation in 
acetonitrile (which can act as a coordinating ligand and destabilise the complex) 
and in PBS buffer, i.e. conditions like those in cell imaging.  10M samples in 
acetonitrile (and PBS) were placed in front of a white light lamp for six hours.  As 
a reference, [Ru(bpy)3]
2+
  was used and the absorbance of both samples were 
measured.   
 
 A key advantage of many ruthenium (II) complexes is that they are not as 
susceptible to photobleaching as many organic based molecular probes.  The 
photobleaching of [Ru(bpy)2htrz-arg8]
9+
 in myeloma cells is discussed in section 
4.3.5, where the sample was irradiated using a 458 nm laser line.  Studies of the 
temperature dependence of the emission of ruthenium – bipyridyl complexes 
containing triazole ligands indicate that thermal population of the deactivating 
triplet metal – centered state does not occur.[104]  As a consequence of this, these 
compounds are expected to be photostable.  This photostability is most likely 
caused by the strong  - donor properties of the deprotonated triazole ligand, 
which induces strong ligand ﬁeld splitting in the complex.[110] 
 
 Shown in Figure 3.30 is the absorbance spectra of and [Ru(bpy)3]
2+
 in 
PBS buffer (pH 7.4) solution and  shown in Figure 3.31 is the absorbance spectra 
of [Ru(bpy)2htrz]
+
 in PBS buffer (pH 7.4) solution; both samples were absorbance 
matched. 
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Figure 3.30: Absorbance spectra of and [Ru(bpy)3]
2+
 in PBS buffer (pH 7.4) 
solution. Sample was absorbance matched with [Ru(bpy)2htrz]
+
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Figure 3.31: Absorbance spectra of [Ru(bpy)2htrz]
+
 in PBS buffer (pH 7.4) 
solution. Sample was absorbance matched with [Ru(bpy)3]
2+
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Shown in Figures 3.30 and 3.31 are the reduction in the absorbance of 
[Ru(bpy)3]
2+
 and [Ru(bpy)2htrz]
+
 respectively in PBS buffer (pH 7.4) solution.  
Monitoring the MLCT band, samples were absorbance matched and both 
complexes found to reduce by approximately 20% each over six hours.  That the 
degradation occurs over such a large time range shows the large advantage that 
these inorganic complexes have over organic fluorophores, which would be 
expected to be completely destroyed in a matter of minutes.
[12, 111]
   
 
As previously described, ruthenium triazole complexes are known to be 
stable compared to those of [Ru(bpy)3]
2+
, so the fact that both complexes showed 
similar stability here is surprising.
[112]
  As this experiment was carried out using a 
UV lamp, it is perhaps not the most accurate method of comparing the 
photostability of the two complexes.  A more accurate test is the photobleaching 
experiment described in section 4.3.5.  To further investigate the stability of both 
dyes under UV irradiation, it is suggested to expose the samples to a greater 
power source, while varying solvent to obtain a broader data set.  The stability 
shown is however, again evidence that these complexes are extremely useful for 
cell imaging and studying the dynamics of cellular processes. 
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3.2.5 Synthesis of ruthenium – BODIPY sensor 
 
 An initial aim of this project was to produce a ruthenium – peptide 
conjugate that also contained a pH and oxygen insensitive fluorophore as a 
reference molecule to the environmentally sensitive ruthenium centre.  The 
BODIPY derivative prepared was BODIPY-NHS ester, which was prepared 
according to a method previously described for this compound but in this case 
modified to yield the for the NHS ester which was new and synthesised with a 
61% yield.  The NHS ester was prepared with the intention of coupling to the NH2 
terminus of the starting material [Ru(NO2phen)2(picNH2)]
2+
 complex described 
above.   
 
 After encountering a number of synthetic difficulties the final BODIPY – 
conjugated ruthenium complex was not successfully isolated.  Two ruthenium 
nitrophenanthroline complexes were however successfully synthesised with an 
amino and carboxyl terminus on respective ancillary ligands.  Carboxy and amino 
terminated BODIPY probes were also successfully synthesised however these 
complexes were ultimately never conjugated with the ruthenium dye.  The 
attempted amine coupling via reactive esters only led to starting materials being 
recovered.  The reaction of the ruthenium dye with the BODIPY – NHS ester may 
in future be achieved in a different solvent system, with DMF or DMF / water 
90/10 mix possible systems worth investigating.  The reaction time and pH for 
these processes are also important as the reaction may become more acidic over 
time; this can drive the reaction backwards by hydrolysing the NHS ester.
[113]
  
Constant monitoring by TLC may be a method of determining if this is the 
process undergone and increasing the starting materials may be necessary. 
 
 Following failure of the NHS ester coupling approach a second synthetic 
strategy described previously in this chapter was attempted to exploit the 
BODIPY molecule‟s carboxyl reactivity with the NH2 terminus of the ruthenium(II) 
complex, [Ru(NO2phen)2(picNH2)]
2+
.  This approach was attempted via a 
EDC/NHS coupling reaction.
[114]
    However, this method failed to produce the 
BODIPY – ruthenium conjugate.  It is surprising that this reaction was 
unsuccessful considering it is a well known often used technique.   
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Each reaction was carried out a total of ten times but the only products 
recovered were starting materials.  For future work different coupling reagents 
may be attempted.  (2-(7-Aza-1H-benzotriazole-1-yl)-
1,1,3,3tetramethyluroniumhexafluorophosphate) [HATU] is used in peptide 
synthesis to introduce the active ester and is an alternative coupling reagent, in 
addition to using DIPEA as base to ensure the pH is raised to 7.5.  [HATU] has 
previously been used for the robust coupling of peptides and allows greater 
experimental flexibility than the EDC/NHS coupling for more challenging 
synthesis.
[115]
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3.3 Conclusions 
 
 The synthesis and characterisation of ruthenium (bis-2,2-5-
nitrophenanthroline)-2(4-aminophenyl)imidazo[4,5-f]1,10-phenanthroline 
[(Ru(NOphen)2PicNH2)]
2+
 and ruthenium (bis-2,2-5-nitrophenanthroline)-2-(4-
carboxylphenyl)imidazo[4,5-f]1,10-phenanthroline [(Ru(NOphen)2PicH2)]
2+
, two 
novel nitrophenanthroline – ruthenium – pic complexes with different terminal 
functionality, as well as the phenanthroline parent complex were described.  Both 
the carboxyl and amino functionalised complexes behave very similarly and may 
be characterised by their comparable absorbance and emission.   
 
The amino and carboxy terminated ruthenium complexes were compared 
using spectroscopic methods, with the MLCT band in the absorbance spectrum 
of [(Ru(NOphen)2PicNH2)]
2+
 exhibiting a shift of approximately 5 nm to longer 
wavelength compared to the carboxyl complexes, is consistent with the amino 
ancillary ligand as a slightly better σ-donating ligand.  Transitions at 340 nm were 
found to be pH dependent and were attributed to π-π* transitions of the [pic-R] 
ligands, contain two ionisable protons on the imidazole ring. 
 
[Ru(bpy)2htrz]
+
, prepared by Dr D Plazuk was characterised by pKa 
titration, Raman spectroscopy and UV irradiation.  Deprotonation of the complex 
above pH 8.5 led to a spectral shift due to the stabilising electrostatic interaction 
between the MLCT generated bpy anion radical and the extra positive charge of 
the triazolium moiety.  Raman spectra showed no significant changes observed 
at different excitation laser lines.  This suggests that the optical transition arises 
mainly from a ruthenium (dπ) to bipyridyl ligand (π*) MLCT transition.  This 
complex was designed for conjugation to a cell penetrating peptide and exploited 
as a tool for resonance Raman mapping in a cellular environment. Resonance 
Raman of the complex in its solid form showed signature bipyridyl vibrational 
Raman modes which were observed using 458, 488 and 514 nm laser lines, with 
no significant changes between the data.  This suggested that the lowest energy 
optical transition arises from a ruthenium (dπ) to bipyridyl ligand (π*) MLCT 
transition.   
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The photostability of [Ru(bpy)2htrz-arg8]
9+
 was compared with [Ru(bpy)3]
2+
 
by monitoring the MLCT band.  Both samples were exposed to UV irradiation for 
six hours, over which times both complexes degraded by approximately 20% 
each over six hours.  Due to the high photostability of previously reported 
ruthenium – triazole complexes, the similar degradation of both dyes is 
surprising.  However the fact that it occurs over such a large time range shows 
the large advantage that these inorganic complexes have over typically photo-
unstable organic fluorophores. 
 
 The initial aim of this work, to produce a BODIPY – conjugated ruthenium 
complex was not achieved, as the target molecule was never successfully 
isolated.  An attempt to conjugate the ruthenium(II) dye with the BODIPY – NHS 
ester may in future be achieved in a different solvent system or using alternative 
reaction conditions.  The well – known EDC/NHS coupling reaction was used in 
an attempt to conjugate the carboxyl group on the BODIPY dye to the amino 
terminus of [Ru(NO2phen)2(picNH2)]
2+
, however this also proved unsuccessful.  
This strategy may be revisited with the use of different coupling reagents.  
Another strategy may be to attach the BODIPY dye to a peg – linker with an 
amino or carboxyl terminus.  The reaction may be more sterically favoured and 
could proceed with a ruthenium – pic complex with a carboxyl or amino terminus 
with the use of a coupling reagent. 
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Chapter 4: Ruthenium – Peptide Conjugates for Cellular Imaging 
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4.1 Introduction 
 
Live cell imaging has been revolutionised by advances in luminescence 
microscopy, in particular laser scanning and confocal microscopy.  In addition, 
such technology has revolutionised Raman spectroscopy and confocal Raman 
microscopes can be used to scan a surface in a similar manner to a 
luminescence confocal microscope, but provide information on structure and 
composition of the material which is beyond the scope of luminescence.  
 
 Raman is however, limited by its low sensitivity and the long acquisition 
times needed.  This means that in imaging the long dwell-times of the laser on a 
single spot are required for each step scan leading potentially to photodamage to 
the sample.  In the case of cells, if they are non-adherent they may possibly 
move during long acquisition times.  Nonetheless, the key advantage of Raman is 
that it directly probes structure and in the case of resonance Raman the 
sensitivity and consequently acquisition times can be dramatically improved. If 
the resonance Raman probe has a structural marker of environment for example 
of protonation status it can be used to sense environmental change within a cell.  
 
 Many organic based molecular probes which have been used for sensing 
diagnostic roles typically have the disadvantage of short-lived fluorescent 
lifetimes (<10 ns) and are susceptible to photobleaching when used in laser 
scanning microscopy. Such probes are also not suitable for resonance Raman as 
their relatively small Stoke‟s shift means ﬂuorescence overwhelms the weaker 
Raman response. Short lived probes are unsuitable as they are unable to monitor 
other long lived processes such as membrane diffusion, protein rotation and 
protein folding.  
 
A key advantage of ruthenium(II) polypyridyl and related luminescent 
metal complexes when compared to traditional ﬂuorescent imaging dyes is their 
long lived triplet excited states, which make them far more sensitive to their 
environment, particularly to molecular oxygen which is itself triplet in the ground 
state.  The long lived fluorescent lifetime of these complexes is of particular 
interest, as it allows for discrimination from the shorter-lived background 
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fluorescence (typically less than 10 ns) present in many biological samples. The 
possible barriers of concentration quenching or self-absorption of the complex 
are removed by their large Stokes shift. Additionally, their emission is red shifted 
and removed from regions of the spectrum where autoluminescence of biological 
samples can occur.  This can facilitate the use of fluorescent light imaging (FLIM) 
and confocal microscopy measurements. As the Stoke‟s shift of Ru(II) complexes 
is typically up to 200 nm, the collection of intense interference free resonance 
Raman spectra is permitted at a wavelength that also excites emission.
[116]
 
Resonance Raman mapping allows the total spatial distribution of the dye in the 
cells to be determined.  
 
The difficulty in transporting luminescent metal complexes across the cell 
membrane of living cells without disrupting the cell was discussed in chapter 1.  
As described, octaarginine as a molecular cargo carrier a derivative of naturally 
occurring of the cell penetrating peptide Tat can be attached to a ruthenium 
complex to facilitate passive transport of the dye across the cell membrane. The 
ability of these peptides to diffuse across the cell membrane is highly dependent 
on the arginine chain length, with a chain length of Arg5 – Arg11 necessary but 
octa – and nona – arginine showing the greatest carrying ability.[13] This work 
details the cellular activity of a ruthenium octaarginine peptide conjugate, using 
confocal microscopy, fluorescent light imaging and resonance Raman mapping to 
determine the uptake, cytotoxicity, and localization of the dye within SP2 
myeloma cells and Chinese Hamster Ovary cells.  
 
 SP2 and CHO lines were both used as examples of mammalian cells. The 
characteristics of these cell lines are discussed in section 1.41, but one of the 
main differences between the lines is that SP2 myeloma cells are a suspension 
line, whereas CHO cells are adherent and will only grow when they are attached 
to a surface.  The surface protein composition of each cell type is expected to be 
quite different which may affect uptake.
[117]
  The differences arising as a result of 
the biochemical nature of these cell lines is examined using commercially 
available probes which exhibit targeted localization within specific organelles. 
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4.2 Experimental Procedure 
 
To examine and compare the cellular uptake of [Ru(bpy)2htrz-arg8]
9+
 and 
it‟s parent (unconjugated) complex, SP2/0-Ag14 myeloma and Chinese Hamster 
Ovary (CHO) cells were investigated as models of mammalian cells.  The uptake 
and distribution throughout each cell type was compared by examining the 
luminescence distribution from the metal complex using confocal laser scanning 
microscopy, fluorescent lifetime imaging (FLIM) and resonance Raman mapping.  
In a typical protocol for the non-adherent SP2 cells, 10 L of an aqueous solution 
of the Ru-complex [Ru(bpy)2htrz]
2+
 or [Ru(bpy)2htrz-arg8] (1.4 x 10
-4
 M) were 
added to 50 L of the cell suspension to yield a final dye concentration of 2.8 x 
10
-5
 M.  
 
The adherent CHO cells were seeded at a concentration of 1 x 10
5
 cells / 
cm
3
 and grown for two days in a six well flask at 1 cm
3
 per well before imaging. 
Immediate cellular uptake of dye observed for the myeloma cells was not 
observed with the CHO cell line, so to each 1 cm
3
 well, 65 L of an aqueous 
solution of the Ru-complex [Ru(bpy)2htrz]
+
 or [Ru(bpy)2htrz-arg8]
9+
 (1.1 x 10
-3
 M) 
were added to yield a final dye concentration of 2.8 x 10
-5
 M and the cells were 
incubated for six hours.  The growth medium was removed by washing the cells 
with PBS buffer (pH 7.4) and the cells were imaged immediately. 
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4.2.1 Cell Imaging 
 
Using confocal laser scanning microscopy, [Ru(bpy)2htrz]
2+
 and 
[Ru(bpy)2htrz-arg8] were excited using a 458 nm argon ion laser line, 
corresponding to the MLCT absorbance of each complex and the emission 
images were recorded through a 615 nm longpass filter, which cuts out any light 
below 615 nm.  For co-localization studies, the commercially available nuclear 
targeting 3,3'-dihexyloxacarbocyanine iodide (DiOC6(3)) was used to investigate 
the cellular localization of the peptide conjugated dye in both cell lines.  Aqueous 
solutions of DiOC6(3) were added to the final cell suspension to yield a final 
concentration of 0.5 M (to target mitochondria) and 5 M (to target lysozomes 
and the endoplasmatic reticulum).  This counter staining probe was also excited 
at 458 nm and the emission images recorded using a band pass filter from 505 
nm – 530 nm.  
 
The nuclear targeting 4′,6-Diamidino-2-phenylindole dihydrochloride 
(DAPI) was prepared with a final concentration of 300 nM in PBS buffer solution. 
Myeloma cells were washed with PBS and incubated with the DAPI standard 
solution for five minutes, before further rinsing and imaging was immediately 
carried out. The emission was collected with a band pass filter from 425 nm – 
530 nm. The same protocol was used for imaging of the DAPI counter stain with 
CHO cells. 
 
 
4.2.2 Fluorescent Lifetime Imaging  
 
 Myeloma and CHO cells were prepared as described in section 3.2.1. and 
using a 458 nm pulsed diode laser line fluorescent light images were collected 
using a 610 nm longpass filter. To achieve a high resolution, yet also ensure the 
cells retained their viability, 128 x 128 pixel scans were recorded over 
approximately twenty minutes. Specific regions of interest were investigated 
using a zoom of up to x 849 to increase the lifetime count per pixel. 
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4.2.3 Cell Mapping Using Resonance Raman Spectroscopy 
 
 Myeloma and CHO cells were prepared as described in section 
3.2.1. and using a 457.9 nm argon ion laser line resonance Raman mapping was 
performed. This excitation wavelength was selected as it matches the MLCT 
absorbance for the Ru(II) complexes.  The mapping technique involves obtaining 
Raman spectra step wise  across a grid of predefined area where Raman spectra 
are collected at discrete step sizes, e.g. 1 um steps . Each image was garnered 
using five accumulations and a sixty second exposition time. A complete map of 
each cell was recorded in approximately twenty minutes.  The step size was set 
at 0.5 m and the grid size was set at 21 m.  
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4.3     Results & Discussion 
 
4.3.1 Confocal Fluorescence Microscopy – Probe Uptake in Myeloma cells 
 
As described, a major limitation of inorganic dyes is their inability to 
passively transport across a cell membrane without membrane permeabilisation.  
The ability of [Ru(bpy)2htrz-arg8]
9+
 to penetrate mammalian cells was investigated 
using mouse Sp2/0-Ag14 myeloma cells.  The myeloma is a cancerous plasma 
cell and was used as an example of a suspension mammalian cell.  As described 
in section 4.2.1., the peptide conjugated complex was added to a cell suspension 
and imaged using confocal fluorescence microscopy.  For all cells studied in this 
section, [Ru(bpy)2htrz-arg8]
9+
 was subject to a final concentration of 2.8 x 10
-5
 M 
in the incubation medium which resulted in uptake and bright luminescence in the 
cell membrane within one minute. 
 
The cellular imaging results in this section reveal that conjugation of a 
metal complex to the cell penetrating peptide facilitates efficient diffusion across 
mammalian cell membranes without destroying the lipid bilayer.  The ability of the 
ruthenium complex
 
to passively transport across the membrane of SP2 cells, only 
when conjugated to a peptide was confirmed by comparing uptake with the 
parent, unconjugated dye.  Shown in figure 4.11 (a) is a luminescence confocal 
image of the parent ruthenium dye which shows no evidence of membrane 
penetration after incubation for 30 minutes at 37°C.  Neugebauer et al. have 
previously demonstrated that a ruthenium complex with a 2+ charge in the absence 
of peptide cannot penetrate an intact cellular membrane.  However, diffusion of the 
ruthenium parent dye into the cell could be achieved upon permeablizing the cell 
with Triton (1% v/v).
[12]
  Shown in 4.11 (b) is a luminescence confocal image of 
the parent ruthenium dye in a PBS solution containing triton (1% v/v).   This 
illustrates the complex can be incorporated into the cell through permeablisation 
of the cell membrane.  These “rainbow images” utilise a custom false colour 
coding to accentuate cellular image.  However, Triton and in other examples in 
the literature organic solvents such as DMSO or ethanol, damage the cell 
membrane and are therefore not an ideal approach to promote dye entry to a cell. 
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To determine the ability of [Ru(bpy)2htrz-arg8]
9+
 to transport passively 
across the cell membrane, the dye was added to a suspension of SP2 cells and 
imaged using confocal fluorescence microscopy. To maintain cellular conditions, 
uptake of the dye was monitored at 37°C, where it was found to penetrate the cell 
membrane extremely rapidly (the process seemed to be complete in approx 
1min).  Our group has previously demonstrated the ability of a ruthenium – 
peptide conjugate to penetrate a cell membrane in less than 5 minutes,
[12]
 but the 
results reported in this thesis are to our knowledge some of the fastest uptake 
rates reported for such metal complexes.  The rapid migration of dye into the cell 
made monitoring individual biological processes difficult and limited the detail in 
which dye uptake could be studied.  To examine if the uptake process was 
energy dependent, uptake was also examined at a lower, temperature i.e. 25°C.  
Interestingly, this slowed uptake, suggesting the process occurs via an energy 
dependent pathway such as endocytosis.
[13]
  Furthermore slowing uptake, 
allowed the transport across the biological membrane, as well as distribution 
throughout organelles within the cell to be more closely examined.  Shown in 
figure 4.12 is the time dependent ability of the ruthenium peptide conjugate to 
passively transport across the cell membrane.  Shown in (a) is a luminescent 
confocal image of an SP2 myeloma cell incubated with [Ru(bpy)2htrz-arg8]
9+ 
at 25° 
for one minute, while (b) shows the same cell after six minutes.  Cell uptake of 
the dye was found to be irreversible and was complete after six to eight minutes.  
Shown in figure 4.13 is a z-stack of a myeloma cell which has been incubated 
with the ruthenium peptide dye.  Shown in figure 4.14 is the detailed dye uptake 
in an SP2 cell over 20 minutes at 25°C.  The distribution of the dye throughout 
the cell was confirmed through these experiments, with the dye showing 
evidence of localization within specific organelles. 
 
Previous studies of ruthenium polypyridyl complexes reported the ability of 
[Ru(bpy)2(picCOOH)Arg8]
10+
 to transport across a cell membrane of SP2 
myeloma cells via a cell penetrating peptide.
[12]
  The plasma membranes of viable 
cells exhibit a membrane potential (−50 to −70 mV), with the inside of the cell 
negative with respect to the outside.  The concentration of the negatively charged 
phosphatidyl serine leads to this negative charge on the cells inner membrane.  
Therefore a complex with a larger charge will have a greater driving force across 
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the membrane assuming the mechanism is energy dependent.  Interestingly, 
[Ru(bpy)2htrz-arg8]
9+ 
was found to transport rapidly across the membrane, in a 
time frame which was even faster than [Ru(bpy)2(picCOOH)Arg8]
10+
.  
 
It has previously been reported that while a positive net charge of 
hydrophilic peptides enhances the speed of their transport across the cell 
membrane, with increasing molecular size the overall charge of the molecule 
becomes less significant.
[118]
  Another possibility is that two different uptake 
pathways occur for each dyes.  While [Ru(bpy)2(picCOOH)Arg8]
10+
 was found to 
transport across the cell membrane in five minutes, the uptake of [Ru(bpy)2htrz-
arg8]
9+ 
in SP2 cells was even faster and was observed at room temperature.  
However, both dyes exhibited temperature dependence in their uptake, 
suggesting an endocytic pathway. 
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  (a)       (b) 
Figure 4.11: Luminescence confocal rainbow images (explain in text what this is) 
(ex = 458 nm, em = 615nm) (a) of live SP2 myeloma cell incubated with parent 
complex [Ru(bpy)2htrz-arg8]
9+ 
(2.8 x 10
-5
 M) in PBS buffer (pH 7.4) for 30 minutes 
and (b) for 7 minutes after permeablizing the cell with Triton (1% v/v). 
 
 
 
    
 
           
     
 
 
 
 
 
 
  (a)       (b) 
Figure 4.12: Luminescence images (ex = 458 nm, em = 615nm) of SP2 myeloma 
cell incubated with [Ru(bpy)2htrz-arg8]
9+ 
(2.8 x 10
-5
 M) in PBS (pH 7.4) after (a) 1 
minute and (b) six minutes. 
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Figure 4.13: Luminescence confocal z-stack images (ex = 458 nm, em = 615nm) 
of SP2 myeloma cell incubated with [Ru(bpy)2htrz-arg8]
9+
 (2.8 x 10
-5
 M) in PBS 
(pH 7.4) after 20 minutes at room temperature.  
 
To assess the distribution of the dye in cellular organelles, myeloma cells 
were counterstained with commercial cell permeable dyes which exhibit specific 
staining.  3,3'-dihexyloxacarbocyanine iodide (DiOC6(3)) selectively stains 
mitochondria at 0.5M and structures in the cell, including the lysozomes and  
endoplasmatic reticulum at 5M.
[50]
  Shown in figure 4.14 are luminescence 
images of SP2 myeloma cells stained with [Ru(bpy)2htrz-arg8]
9+ 
and counter 
stained with DiOC6(3) (0.5 M).  Shown in figure 4.15 is a z-stack of cells stained 
with the ruthenium peptide dye and counter stained with a higher concentration of 
DiOC6(3) (5 M).   
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From both figures, it is evident that there is no overlap between 
[Ru(bpy)2htrz-arg8]
9+ 
and DiOC6(3) it can therefore be concluded that 
[Ru(bpy)2htrz-arg8]
9+ 
does not localize in mitochondria, lysozomes or endoplasmic 
reticulum of the myeloma cells.  It is clear that although the dye permeates 
throughout the cell the highest intensity emission come from the outer membrane 
or other membrane bound structures within the cell.  One possibility is that 
luminescence is promoted when the complex binds to lipid membrane.  Both 
parent and conjugated dyes were excited with 458nm laser irradiation.  The 
green DiOC6(3) luminescence was collected with a band pass filter from 505nm – 
530nm, while the red luminescence of [Ru(bpy)2htrz-arg8]
9+ 
through a 615 nm 
longpass filter.  
 
 Cells were also stained with the nuclear targeting 4′,6-Diamidino-2-
phenylindole dihydrochloride (DAPI) to further investigate the distribution of dye. 
DAPI stains nuclei specifically, with little or no cytoplasmic labelling.  Shown in 
figure 4.16 are luminescence images of SP2 myeloma cells stained with 
[Ru(bpy)2htrz-arg8]
9+ 
and counter stained with DAPI (300 nM).  DAPI was excited 
with 375nm laser irradiation, while [Ru(bpy)2htrz-arg8]
9+ 
was excited at 488nm. 
The blue DAPI luminescence was collected with a band pass filter from 425nm-
530nm, while the red luminescence of [Ru(bpy)2htrz-arg8]
9+ 
through a 615 nm 
longpass filter.  Shown in Figure 4.17 is luminescence confocal z-stack images of 
SP2 cells stained with the ruthenium – peptide conjugate and then counter 
stained with DAPI.  While the extent of co-localization appears unclear from the 
single confocal image, the z-stack images clearly show that the ruthenium probe 
does not show significant overlap with the DAPI emission, but appears to localize 
just outside the nucleus. 
  
A problem which may arise from these co-localization studies is the 
quenching of DiOC6(3) and DAPI by the ruthenium dye.  In it‟s excited state 
DiOC6(3) emits in the region of 452 nm to 535 nm, while DAPI has an emission 
maxima at 460 nm.  When either DiOC6(3) or DAPI are in their excited state, they 
may act as a donor molecule, transferring energy to the ruthenium dye, a ground 
state acceptor molecule.  This non – radiative energy transfer may be by Förster 
resonance energy transfer (FRET), a mechanism based transition dipoles 
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between the donor and acceptor, or may even occur through a trivial mechanism.  
The extent of energy transfer is determined by the distance between the donor 
and acceptor, and the extent of spectral overlap.  It is important to note that if this 
is occurring it may reduce the intensity of the localisation stain at regions where 
the ruthenium is co-localised and may enhance the emission of the ruthenium 
dye. 
 128 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.14   Luminescence  images  (ex = 458 nm, em =  515nm(a), 615 nm(b))  
of SP2 cells incubated with [Ru(bpy)2htrz-arg8]
9+ 
(2.8 x 10
-5
 M) (b) for ten minutes 
at room temperature before addition of  DiOC6(3) (5 M) (a) in PBS (pH 7.4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.15   Luminescence z-stack  images  (ex = 458 nm, em =  515nm(a), 615 
nm(b))  of SP2 cells incubated with [Ru(bpy)2htrz-arg8]
9+ (2.8 x 10-5 M) (b) for ten 
minutes at room temperature before addition of  DiOC6(3) (5 M) (a) in PBS (pH 7.4).  
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Figure 4.16:   Luminescence confocal images  (ex  =  375  nm,  em  =  440 nm(a), 
(ex  =  488  nm,  em  =  615 nm(b))  of SP2 cells incubated with [Ru(bpy)2htrz-arg8]
9+ 
(2.8 x 10-5 M) (b) for ten minutes at room temperature before addition of  DAPI (300 
nM) (a) to the same cells in PBS (pH 7.4).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.17: Luminescence confocal z-stack  images  (ex  =  375  nm,  em  =  440 
nm(a), (ex  =  488  nm,  em  =  615 nm(b))  of SP2 cells incubated with 
[Ru(bpy)2htrz-arg8]
9+ (2.8 x 10-5 M) (b) for ten minutes at room temperature before 
addition of  DAPI (300 nM) (a) to the same cells in PBS (pH 7.4).  
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To ensure that [Ru(bpy)2htrz-arg8]
9+ 
penetration into live cells occurred 
without leading to their destruction, it was necessary to perform cell viability 
assays.  Sytox green is a probe which only penetrates cells with compromised 
plasma membrane and it is therefore a reliable probe of cell viability. Shown in 
figure 4.17 are SP2 cells stained with the ruthenium peptide dye and counter 
stained with Sytox green.  A cell suspension containing [Ru(bpy)2htrz-arg8]
9+ 
(2.8 
x 10
-5
 M) was incubated at 37°C for one hour to ensure transport across the cell 
membrane.  The cells were then washed with PBS and left in which the external 
buffer containing Sytox green (10 M).   
 
[Ru(bpy)2htrz-arg8]
9+ 
and Sytox green were both excited with 458nm laser 
irradiation.  The Sytox green luminescence was collected with a band pass filter 
from 490nm – 515nm, while [Ru(bpy)2htrz-arg8]
9+ 
was collected through a 615 nm 
longpass filter.  Figure 4.17 (A) shows the Sytox green luminescence within the 
cells, the red channel (B) shows the luminescence arising from [Ru(bpy)2htrz-
arg8]
9+
.  From these Figures, it is clear that the ruthenium dye is present in the 
cytoplasm of an SP2 cell where there is no Sytox present, demonstrating the 
ability of the ruthenium – peptide conjugate to penetrate live myeloma cells.  
Formation of vesicles at the cell membrane known as blebbing is observed in 
figure 4.17 and figure 4.18 and such structures are usually an indication of cell 
death and correspondingly an overlap is observed between the ruthenium dye 
and the Sytox green in these images when blebbing is observed.  This 
demonstrates the ability of the ruthenium – peptide conjugate to penetrate cells 
once their membrane has been permeabilized, which the parent complex was 
already shown to do in figure 4.11.  The important thing to note from this figure is 
the ability of the dye to penetrate live cells.  This work was carried out on a time 
scale not exceeding one hour, in line with previous experiments, so as to confirm 
the viability over that period.  
 
It has previously been reported in the literature that a similar ruthenium 
polypyridyl labelled cell penetrating peptide shows approximately 30% cell death 
upon incubation for two days with SP2 myeloma cells.  Despite this, the cell 
culture was still found to be viable and suitable for imaging purposes.
[13]
  
Inorganic  metal complexes  are  known  to  produce  singlet  oxygen  typically  
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through  an  energy  transfer process  from  its  excited  triplet  state  to  triplet  
oxygen (
3
O2).  Singlet oxygen is known to react with the DNA base guanosine as 
well as a number of amino acids and may lead to cell apoptosis.
[119]
   Although 
the cells here appear viable over the time scale of the experiment explored.  Long 
term exposure of the cells with the complex present under irradiation are likely to 
lead to cell death through this mechanism.  
 132 
 
Figure 4.17: Luminescence  images  (ex  =  458  nm,  em  =  520(A), 615  nm(B))  
of SP2 cells incubated with Sytox green (10 M) and [Ru(bpy)2htrz-arg8]
9+ 
(2.8 x 
10
-5
 M) in PBS (pH 7.4) 
 
 
Figure 4.18:   Luminescence z-stack  images  (ex  =  458  nm,  em  =  520(A), 
615  nm(B))  of SP2 cells incubated with Sytox green (10 M) and [Ru(bpy)2htrz-
arg8]
9+
 (2.8 x 10
-5
 M) in PBS (pH 7.4) 
 133 
4.3.2 Cellular Uptake of [Ru(bpy)2htrz-arg8]
9+
 in CHO Cells 
 
As described in section 1.3.2, Svensson has previously described the 
ability of ruthenium polypyridyl complexes to transport across the cell membrane 
of Chinese Hamster Ovary (CHO) cells.
[43]
  Each dye was dissolved in medium 
and DMSO (1% v/v), which is commonly used when imaging various metal 
complexes to aid solubility issues.
[45]
  While DMSO is not toxic at this 
concentration, it does permeabilize  cells, meaning the dye is not penetrating a 
healthy cell membrane.
[47, 48]
  Ruthenium dipyridophenazine (dppz) complexes 
were found to localize in the endoplasmic reticulum or nucleus of CHO cells.  
Slight modifications of the dppz ligand‟s lipophilicity led to great variations in 
membrane binding.  The least lipophilic complex was found predominantly in the 
nucleus, while complexes of increasing lipophilicity were found to be more 
homogenously distributed in the cells with comparable emission intensities inside 
the nucleus and in the cytoplasm.
[43]
  The cell membrane binding, uptake and 
intracellular localization of [Ru(bpy)2htrz-arg8]
9+ 
in  CHO-K1  cells  were  studied  
with  confocal microscopy. 
 
Interestingly the behaviour was quite different to that of the SP2 cells.  In 
this instance, incubation of the peptide bound ruthenium dye with CHO cells at 
room temperature, no cellular uptake was observed, with little or no 
luminescence seen after an hours incubation.  The minimum incubation time 
found which was suitable for imaging was four hours at 37C, after which bright 
luminescence results in the cell.  For comparison purposes, the concentration of 
[Ru(bpy)2htrz-arg8]
9+ 
was kept at (2.8 x 10
-5
 M), as in the SP2 myeloma 
experiments.  As with the SP2 cells, dye uptake was found to be irreversible, 
however uptake was considerably less efficient, and the final intensity was 
identical once uptake was complete in CHO cells.  Remarkably, in SP2 cells the 
dye was found to passively cross the cell membrane in less than ten minutes at 
room temperature, however even after one hour this was not observed in CHO 
cells.  While some uptake of the ruthenium – peptide conjugate was observed in 
CHO cells after two hours, the intensity shown in SP2 uptake after ten minutes 
was not reached via CHO uptake for four hours.  This result suggests that uptake 
is approximately 20 times faster in the SP2 myeloma cell line than in CHO cells.  
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To the best of our knowledge, there are no examples in the literature of similar 
comparative studies of uptake speed between cell lines where such differences 
are observed. 
  
Shown in figure 4.21 are confocal images of CHO cells after incubation 
with [Ru(bpy)2htrz-arg8]
9+
 at room temperature for one hour. The dye appears to 
distribute throughout the cellular plasma but shows little affinity for individual 
CHO cells or specific organelles.   
 
 Shown in figure 4.22 are confocal images of CHO cells following 
incubation with [Ru(bpy)2htrz-arg8]
9+
 at 37C for four hours.  The ability of the 
ruthenium peptide conjugate to passively transport across the cell membrane is 
again demonstrated here.  The red luminescence was collected through a 615 nm 
longpass filter.  In contrast to the SP2 cells, the ruthenium peptide dye appears to 
localize in the cellular cytoplasm.  Shown in figure 4.23 is a z-stack of a CHO cell 
which has been incubated with the ruthenium peptide dye for four hours, which 
confirms the internalisation of the dye in the cell.   
 
Ruthenium dyes in DMSO (1% v/v) have previously been shown to 
internalise in CHO cells after five minutes
[43]
 but as discussed earlier, these cells 
may have been permeabilized.  Shown in figure 4.24 is a luminescent confocal 
image of CHO cells after incubation for five minutes with DiOC6(3) (5 M).  The 
green DiOC6(3) luminescence was collected with a band pass filter from 505nm – 
530nm.  The outer membrane of the cells are found to be approximately 20 m 
each with nuclear radii of 12 m when measured using the Zeiss LSM Image 
Browser program.  While DiOC6(3) is known to penetrate live cells, what is 
significant here is the rapid uptake seen, which was also observed for the SP2 
cells.  The rapid diffusion shown by the probe may be due to it‟s small size 
allowing faster transport.
[13]
  
 
 
Uptake of the ruthenium dye in CHO cells was considerably less efficient 
than for the myeloma cells.  [Ru(bpy)2htrz-arg8]
9+
 was found to passively cross 
the cell membrane of SP2 myeloma cells in less than ten minutes at room 
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temperature, however even after one hour this was not observed in CHO cells.  
One of the main differences between the cell types are that SP2 myeloma cells 
are a suspension line, whereas CHO cells are adherent and will only grow when 
they are attached to a surface.  It has been previously reported that trypsinization 
had no effect on the binding of alginate – chitosan complexes in CHO cells.[64]  
However, it is possible that the decrease in [Ru(bpy)2htrz-arg8]
9+
 uptake speed 
may be due to specific trypsin – cleavable proteins involved in the 
internalization.
[120]
  Although internalization was effective in both cell lines, the 
significant difference in uptake speed and localization suggests alternative uptake 
pathways in each cell line.
[117]
  Significantly, the speed of uptake in both cell types 
was found to be temperature dependent, which is consistent with endocytosis.
[44] 
 
As both cell lines express both clathrin and caveolin proteins, the reasons 
for alternative uptake pathways are not immediately evident.  Previous studies 
have reported that complex size may be a determining factor in clathrin – 
mediated or caveolin – dependent uptake.[117]  However, the pathway 
dependencies observed here cannot be explained by complex size, nor can 
these results be explained by the composition of the complex as both cell lines 
were treated with one dye at identical concentrations.  While the reasons for cell 
line dependence remain unconfirmed, these results infer that cell physiology is 
critical in complex internalization. 
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  (a)       (b) 
Figure 4.21: Luminescence confocal image (a) and rainbow image (b) (ex = 458 
nm, em = 615nm) of live CHO cells incubated with [Ru(bpy)2htrz-arg8]
9+
 (2.8 x 10
-
5
 M) after one hour in PBS (pH 7.4) at room temperature. 
 
 
 
   (a)       (b) 
Figure 4.22: : Luminescence confocal image (a) and rainbow image (b) (ex = 458 
nm, em = 615nm) of live CHO cells incubated with [Ru(bpy)2htrz-arg8]
9+
 (2.8 x 10
-
5
 M) for four hours in PBS (pH 7.4) at 37C.  
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Figure 4.23: : Luminescence z-stack confocal image (ex = 458 nm, em = 615nm) 
of live CHO cells incubated with [Ru(bpy)2htrz-arg8]
9+
 (2.8 x 10
-5
 M) for four hour 
in PBS (pH 7.4) at 37C.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.24: Luminescence confocal image (ex = 458 nm, em = 515 nm) of live 
CHO cells incubated with DiOC6(3) (5 M) for five minutes in PBS (pH 7.4) at 
room temperature.  At this concentration, the dye localizes in lysozomes and the 
endoplasmatic reticulum. 
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   To ensure that [Ru(bpy)2htrz-arg8]
9+
 was penetrating live CHO cells, it was 
necessary to perform a cell viability assay as for the SP2 cell line to see if Ru and 
Sytox uptake were coincidental.  Sytox green was again used to determine 
viability.  Shown in figure 4.24 is CHO cells stained with the ruthenium peptide 
dye and counter stained with Sytox green.  Both dyes were excited with 458nm 
laser irradiation.  The Sytox green luminescence was collected with a band pass 
filter from 490nm – 515nm, while [Ru(bpy)2htrz-arg8]
9+
 was collected through a 
615 nm longpass filter.  As shown in (c), the ruthenium dye is present in the 
cytoplasm of an SP2 cell where there is no Sytox present.  Channel (b) shows 
the presence of a cell with a damaged membrane that Sytox green has 
successfully localised in the nucleus.  As confirmed in channel (c) the ruthenium 
dye is able to penetrate live cells, with no evidence of any Sytox counter staining 
present. 
 
As mentioned previously in this section, ruthenium dipyridophenazine 
(dppz) complexes with alkyl ether chains localize in the endoplasmic reticulum of 
CHO cells when permeabilized with DMSO (1% v/v).  Shown in figure 3.25 is a 
confocal image of CHO cells stained with [Ru(bpy)2htrz-arg8]
9+
 (2.8 x 10
-5
 M) and 
counter stained with DAPI (300 nM).  4′,6-Diamidino-2-phenylindole 
dihydrochloride (DAPI) stains nuclei specifically, with little or no cytoplasmic 
labelling.  These results demonstrate the ability of the ruthenium dye to enter the 
cell, via a cell penetrating peptide without requirement for permeablisiation.  A 
major advantage of the peptide bound dye is its ability to diffuse passively across 
a cell membrane, ensuring no damage occurs to the cell.  Another key advantage 
of a conjugated peptide is that they render the ruthenium complex water soluble 
in cases where the parent is not.  The cell membrane may become permeabilized 
when DMSO is used due to the toxic nature of it and other organic solvents.  
 
DAPI was excited with 375nm laser irradiation, while [Ru(bpy)2htrz-arg8]
9+
 
was excited at 488nm.  The blue DAPI luminescence was collected with a band 
pass filter from 425nm – 530nm, while the red luminescence of [Ru(bpy)2htrz-
arg8]
9+
 through a 615 nm longpass filter.  As there is no overlap between 
[Ru(bpy)2htrz-arg8]
9+
 and DAPI it can be concluded that [Ru(bpy)2htrz-arg8]
9+
 
does not penetrate the nucleus.  Conversely, comparison of confocal images of 
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the ruthenium probe in CHO cells with DiOC6(3), which localizes in the 
endoplasmatic reticulum at 5 M concentration, suggests that [Ru(bpy)2htrz-
arg8]
9+
 localizes in the endoplasmatic reticulum.  The non – continuous nature of 
the distribution is in agreement with previously mentioned studies which show 
ruthenium dyes in CHO cells which localize endoplasmic reticulum which has a 
large convoluted membrane structure.
[43]
 
  (a)     (b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  (c)     (d)  
Figure 4.24: Luminescence  images  (ex  =  458  nm,  em  = 470 nm (a), 520 nm 
(b), 615  nm(c))  of CHO cells incubated with [Ru(bpy)2htrz-arg8]
9+
 (2.8 x 10
-5
 M) 
(c) for four hours before addition of  Sytox green (10 M) (b) in PBS (pH 7.4).  
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 (a)      (b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      (c) 
 
Figure 4.25   Luminescence  images  (ex  =  375  nm,  em  =  440 nm(a), (ex  =  
488  nm,  em  =  615 nm(b))  of CHO cells incubated with [Ru(bpy)2htrz-arg8]
9+
 
(2.8 x 10
-5
 M) (b) for four hours before addition of  DAPI (300 nM) (a) in PBS (pH 
7.4). 
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4.3.3 Fluorescence Lifetime Imaging Microscopy 
 
A key advantage of ruthenium polypyridyl complexes when compared to 
traditional luminescent imaging dyes are their long lived excited states due to the 
phosphorescent character of their emission, making them far more sensitive to 
their environment.  For example a reduction of over 70% is observed for the 
lifetimes of [Ru(dppz)2Pic]
2+
 and [Ru(bpy)3)]
2+
 in the presence of oxygen in 
acetonitrile compared with deaerated solution.
[5]
  As the emission lifetime is 
independent of luminophore concentration, it is ideal for measurements in a 
cellular environment where the exact concentration of dye may be difficult to 
determine as uptake may vary or the dye may accumulate preferentially in 
different domains within single cells.  From chapter 3, the excited state lifetime of 
[Ru(bpy)2htrz-arg8]
9+ 
in the presence of oxygen in PBS is reduced from 147 ns to 
91 ns, with the parent complex reduced from 139 ns to 84 ns in an air saturated 
solutions.  
 
As described, the luminescence intensity and lifetime of [Ru(bpy)2htrz-
arg8]
9+
 exhibits oxygen dependence.  Shown in figure 4.11 (a) and (c) is the 
luminescence intensity of [Ru(bpy)2htrz-arg8]
9+
 in SP2 and CHO cells 
respectively.  Both cell lines were prepared for fluorescence lifetime imaging as 
described for confocal microscopy experiments described previously.  Shown in 
figure 4.11 (b) and (d) is the luminescence lifetime image of these cells.  These 
false colour images reﬂect the average lifetime of the probe throughout the cell.  
As can be seen from the fluorescent lifetime images, it is difficult to observe 
significant variations in lifetime.  The lifetime of [Ru(bpy)2htrz-arg8]
9+
 was 
measured at specific regions of each cell, with values varying between 119 ns 
and 138 ns.   
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The luminescence lifetime image of myeloma cells are shown in Fig. 4.26, 
with (b) showing the outer membrane of the cell; and (d) showing internal 
structures are a lower depth.  For image (b), a longer lifetime appears at some of 
the external membrane structures, while in contrast the lifetime shown internally 
in the cell in image (d) appears to be fairly uniform.  Interestingly, in the CHO cell 
(f), the lowest lifetime appears on the outer structure of the cell, which is 
consistent with previous studies by Neugebauer
[12]
 which showed that oxygen 
sensitive peptide labelled ruthenium luminophore exhibits its shortest lifetime 
when residing the membrane of a cell. This is expected as the higher solubility of 
O2 in the membrane will result in greater quenching.
[52]
  The CHO cell also 
exhibited no fluorescent lifetime within the nucleus of the cell, which is consistent 
with confocal microscopy images shown in section 4.3.2 which showed that the 
ruthenium – peptide conjugate did not enter the nucleus. 
 
As the ruthenium complex does not exhibit as significant a reduction in 
lifetime as other long lived ruthenium complexes in the presence of oxygen, this 
approach makes it difficult to differentiate various components of the cell.
[13]
  It 
must also be considered that the lifetime within the cell may change as a result of 
something other than O2 e.g. association with membrane, DNA or ROS.  
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Figure 4.26 (a) Luminescence Intensity Image of SP2 Myeloma cells after 
incubation for 10 minutes with [Ru(bpy)2htrz-arg8]
9+
 (2.8 x 10
-5
 M) in PBS (pH 
7.4),  
(b) Fluorescent Lifetime image of the same cell  (ex  =  458  nm,  em  =  615nm);  
(c) Luminescence Intensity Image of SP2 Myeloma cell after incubation for 10 
minutes with [Ru(bpy)2htrz-arg8]
9+
 (2.8 x 10
-5
 M) in PBS (pH 7.4), 
(d) Fluorescent Lifetime image of the same cell  (ex  =  458  nm,  em  =  615nm);  
(e) Luminescence Intensity Image of CHO cell after incubation for four hours with 
[Ru(bpy)2htrz-arg8]
9+
 (2.8 x 10
-5
 M) in PBS (pH 7.4), 
(f)  Fluorescent Lifetime image of the same cell  (ex  =  458  nm,  em  =  615nm) 
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4.3.4 Cell Mapping Using Resonance Raman 
 
Raman mapping is a technique which generates detailed images based 
on a compound‟s Raman spectrum and is discussed in greater detail in section 
1.3.3.  A complete map is acquired by collecting Raman spectra in a step wise 
fashion from a grid established over the area to be imaged.  Each spectrum 
forms a pixel of the final image and similar spectra/pixels are then used to 
generate false colour images.  From an image, it is possible to interrogate a 
compound‟s structure as well as its distribution, which is not possible with 
standard fluorescence microscopy.
[59, 60]
    
 
In order to investigate the dye‟s distribution and structure following uptake 
by living cells, Raman maps were obtained of [Ru(bpy)2htrz-arg8]
9+
 under 473 nm 
laser excitation in both SP2 and CHO cells.  To investigate the presence of the 
complex within the cell, individual cells were analysed using resonance Raman 
mapping.  This was achieved by recording the Raman spectra at a series of 
intervals across the cell.  The step size was set at 0.5 m and the grid size was 
set at 21 m.  
 
The successful transport of [Ru(bpy)2htrz-arg8]
9+
 across the plasma 
membrane evident from confocal fluorescence microscopy is confirmed from a 
Raman map of a myeloma cell and is shown in figure 4.42.   Shown in figure 4.41 
is a white light image of the myeloma cell prior to mapping.  As the myeloma cells 
investigated are a suspension cell line, it was possible that the cell may drift and 
change it‟s position throughout the scan.  To ensure this did not happen, the cell 
was held between two cover slips, ensuring a uniform position and more accurate 
final map.  The resonance Raman image was generated by analysing the 
intensity of the 1490, 1561 and 1601 cm
-1
 bands at each point in the map.  The 
plot intensity represents the intensity of these vibrational modes and therefore the 
relative dye concentration throughout the cell.  Shown in figure 4.44 is a Raman 
map of a CHO cell which clearly confirms that the dye penetrates and is 
distributed throughout both cell types investigated.   
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The most intense Raman signal, corresponding to the greatest 
concentration of dye, can be observed in the center of the cell (represented by 
the pink and yellow regions).  The least intense peaks (indicated by the blue 
regions) were observed outside the cell membrane which is a further indication of 
the dye‟s cell penetrating ability.  While the mapping of three peaks is shown for 
both maps, each cell line was mapped from individual peaks across the Raman 
spectra, with each band showing the same map.  
  
Shown in figure 4.43 is an overlay of individual spectra from selected 
regions of varying Raman intensity within an SP2 cell.  The greatest signal 
intensity according to Raman signal was found to be at the center of the cell, but 
there was little difference between the peak frequency of the three regions, 
suggesting the dye exhibits little change due to environmental pH in these 
regions.  In both cell lines, the dye appeared to localize in the centre of the cell, 
which was not expected from the results obtained from confocal imaging.  A 
possible reason for this may be the low resolution of the Raman maps.  The 
maps were generated from spectra from 20 designated pixels of an image, a 
higher resolution could be generated with a greater number of data points across 
each cell.  The image is rather low resolution therefore and this may also account 
for the similarities in the spectra across the sample.  A disadvantage of Raman 
and to a greater extent Raman mapping is that it is a slow process when 
compared to other spectroscopic techniques.  Acquisition of Raman maps can, in 
some cases, extend to several days.
[121]
  Each map was acquired in 
approximately 20 minutes; the slow speed of the technique limits the level of 
detail of each cell map primarily for two reasons: the relatively long dwell time of 
the laser on a single spot required is potentially damaging to both the cell and the 
dye; the short lifetime of the cells in question when removed from an incubator.  
Furthermore, this technique as it currently stands is not appropriate for studying 
dynamic processes in cells.  However one way around is to combine this method 
directly with fluorescence to identify the region of interest and just collect Raman 
from selected regions, e.g. organelles.  While the results shown here confirm the 
cell-penetrating ability of the octoarginine peptide and also highlights the 
effectiveness of our dye as a resonance Raman probe, it did not allow for a clear 
distinction of specific cellular regions.   
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Figure 4.41: Image of myeloma cell mapped with [Ru(bpy)2htrz-arg8]
9+
 
 
 
 
    3 
 
 
          1 
   2 
 
 
 
 
 
Figure 4.42: Raman intensity plot of a live SP2 myeloma cell constructed from the 
intensity of the peak at 1561 cm
-1
 in the spectrum of [Ru(bpy)2htrz-arg8]
9+
 (2.8 x 
10
-5
 M) after excitation at 473 nm. The colour bar indicates the relative Raman 
signal intensity that decreases from top to bottom.  
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Figure 4.43: Raman Spectra of [Ru(bpy)2htrz-arg8]
9+
 (2.8 x 10
-5
 M) after excitation 
at 473 nm inside the myeloma cell. Shown are individual spectra from regions of 
varying Raman intensity from map shown in Figure 4.42.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.44: Raman intensity plot of a live CHO cell incubated with [Ru(bpy)2htrz-
arg8]
9+
 (2.8 x 10
-5
 M) for four hour in PBS (pH 7.4) at 37C and constructed from 
the intensity of the peak at 1561 cm
-1
 in the spectrum of [Ru(bpy)2htrz-arg8]
9+ 
after 
excitation at 473 nm. The colour bar indicates the relative Raman signal intensity 
that decreases from top to bottom.  
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4.3.5 Photostability 
 
4.3.5.1 Photostability of ruthenium complexes in myeloma cells 
 
  Photostability is a phenomenon which describes the ability (or inability) of 
a molecule to fluoresce after it has undergone repetitive excitation cycles.  Most 
fluorophores can undergo a limited number of excitation and emission cycles, 
before their emission fades due to photodecomposition and eventually the 
fluorophore becomes inactive.
[122]
  Many organic based molecular fluorophores 
commonly used for imaging purposes typically are susceptible to photobleaching 
when used in laser scanning microscopy.  Such organic probes are not very well 
suited to examine environmental sensitivity in biological samples or to follow long 
lived dynamic processes such as membrane diffusion, protein rotation and 
protein folding.  A key advantage of ruthenium(II) complexes is that they do not 
tend to exhibit such rapid degradation and have been reported to retain more 
than 50% of their initial luminescence intensity from within cells under 20 minutes 
continuous irradiation using a 458 nm argon ion laser line.
[123] 
 
As reported in section 3.2.4.4, upon monitoring the MLCT band of 
[Ru(bpy)2(htrz)]
+
 and [Ru(bpy)3]
2+
, both complexes found to reduce by 
approximately 20% each over six hours upon irradiation with UV light.  In order to 
determine the photostability of [Ru(bpy)2(htrz)]
+
 in a cellular environment, the 
peptide conjugate was first internalized into SP2 myeloma cells.  To encourage 
photobleaching, the 458 nm line of an argon ion laser was used for excitation at 
100% transmission (overall power did not exceed 10 milliwatts).  The sample was 
irradiated for 10 μs cycles, allowed to recover for and then irradiated again.  In total, 
each sample was exposed to a 10 μs cycle six times in a second and were imaged 
for over 600 seconds.   
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To compare the photostability of the dye with another ruthenium(II) complex 
and an organic reference, the experiment was separately carried out using 
[Ru(bpy)3]
2+
 and 3,3'-dihexyloxacarbocyanine iodide (DiOC6(3)).  Shown in figure 
4.51 is the photodegradation of the emission intensity of the three dyes under the 
conditions described.  Shown in figure 4.52 is the loss of emission intensity of 
[Ru(bpy)2htrz]
+ 
in the membrane of an SP2 cell, before (a) and after (b) irradiation 
(a separate cell is shown before (c) and after (d) irradiation in the same figure).  
 
As expected, the organic DiOC6(3) was found to be almost completely 
photobleached after less than 150 seconds, while both ruthenium complexes 
were still found to luminesce after 800 seconds.  Surprisingly, there was no 
distinct difference in the extent of bleaching experienced between [Ru(bpy)2htrz]
+ 
and [Ru(bpy)3]
2+
.   
 
The ruthenium – triazole complex was expected to have far greater 
photostability due to the strong  - donor properties of the deprotonated triazole 
ligand, which induces strong ligand ﬁeld splitting in the complex.[110, 112]  The 
photostability of the triazole complex may be better demonstrated by varying the 
parameters of this experiment, such as increasing and decreasing the dwell time 
while bleaching or altering the number of excitation cycles the sample is exposed 
to.  Further bleaching experiments could focus on solid samples of both 
complexes, which may provide a greater insight into the photostability of each 
complex. 
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Figure 4.51: Luminescence emission intensity of [Ru(bpy)2htrz]
+ 
(20μM), 
[Ru(bpy)3]
2+
  (20μM) and DiOC6(3) (5μM) in SP2 cells upon 10μs 100% irradiation 
cycles using a 458 nm argon ion laser line
 
 
Figure 4.52: Luminescence images (ex = 458 nm, em = 615nm) of SP2 myeloma 
cell incubated with [Ru(bpy)2htrz-arg8]
9+
 (20 M) in PBS (pH 7.1) before (a) and 
after (b) 100% irradiation cycles using a 458 nm argon ion laser line 
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4.4   Conclusion  
 
The results presented in this chapter report on the ability of the ruthenium 
peptide conjugate to diffuse passively across the cell membrane of two cell lines, 
SP2 myeloma and Chinese Hamster Ovary cells.  Importantly, the parent 
ruthenium complex in the absence of peptide cannot penetrate the cellular 
membrane and only upon permeablizing the cell with Triton (1% v/v) can 
[Ru(bpy)2htrz]
+
 achieve this. 
 
 
The peptide conjugated ruthenium complex was found to have a short lifetime 
(149 ns) relative to other Ru polypyridyl complexes (s scale).  As a result, it was 
difficult to differentiate various components of the cell using fluorescent light 
imaging.  Resonance Raman mapping was used to investigate the presence of 
the complex within both cell types, by analysing individual cells. The most intense 
Raman signals, corresponding to the greatest concentration of dye, were 
observed in the center of each cell.  Utilising commercially available specifically 
targeting cellular probes, the location of [Ru(bpy)2htrz-arg8]
9+
 within both cell lines 
was investigated.  The dye was found to bind to non specific organelles in the 
SP2 cells and was mainly found outside the nucleus of CHO cells, presumably in 
the endoplasmic reticulum. 
 
The uptake speed in both cell types was found to be temperature 
dependent, which is consistent with endocytosis.  Although internalization was 
effective in both cell lines, the significant difference in uptake speed and 
localization suggests alternative uptake pathways in each cell line.  However, the 
different uptake speeds may arise from the difference in cell physiology between 
the SP2 and CHO cell lines. 
 
The reasons for alternative uptake pathways were not determined in this 
thesis, as the pathway dependencies observed cannot be explained by complex 
size, or by the composition of the complex as both cell lines were treated with 
one dye at identical concentrations.   
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While the reasons for cell line dependence remain unconfirmed, these 
results showing different uptake speed and localization of [Ru(bpy)2htrz-arg8]
9+
 in 
SP2 and CHO cell lines infer that cell physiology is critical in complex 
internalization. 
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Chapter 5: Conclusions and Future Work    
 
5.1 Conclusions and Future Work 
 
 This MSc thesis focused on the synthesis of ruthenium probes which 
contained functional groups suitable for bioconjugation and detailed 
photophysical characterisation of these complexes as a function of their 
functional group.   In the second part of this thesis, the spectroscopy, 
photophysics and cell uptake of a related Ru(II) polypyridyl complex conjugated 
to a polyarginine peptide was explored.   
 
Chapter 3 detailed the synthesis and detailed comparative spectroscopic, 
photophysical and redox characterisation of two ruthenium (II) complexes of 
[(Ru(NOphen)2PicNH2)]
2+
 and [(Ru(NOphen)2PicCOOH)]
2+
 from a family based 
on pic (define) developed in our group containing two nitrophenanthraline ligands 
and only differed in their terminal functionality on the pH sensitive pic ancillary 
ligand. The amino and carboxy terminated ruthenium complexes were compared 
using spectroscopic methods, with the shifts in the absorbance and emission 
spectra of [(Ru(NOphen)2PicNH2)]
2+
 consistent with the electron donating nature 
of the amino substituent.  Transitions at 340 nm were found to be pH dependent 
and were attributed to π-π* transitions of the [pic-R] ligands, which contains two 
ionisable protons on the imidazole ring, with a slight shift in this peak for the 
amino functionalised complex.  
 
 A further aim in chapter 3 was to produce a ruthenium – peptide conjugate 
with both an oxygen or pH sensitive and insensitive fluorophore as a self-
referenced sensor for confocal microscopy.  The purpose of synthesising both 
amino and carboxy functionalised luminophores was to allow increase the 
possible conjugation routes for this complex with a sensor.  Attempts to produce 
a BODIPY – conjugated ruthenium complex proved unsuccessful, with the target 
molecule never successfully isolated.  Conjugation of the ruthenium complex to a 
BODIPY probe was attempted ten times via an EDC/NHS coupling reaction.  
Despite this being a well known coupling technique, the only products recovered 
were starting materials.   
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 Chapter 3 also described the optical characterisation of  [Ru(bpy)2htrz]
+
, a 
ruthenium – bipyridyl complex containing a triazole ancillary ligand.  The ground 
and excited state pKa, Raman spectroscopy and photostability of the complex 
was investigated under white light irradiation.  Deprotonation of the complex 
above pH 8.5 led to a spectral shift due to the stabilising electrostatic interaction 
between the MLCT generated bpy anion radical and the extra positive charge of 
the triazolium.  Signature bipyridyl vibrational Raman modes were observed 
using 458, 488 and 514 nm laser lines, with no significant changes between the 
data, suggesting the lowest energy optical transition arises from a ruthenium (dπ) 
to bipyridyl ligand (π*) MLCT transition.  The effect of conjugation of the peptide, 
octaargine to the carboxy terminus of this complex on the optical properties of the 
complex was also explored and the influence found to be minimal 
 
The conjugation of ruthenium complexes to cell penetrated peptide has 
previously reported by our group, with these probes capable of passively 
transporting across the cell membrane. In chapter 4 confocal microscopy was 
used to investigate the interaction of [Ru(bpy)2htrz]
+
 and its octaargnine 
conjugate on two mammalian cell lines; SP2 myeloma and CHO cells.  It was 
found that the parent complex [Ru(bpy)2htrz]
+
 failed to transport across the cell 
membrane.  The peptide conjugate of the complex was then added to a 
suspension of SP2 cells at 37°C, where it was found to rapidly penetrate the cell 
membrane.  is the uptake rate was approximately four times faster than previous 
ruthenium probes reported and to our knowledge one of the fastest uptake rates 
for such metal complexes.  Uptake of the ruthenium peptide conjugate in CHO 
cells was also investigated using confocal microscopy but the dye was only 
observed in the cell after four hours.  The uptake in both cell lines was 
determined to be temperature dependent, which is indicative of an activated 
process such as endocytosis; however the significant difference in uptake speed 
suggests alternative uptake pathways in each cell line. 
 
 The localization of [Ru(bpy)2htrz-arg8]
9+
 in SP2 and myeloma cells was 
also determined to differ when cells were stained with the complex and then 
counter stained with nuclear targeting and endoplasmic reticulum targeting 
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probes.  Upon counter staining both cell lines with DiOC6, [Ru(bpy)2htrz-arg8]
9+ 
was found not localize in the endoplasmic reticulum of myeloma cells, but 
appears to localize in the endoplasmatic reticulum of CHO cells.  The nuclear 
targeting DAPI probe was used to determine that [Ru(bpy)2htrz-arg8]
9+
 localizes 
just outside the nucleus in both SP2 and CHO cells.  As dye concentration and 
imaging conditions were kept constant, these results infer that cell physiology is 
critical in complex internalization. 
 
Resonance Raman mapping was also used to confirm the successful 
transport of [Ru(bpy)2htrz-arg8]
9+
 across the plasma membrane of both SP2 and 
CHO cells.  The resonance Raman image was generated by analysing the 
intensity of the 1490, 1561 and 1601 cm
-1
 bands at each point in the map.  In 
both cell lines, the dye appeared to localize in the centre of the cell, which was 
not expected from the results obtained from confocal imaging. 
 
Future work emerging from this thesis should focus on developing a new 
approach to conjugate the ruthenium – bisnitrophenanthraline – pic complex to 
the pH and O2 insensitive BODIPY probe.  The BODIPY – NHS reaction may 
proceed using a different solvent system, for example DMF or a DMF water 
mixture.  Alternatively, the conjugation may become more sterically favoured by 
attaching the BODIPY dye to a peg – linker with an amino or carboxyl terminus, 
before coupling to the ruthenium complex.  The exploitation of a different coupling 
reagent is another possibility; [HATU] has been used for the robust coupling of 
peptides and allows greater experimental flexibility than the EDC/NHS coupling. 
 
There is currently an intense interest in the use of metal complexes in live 
cell imaging and further work can expand on both the results and techniques 
shown here.  Confocal microscopy confirmed [Ru(bpy)2htrz-arg8]
9+
 passively 
crossed the cell membrane of both SP2 and CHO cells yet the results suggested 
that cell physiology may affect the uptake mechanism.  The uptake of the dye in 
both cell lines may be further investigated using AlexaFluor 350, which emits at 
425 nm and selectively stains the plasma membrane.  This could be used to gain 
a more precise idea of the time taken for the dye to transport through the 
membrane for each cell type.  The Raman mapping described was limited by 
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image resolution and acquisition time, which if increased, could lead to far more 
informative images.  While whole cell mapping involves monitoring an area of at 
least 100 m, focusing on individual cellular compartments may produce a 
greater insight into the localization and concentration of a metal complex within a 
cell. 
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1
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Figure A2: 
1
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Figure A3: 
1
H-NMR of [PicCOOH] ligand in DMSO-d6 
 
Figure A4: 
1
H-NMR of [BODIPY] ligand in DMSO-d6 
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Figure A5: 
1
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 ligand in DMSO-d6 
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Figure A7: COSY 45 Spectrum of [Ru(NO2phen)2Cl2]
2+
 ligand in DMSO-d6 
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1
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 ligand in DMSO-d6 
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Figure A9: 
1
H-NMR of [Ru(phen)2COOH]
2+
 ligand in MeOD 
 
 
 
Figure A10:  Mass Spectrum of [Ru(phen)2COOH]
2+
  
 
 
 vi 
 
Figure A11:  
1
H-NMR spectrum of [Ru(NO2phen)2COOH]
2+
 in MeOD 
 
 
Figure A12: COSY 45 spectrum of [Ru(NO2phen)2COOH]
2+
 in MeOD 
 
 vii 
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Figure A15: COSY 45 spectrum of [Ru(NH2phen)2COOH]
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Figure A17: 
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